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Abstract 
 
Traumatic experiences in early life are risk factors for the development of behavioural 
and emotional disorders.  Such disorders can persist through adulthood and have been 
reported to be transmitted across generations.  Here, an epigenetic mechanism for the 
transgenerational inheritance of behavioural alterations caused by early stress is 
described.  Chronic and unpredictable maternal separation, a mouse model of early 
stress, induces enhanced novelty-seeking and depressive-like behaviours in adulthood.  
Aspects of these behaviours can be reversed by environmental enrichment during 
adolescence only, or to a greater extent, when enrichment occurs throughout 
adolescence and adulthood.  Interestingly, behavioural abnormalities induced by early 
stress are transmitted to the offspring of animals exposed to maternal separation, 
despite being reared under normal conditions. Transmission is associated with altered 
DNA methylation in the CpG island of several genes including corticotropin-releasing 
factor receptor 2 (CRFR2), methyl CpG-binding protein 2 (MeCP2) and cannabinoid 
receptor 1 (CB1), in both the germ line of separated animals and the brain of the 
offspring. Altered DNA methylation in the brain of the offspring is associated with 
changes in gene expression.  Together, these findings highlight the importance of DNA 
methylation for the inheritance of behavioural disorders induced by early stress.  
  xi 
Résumé 
 
Des traumatismes psychologiques et des conditions de stress subis pendant lʼenfance 
sont des facteurs de risque pour le développement de troubles comportementaux et 
émotionnels chez lʼhomme. De tels troubles ont souvent la caractéristique de persister 
jusquʼà l'âge adulte et de plus, dʼêtre transmis aux générations suivantes. Parce quʼils 
sont provoqués pas des facteurs environnementaux, leur expression et leur transmission 
sont postulés être dépendants de mécanismes dʼépigénése. Lʼétude moléculaire de ces 
mécanismes est difficile et nécessite la mise au point de modèles animaux. Ce travail de 
thèse sʼest attaché à développer un modèle de souris basée sur la séparation maternelle 
chronique et imprévisible reproduisant les effets de traumatismes et de stress précoces 
sur le comportement. Ce modèle manifeste de sévères comportements impulsifs et 
dépressifs chez l'adulte, qui sont transmis aux générations suivantes. Certains aspects 
de ces comportements peuvent être reversés par l'enrichissement environnemental 
pendant l'adolescence et à l'âge adulte, et par des traitements pharmacologiques. 
Lʼétude de ces mes mécanismes de transmission démontre quʼils sont associés à une 
altération de la méthylation de l'ADN dans des îlots CpG de plusieurs gènes candidats, 
tels que le gène codant pour le récepteur du facteur corticotropique 2 (CRFR2), et ceux 
codant pour le methyl-CpG binding protein 2 (MeCP2) et le récepteur au cannabinoide 1 
(CB1). Ces altérations affectent les cellules germinales mâles des animaux séparés, 
ainsi que  le cerveau de leur progéniture, qui conduisent à des changements de 
l'expression des gènes dans le cerveau. Dans son ensemble, ces découvertes mettent 
en évidence l'importance de la méthylation de lʼADN comme mécanisme de transmission 
transgénérationelle de troubles comportementaux induits par des traumatismes et stress 
précoces. 
   1 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.0 Epigenetics and Epigenetic Inheritance1 
 
                                                        1 Excerpts of the introduction included in Franklin and Mansuy (submitted) and Graeff, Franklin 
and Mansuy (submitted).  See Appendix. 
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1.1 Introduction to Epigenetics and Heritable Epigenetic Variation 
 
A core concept in biology is that it is the sequence of nucleotides in the genome which 
determines the traits of an organism.  It is further accepted that heritable information is 
transmitted to offspring through these sequences of DNA and that any changes 
occurring on the chromosome during this process are random, and not due to 
environmental influences.  However, recent work in the field of epigenetics has proposed 
that inheritance of the DNA sequence is not the only mechanism underlying the 
transgenerational transmission of physical, behavioural, and emotional traits.   
 
The term “epigenetics” was coined by Conrad Waddington in the 1940s to describe the 
gene-environment interactions that ultimately lead to a particular phenotype (Waddington 
1942).  Waddington originally used this term in a developmental context to describe the 
permanent changes in gene activation and deactivation required for the differentiation of 
cell types.  While the mechanism for these changes was unknown at the time, it is now 
suggested to be the result of post-translational chemical modifications to the DNA itself 
(Scarano 1971; Holliday and Pugh 1975; Riggs 1975).  Thus, the current use of the term 
has shifted focus to emphasize the heritable changes (both mitotic and meiotic) in gene 
expression which are not due to the sequence of nucleotides, but rather to DNA and 
chromatin modifications.  These modifications include biochemical modifications of the 
DNA or of the core histones, variant histones, DNA looping, and higher-order chromatin 
structure (Mager and Bartolomei 2005).  Of these, the biochemical modification of 
nucleotides, more specifically DNA methylation, is thought to serve as a mark for the 
establishment and maintenance of the chromatin structure (Jaenisch and Bird 2003; 
Wang, Wysocka et al. 2004). The establishment or maintenance of DNA methylation 
patterns is regulated by DNA methyltransferases (DNMTs), methyl CpG-binding 
proteins, and most recently demonstrated, small RNA molecules (Cheng 1995a; Cheng 
1995b; Morris, Chan et al. 2004; Fan and Hutnick 2005; Matzke and Birchler 2005; 
Wassenegger 2005; Zemach and Grafi 2007; Chahrour, Jung et al. 2008). 
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1.2 DNA methylation 
 
DNA methylation has many well-known roles in the mammalian organism.  During 
development, DNA methylation is necessary to establish tissue-specific gene expression 
patterns (Scarano 1971; Holliday and Pugh 1975).  Additionally, X-chromosome 
inactivation, in which one X-chromosome in females is silenced (Riggs 1975; Delaval 
and Feil 2004) (see below section 1.2.1), and parental imprinting, in which one parental 
allele is inactivated by DNA methylation (see below section 1.3.1), have been particularly 
well studied. 
 
In mammals, the most common epigenetic modification of the DNA strand involves the 
enzymatic transfer of a methyl group to the fifth position of cytosine residues in CpG 
dinucleotides (a cytosine immediately followed by a guanine) (Richards 2006).  Across 
the genome, CpG dinucleotides are largely methylated, while the opposite is true in 
CpG-dense regions known as CpG islands (Bird 1986; Gardiner-Garden and Frommer 
1987).  The methylation level of CpG islands found within or near promoter regions are 
known to affect the transcription rate of the gene by altering local chromatin structure 
and thereby modifying the access that transcription factors have to the underlying DNA 
strand (Richards 2006). 
 
1.2.1 The establishment and maintenance of DNA methylation 
 
DNMTs are enzymes which catalyze the methylation reaction.  Currently, there are four 
known DNMTs in mammals.  DNMT1, known as a maintenance methylase, displays a 
preference for hemi-methylated CpGs occurring following DNA replication in the 
daughter strand, and acts to maintain the methylation patterns of the parent strand 
(Lyko, Ramsahoye et al. 1999).  The biological role of DNMT2 is rather controversial, as 
it is currently unclear whether its main role is as a nuclear DNA methyltransferase, or as 
a cytoplasmic RNA methyltransferase.  A recent paper has shown that the latter function 
is true in zebrafish development (Rai, Chidester et al. 2007).  Moreover, human DNMT2 
was shown to act as a RNA methyltransferase using a mechanism similar to DNA 
methyltransferases (Goll, Kirpekar et al. 2006; Jurkowski, Meusburger et al. 2006).  
Additionally, DNMT2 mutant mice and Drosophila lack phenotypes (Okano, Xie et al. 
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1998; Kunert, Marhold et al. 2003).  DNMT3A and 3B, known as de novo methylases, 
play a critical role in determining methylation patterns during embryogenesis (Okano, 
Bell et al. 1999).    Recently it has been demonstrated that DNMT3A/B may also have 
demethylating activity (Metivier, Gallais et al. 2008).   
 
RNA-directed DNA methylation is well established in plants.  However, despite the fact 
that some of the components required for RNA-directed DNA methylation to occur are 
present in mammals, evidence for its occurrence has been limited (Matzke and Birchler 
2005; Wassenegger 2005).  One study in mouse oocytes reports that siRNA knockdown 
of a gene does not involve de novo methylation (Svoboda, Stein et al. 2004).  However, 
there is also one report in human cells of siRNA directed transcriptional silencing 
associated with increased DNA methylation (Morris, Chan et al. 2004).  Obviously, 
further investigation is needed to better clarify what role, if any, RNA plays in the 
establishment of DNA methylation. 
 
Demethylation is known to occur by both passive and active mechanisms.  Passive 
demethylation occurs during DNA replication in the absence of DNMT1.  Active 
demethylation is also known to occur although, in mammals, the mechanism for this has 
not yet been determined.  However, two possible mechanisms for active demethylation 
have been suggested: (1) the direct removal of the methyl group from the fifth position of 
the cytosine residue (Bhattacharya, Ramchandani et al. 1999), and (2) the replacement 
of the methylated cytosine by base excision repair through the directed deamination of 
the methylated cytosine to uracil (Metivier, Gallais et al. 2008).  
 
X-chromosome inactivation provides a clear example of the importance of DNA 
methylation in the regulation of gene transcription in mammals.  In order to compensate 
for differences in gene dosage between males (XY) and females (XX), one X-
chromosome is silenced in female mammals.  In somatic cells, the only RNA to be 
transcribed from the inactive, but not active, X-chromosome is an untranslated RNA 
originating from the X-inactivation center (Xic), the X-inactive specific transcript (Xist) 
(Chang, Tucker et al. 2006).  This gene is required for dosage equalization as it recruits 
repressive chromatin factors and silences one of the two X-chromosomes (Jaenisch and 
Bird 2003). Transcription of the antisense Tsix negatively regulates Xist by regulating 
Chapter 1: Epigenetics and Epigenetic Inheritance 
  5 
chromosome structure at the Xist promoter, thereby protecting one X-chromosome from 
inactivation by Xist.  One of the features of the inactivated X-chromosome is increased 
DNA methylation at the 5ʼ end of genes on the inactive X-chromosome. Thus, while not 
playing a crucial role in the initiation of X-inactivation, the continuous activity of DNMT1 
is suggested to be important in the maintenance of X-inactivation through mitotic cell 
divisions (Panning and Jaenisch 1996).  Indeed, in the case of X-inactivation, the 
accuracy of DNA methylation patterns across mitotic divisions is extremely precise; the 
reversion events per cell division are in the 10-6 range (Kahan and DeMars 1980). 
 
 
1.3 Transgenerational transmission of DNA methylation patterns 
 
There are several examples in which DNA methylation is transmitted across generations.  
The following is a brief discussion of genomic imprinting, paramutation, and epigenetic 
inheritance occurring at two intracisternal A-particle (IAP) retrotransposons.  
 
1.3.1 Genomic Imprinting 
 
Perhaps the most obvious example of the transmssion of DNA methylation patterns 
across generations is imprinting.  Imprinted genes are genes which are expressed from 
only one of two parental alleles; paternally expressed genes are derived from the 
paternal allele and maternally expressed genes are derived from the maternal allele.  
Presently, it is believed that imprinted genes make up about 1% of all autosomal genes 
(for reviews see Reik and Walter 2001; Jirtle and Skinner 2007).  Approximately 80% of 
imprinted genes occur in clusters in chromosomal domains, which also may contain 
imprinting control regions (ICRs).  These ICRs are differentially methylated depending on 
the parental allele, and regulate gene silencing for all the genes in the cluster.  A high 
proportion of imprinted genes contain CpG islands, and direct repeats near or within the 
CpG island.  Further, a high number of imprinted genes are linked with fetal growth 
rates, leading to the theory that genetic conflict underlies the evolution of imprinted 
genes (Moore and Haig 1991).  Thus, a number of maternally expressed genes minimize 
fetal growth, thereby conserving the motherʼs resources and enhancing her overall 
reproductive success, while paternally expressed genes increase fetal growth, thereby 
Chapter 1: Epigenetics and Epigenetic Inheritance 
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encouraging the success of each individual offspring. 
 
Imprints are thought to be present during the development of the germ cell into sperm or 
oocytes, and are thought to be maintained after fertilization.  This is despite the fact that 
there are two large-scale demethylation events occurring, one during gametogenesis 
and one following fertilization during preimplantation development (Reik 2007).  In the 
mouse, the former is completed by embryonic day (E) 12-13 in both sexes and is 
followed by de novo methylation, which begins at the end of the embryonic period and 
continues into postnatal development (Kafri, Ariel et al. 1992; Brandeis, Ariel et al. 1993; 
Brandeis, Kafri et al. 1993; Tada, Tada et al. 1998).  
 
Imprinted genes escape the massive demethylation and de novo methylation during 
gametogenesis.   While the mechanism for this is not well understood, it has recently 
been suggested that the protein Stella (also called developmental pluripotency-
associated 3 (DPPA3) or primordial germ cell 7 (PGC7)) can protect certain maternally 
methylated genes from demethylation (Nakamura, Arai et al. 2007).  Increased levels of 
Stella are present during early primordial germ cell development, are expressed in high 
amounts in oocytes and are transferred to the zygote after fertilization (Nakamura, Arai 
et al. 2007).   
 
Further, the binding of non-histone proteins to ICRs can prevent methylation during 
gametogenesis in one of two alleles, as is the case for the ICR which controls 
expression of the maternally imprinted gene insulin-like growth factor-2 in the mouse 
(Pant, Mariano et al. 2003; Schoenherr, Levorse et al. 2003).  In this case, the ICR is 
methylated during late spermatogenesis, but in oogenesis the ICR is blocked from being 
methylated by the chromatin boundary element binding protein CTCF (Schoenherr, 
Levorse et al. 2003; Fedoriw, Stein et al. 2004).  Additionally, a transgenic mouse model 
of Angelmanʼs syndrome, a disease characterized by prominent laughing and smiling, 
hypermotor behaviour, and stereotypies, has demonstrated that an ICR can both protect 
the Snrpn promoter in the maternal allele from being demethylated after fertilization, and 
the paternal allele from being de novo methylated in the embryo (Shemer, Hershko et al. 
2000).  It has been suggested that the sequence and allele-specific methylation present 
on imprinted genes may be established by miRNAs (Lin, Youngson et al. 2003; Seitz, 
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Youngson et al. 2003).  
 
1.3.2 RNA-mediated paramutation in the mouse 
 
Another well characterized example of the transmission of epigenetic information across 
generations is paramutation.  Paramutation is when the silencing of one allele, by 
interaction in trans with the homologous allele, is meiotically heritable (Ashe and 
Whitelaw 2007).  The large majority of examples of paramutation occur in plants (Ashe 
and Whitelaw 2007; Bond and Finnegan 2007; Chandler 2007).  However, paramutation 
at the Kit locus has now also been demonstrated in the mouse (Rassoulzadegan, 
Grandjean et al. 2006; Wagner, Wagner et al. 2008).  Mice heterozygous for Kit 
mutations display changes in pigment patterns, and reduced Kit mRNA.  It was found 
that a proportion of the offspring of heterozygous Kit mice display this mutant phenotype 
while having a wild-type genotype (Rassoulzadegan, Grandjean et al. 2006).  Abnormal 
RNA in the sperm of Kit mutant mice was suggested to be the cause of this 
phenomenon, as microinjection of sperm of Kit mutant mice or injection of miRNAs which 
target Kit mRNA produced the same effect (Rassoulzadegan, Grandjean et al. 2006).  
This suggests that functional information not encoded in the DNA sequence itself can be 
transmitted through the germ line and that this effect is RNA-mediated. This was further 
developed in a recent paper demonstrating that fertilized mouse eggs injected with 
miRNA targeting a regulator of cardiac growth,  cyclin-dependent kinase 9 (Cdk9), 
induced cardiac hypertrophy in adulthood, and the presence of trace amounts of this 
same miRNA in sperm cells (Wagner, Wagner et al. 2008).  Furthermore, this cardiac 
hypertrophy was inherited across at least three generations, mimicking human 
hypertrophic cardiomyopathy which is often familial (Wagner, Wagner et al. 2008). 
 
1.3.3 Epigenetic Inheritance at Endogenous Alleles (Agouti viable yellow (Avy) and 
axin-fused (AxinFu)) 
 
The agouti viable yellow (Avy) and axin-fused (AxinFu) alleles, referred to as metastable 
epialleles, display inter-individual variability in expression state, as well as intra-
individual variability in the case of Avy.  Thus, as a result of epigenetic modifications, 
there is a distribution of phenotypes which may occur despite being genetically identical.  
The transcriptional activity of these genes are regulated by an IAP retrotransposon.  
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These variations in expression state are not the result of genotypic variation, but rather 
variation in the level of DNA methylation of the IAP long terminal repeat upstream of the 
gene (in the case of Avy) or the IAP within intron 6 of the gene (in the case of AxinFu) 
(Morgan, Sutherland et al. 1999; Rakyan, Chong et al. 2003).  Ectopic expression of the 
Avy protein results in yellow fur, obesity, diabetes and increased tumour susceptibility 
and, in the case of AxinFu, a kinked tail (Reed 1937; Duhl, Vrieling et al. 1994).   
 
Methylation levels of the Avy gene and AxinFu genes can be affected by environmental 
input, specifically maternal diet. The offspring of dams fed a methyl-rich diet have 
increased levels of methylation of both the Avy gene and AxinFu genes and therefore 
display the associated phenotypes (Waterland and Jirtle 2003; Waterland, Dolinoy et al. 
2006).  While naturally occurring variably expressed phenotypes resulting from 
differential methylation can be transmitted to the subsequent generation, paternally in 
the case of Avy, and both maternally and paternally in the case of AxinFu (Morgan, 
Sutherland et al. 1999; Rakyan, Chong et al. 2003; Blewitt, Vickaryous et al. 2006),  the 
diet-induced change in Avy methylation can not be transmitted maternally to the next 
generation (Waterland, Travisano et al. 2007). Thus, while differential methylation of 
these two IAPs can induce variably expressed phenotypes in mice carrying the same 
genes in a transgenerational manner, the environmental impact of maternal diet on 
phenotype is reset between generations.   
 
 
1.4 Aberrant DNA methylation and disease 
 
1.4.1 Aging, cancer and DNA methylation 
 
An emerging theory in the field of cancer research is that there is an increased risk of 
cancer as individuals age due to changes in DNA methylation which occur during the 
aging process.  As cells age, overall methylation levels are decreased (Wilson and 
Jones 1983).  This is thought to be largely the result of a progressive loss in efficiency of 
DNMT1 and thus an increase in passive demethylation (Lopatina, Haskell et al. 2002).  
Global DNA hypomethylation is linked to carcinogenesis because it is thought to induce 
aberrant gene expression, chromosomal instability, reactivation of retrotransposons, and 
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the loss of imprinting (Wilson, Power et al. 2007).  In addition to the general 
hypomethylation, there are also localized increases in methylation in the CpG islands 
surrounding gene promoters (Richardson 2002; Fraga, Agrelo et al. 2007).  It has been 
suggested that this increase in methylation of the CpG island is due to overexpression of 
DNMT3b that may occur as a compensatory mechanism for the general loss of 
methylation in the cell (Fraga, Agrelo et al. 2007).  This hypermethylation in the CpG 
islands is thought to lead to the deactivation of tumour suppressor genes which should 
normally be active (Ahuja and Issa 2000; Fraga, Agrelo et al. 2007). 
 
This provides an interesting treatment strategy in preventative and therapeutic medicine.  
Indeed, it has been shown that in mice predisposed to developing cancer, reduced DNA 
methylation induced by treatment with a DNMT inhibitor, 5-aza-2ʼ-deoxycytidine, 
decreases the number of intestinal polyps which develop (Laird, Jackson-Grusby et al. 
1995).  5-aza-2ʻdeoxycytidine treatment also reduced cell proliferation via an apoptotic 
mechanism in three different prostate cancer cell lines (Walton, Li et al. 2008).  
Interestingly, when these cell lines were treated with a combined treatment of 5-aza-
2ʻdeoxycytidine and an histone deacetylase inhibitor, trichostatin A, this effect was 
amplified (Walton, Li et al. 2008).  Combined treatment with 5-aza-2ʻdeoxycytidine and 
the histone deacetylase (HDAC) inhibitor valproic acid also prevented medulloblastoma 
and rhabdomyosarcoma in mice heterozygous for a tumour-suppressor gene (Ecke, 
Petry et al. 2009).  Studies such as these have now led to the use of DNMT inhibitors, 
like Decitabine 6 and 5-Azacytidine, in the treatment of cancer, and additionally point to 
the synergistic role that promoter CpG island hypermethylation and histone 
hypoacetylation may play in tumour formation. 
 
1.4.2 Cognitive function and DNA methylation 
 
DNA methylation has been shown to play a role in memory formation. This relationship 
has been confirmed experimentally using contextual fear conditioning, a hippocampal-
dependent learning model commonly used in rodents (Phillips and LeDoux 1992).  Here, 
an animal learns to associate a novel context with an aversive stimulus, usually an 
electric shock (Phillips and LeDoux 1992).  DNMT inhibition in the CA1 subregion of the 
hippocampus blocks memory formation when administered following contextual fear 
Chapter 1: Epigenetics and Epigenetic Inheritance 
  10 
conditioning (Miller and Sweatt 2007).  This is consistent with findings that DNMT 
inhibition of acute hippocampal slices blocks the induction of long-term potentiation at 
the Schaeffer collateral synapse (Levenson, Roth et al. 2006).  Additionally, fear 
conditioning itself is associated with methylation of the memory suppressor gene protein 
phosphatase 1 (PP1) and demethylation of the synaptic plasticity genes, reelin and brain 
derived neurotrophic factor (BDNF) (Miller and Sweatt 2007; Lubin, Roth et al. 2008).  In 
turn, these methylation alterations are associated with a decrease in PP1 gene 
expression, an increase in reelin expression, and exon-specific alterations in BDNF gene 
expression (Miller and Sweatt 2007; Lubin, Roth et al. 2008).  
 
Fittingly, many of the genetic diseases in humans linked to aberrant methylation are 
associated with intellectual disabilities.  Germline inheritance of epimutations underlie a 
variety of diseases characterized by mental retardation and associated with abnormal 
genomic imprinting, including Angelmanʼs syndrome, Prader-Willi syndrome, and 
Beckwith-Wiedemann syndrome (Egger, Liang et al. 2004).  It is also the germline 
mutation of methyl CpG-binding protein 2 (MeCP2), an X-linked methyl-CpG-binding 
domain protein, which results in the most common form of mental retardation in young 
girls, Rett syndrome.  
 
1.4.3 Psychiatric disorders and DNA methylation  
 
Depression 
Depression is a common multifaceted mental disease characterized by pessimistic 
thoughts, reduced vitality and anhedonia. This chronic illness affects roughly five per 
cent of the US population and is difficult to treat; only half of depressed patients show 
complete remission (Berton and Nestler 2006; Tsankova, Renthal et al. 2007). One of 
the major questions in regard to therapies used for the treatment of depression is the 
delayed response between the onset of treatment and amelioration of the symptoms. 
This suggests the involvement of epigenetic modifications in the therapeutic actions of 
antidepressant treatments, and as a consequence, epigenetic dysregulation as an 
underlying mechanism in the etiology of depression. 
 
There is evidence for the influence of antidepressant treatments on DNA methylation. 
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Chronic antidepressant treatment has been demonstrated to increase methyl MeCP2 
and methyl binding domain protein 1 (MBD1), two proteins which bind methylated CpG 
dinucleotides and thereby act as either a transcriptional activator or repressor in the 
rodent brain (Cassel, Carouge et al. 2006). The antidepressant-dependent increase in 
MeCP2 is specific to gamma aminobutyric acid (GABA)-ergic interneurons (Cassel, 
Carouge et al. 2006). This finding is of particular interest, since abnormal GABAergic 
transmission and abnormalities in GABA-related gene methylation has been linked with 
suicide and major depression. Depressed patients who had died from suicide display 
higher methylation levels in the GABA-A α1 receptor subunit promoter and increased 
DNA methyltransferase 3b (DNMT3b) mRNA expression and protein levels in the 
prefrontal cortex when compared to control individuals who died of other causes 
(Poulter, Du et al. 2008). This suggests the intriguing possibility that antidepressant 
treatments specifically target the epigenetic machinery in cell types affected by 
depression.  
 
Schizophrenia  
 
Schizophrenia is a debilitating mental disorder, affecting approximately one percent of 
the US population, 18 years old or more (Regier, Narrow et al. 1993). Schizophrenia is 
characterized by two main psychotic symptoms: positive symptoms such as delusions 
and hallucinations, and negative symptoms such as social withdrawal, lack of motivation, 
and overall apathy. While the causes of schizophrenia are not well understood, they are 
likely to involve both a multigenic predisposition and environmental factors occurring 
during pre- and postnatal development. Accordingly, the concordance rate for 
schizophrenia in monozygotic twins is approximately 50 percent (Singh, Murphy et al. 
2002). The question of how the environment can influence the development of 
schizophrenia is still open. However, there is increasing evidence for the role of aberrant 
epigenetic profiles in the pathogenesis of this disease, with the majority of the evidence 
pointing to abnormal GABAergic neurotransmission in cortical areas (Costa, Chen et al. 
2009).   
 
The first line of evidence concerns reelin, a glycoprotein expressed both during 
development and in adult GABAergic neurons that is important for appropriate neuronal 
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migration during brain development, and which has been linked with schizophrenia 
pathology (Fatemi 2005; Costa, Chen et al. 2009). Post-mortem samples taken from 
brains of schizophrenic patients indicate significantly reduced reelin mRNA expression 
and protein levels in several different brain regions, despite normal overall neuronal 
numbers (Impagnatiello, Guidotti et al. 1998; Guidotti, Auta et al. 2000). Since the reelin 
promoter contains a large CpG island, this suggests that DNA methylation in this 
promoter region may be particularly important in establishing its expression levels (Chen, 
Sharma et al. 2002; Tsankova, Renthal et al. 2007). Reelin expression is indeed 
sensitive to manipulations of DNA methylation, suggesting that lower reelin expression in 
schizophrenic patients may be the result of hypermethylation in the promoter region of 
the reelin gene. Thus, in vivo, repeated methionine administration increases methylation 
of the reelin promoter, induces binding of MeCP2 to the reelin promoter, and 
downregulates reelin expression (Tremolizzo, Carboni et al. 2002; Dong, Agis-Balboa et 
al. 2005), and in vitro administration of a methylation inhibitor, 5-aza-2ʼ-deoxycytidine, 
increases its expression (Chen, Sharma et al. 2002).  
 
Further evidence for the involvement of increased DNA methylation in the GABAergic 
dysfunction observed in schizophrenic patients involves glutamate decarboxylase 
(GAD67), an enzyme that catalyzes the production of GABA. GAD67 mRNA expression 
and protein levels are downregulated in cortical structures of schizophrenic patients 
(Impagnatiello, Guidotti et al. 1998; Guidotti, Auta et al. 2000) and this is correlated with 
increased methylation of the GAD67 promoter in prefrontal cortical samples taken from 
post-mortem brains of schizophrenic patients (Huang and Akbarian 2007).  
 
In addition to the GABAergic system, increased methylation of the CpG island of an 
oligodendrocyte-specific transcription factor, sex-determining region Y-box containing 
gene 10 (SOX10), and decreased expression of SOX10 (Iwamoto, Bundo et al. 2005), 
was observed in brains of schizophrenic patients, providing a possible mechanism for 
the oligodendrocyte abnormalities observed in schizophrenic patients.  
 
The involvement of abnormal hypermethylation of promoters such as reelin, GAD67, and 
SOX10, is suggested to be caused by elevated levels of s-adenosylmethioninne (SAM), 
and increased expression of DNMT1 mRNA observed in the brain of schizophrenic 
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patients (Veldic, Guidotti et al. 2005; Guidotti, Ruzicka et al. 2007). Accordingly, SAM 
administration per se can induce psychotic episodes in some schizophrenic patients 
(Antun, Burnett et al. 1971). Due to the involvement of aberrant hypermethylation in 
schizophrenic patients, DNMT inhibitors have been suggested as potential therapeutic 
agents for this disease (Chen, Sharma et al. 2002; Costa, Chen et al. 2002; Levenson 
and Sweatt 2005). 
 
While in the GABAergic system and in oligodendrocytes several instances of 
hypermethylation have been demonstrated in schizophrenic patients, in the 
dopaminergic system there is also evidence of hypomethylation. Increased activation of 
catechol-O-methyltransferase (COMT), an enzyme involved in the degradation of 
neurotransmitters like dopamine, epinephrine, and norepinephrine, is associated with 
impairments in attention, executive cognition, and working memory, as well as an 
increased risk of several psychiatric disorders including schizophrenia (van Vliet, Oates 
et al. 2007). Reduced methylation of the COMT promoter is present in the frontal lobe of 
schizophrenia patients, and this is associated with increased activation of the gene 
(Abdolmaleky, Cheng et al. 2006). Moreover, aberrant methylation of genes within the 
dopaminergic system has also been observed in monozygotic twins studies. In one 
study, methylation profiles upstream of the dopamine D2 receptor was investigated in 
two sets of twins, one concordant and one discordant for schizophrenia. Of the 
discordant twins, the affected twin was epigenetically more similar to the twins 
concordant for schizophrenia than to his unaffected brother, suggesting that DNA 
methylation is playing an important role in the development of this disorder (Petronis, 
Gottesman et al. 2003).  
 
1.4.4 Transgenerational transmission of disease states 
 
Many of the diseases associated with aberrant DNA methylation have been shown to be 
transmitted across generations suggesting that there is not only mitotic but also meiotic 
transmission of DNA methylation patterns.  Tumour susceptibility is one trait which has 
been found to be both associated with aberrant DNA methylation and transmissible.  In 
Drosophila it has been demonstrated that an over-activated form of Janus kinase (JAK), 
an oncoprotein, blocks the epigenetic reprogramming which normally occurs in the early 
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embryo (Xing, Shi et al. 2007).  Thus, an overexpression of JAK allows the inheritance of 
aberrant parental DNA methylation, thereby increasing turmor susceptibility in future 
generations (Xing, Shi et al. 2007).   Furthermore, hypermethylation of two tumour-
suppressor mismatch repair genes, MLH1 and MSH2, have been associated with 
hereditary nonpolyposis colorectal cancer, and have been documented in families with 
inheritance of the disease (Herman, Umar et al. 1998; Chan, Yuen et al. 2006; Hitchins, 
Wong et al. 2007).  Additionally, germline hypermethylation of both MLH1 and MSH2 
was found, albeit in a low proportion of cells (Suter, Martin et al. 2004; Chan, Yuen et al. 
2006). 
 
There is also accumulating evidence that chemical toxins have detrimental effects not 
only on those exposed directly to the toxin, but on their offspring.  Diethylstilbestrol is a 
synthetic nonsteroidal estrogen which was originally prescribed to prevent miscarriage in 
those with prior history.  Mothers exposed to diethylstilbestrol during the first trimester of 
pregnancy had daughters with developmental abnormalities and an increased risk of 
developing both breast cancer and a rare form of adenocarcinoma (Palmer, Wise et al. 
2006).  Although the granddaughters of exposed mothers are not yet old enough for a 
full study of the transgenerational effects of diethylstilbestrol exposure to take place, 
there is one reported diagnosis of a 15 year-old girl, whose maternal grandmother was 
exposed to diethylstilbestrol during pregnancy, with a very rare case of small cell 
carcinoma in the ovary (Blatt, Van Le et al. 2003).   The possibility of a transgenerational 
effect of diethylstilbestrol prompted researchers to reproduce this in the mouse.  Similar 
to that seen in humans, perinatal exposure to diethylstilbestrol induced both 
abnormalities in uterine development and uterine cancer in both the F1 and F2 
generation and this was suggested to be the result of abnormal DNA methylation in 
uterine cancer genes (Walker and Haven 1997; Li, Hansman et al. 2003; Newbold, 
Padilla-Banks et al. 2006). 
 
Transgenerational transmission of detrimental effects of endocrine disruptors present in 
our environment has also been demonstrated in rats, this time through both the male 
and female line.  Rats exposed to an endocrine disruptor (vinclozolin, a commonly used 
fungicide in agricultural fruit crops, or methoxychlor, a commonly used pesticide) during 
the period of gonadal sex determination (E8-E15) (F1) exhibit reduced epididymal sperm 
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counts and sperm motility, and increased spermatogenic cell apoptosis (Cupp, Uzumcu 
et al. 2003; Uzumcu, Suzuki et al. 2004).  These traits were transmitted through the male 
germline to male offspring up to three generations downstream (F2-F4) from exposure to 
the toxin, and were associated with aberrant methylation in sperm (Anway, Cupp et al. 
2005).  Exposure to vinclozolin from E8-E14 was also found to induce pregnancy 
abnormalities, including uterine hemorrhage and/or anemia, up to two generations 
downstream from the original exposure in females (Nilsson, Anway et al. 2008).  Besides 
affecting fertility, vinclozolin was also found to increase the incidence rate of tumor 
formation in aging males exposed to vinclozolin prenatally (F1) and their offspring (F2-
F4) (Anway, Leathers et al. 2006). 
 
It is also now becoming clear that poor nutrition or reduced food availability can exert its 
effects across several generations.  For example, women subjected to severe food 
restriction during the last trimester of their pregnancies (the effects of a Nazi embargo on 
food supplies to Western Holland) delivered babies with lower birth weights. This was 
also true for the subsequent generation which was conceived and reared under no 
dietary restrictions suggesting a transgenerational effect of diet on birth weight (Susser 
and Stein 1994). Further, a recent study found that paternal grandfatherʼs and 
grandmotherʼs food supply were linked to mortality risk for grandsons and 
granddaughters, respectively, when reduced food supply was present during the slow 
growth period during mid-childhood in both grandparents or during early pre- and 
postnatal life of the grandmother (Pembrey, Bygren et al. 2006).   
 
These findings in humans have also been demonstrated in controlled experimental 
environments in rats malnourished either before or during gestation, but not following 
delivery (Cowley and Griesel 1966; Zamenhof, van Marthens et al. 1971).  Similar to that 
demonstrated by the Dutch famine in humans, female rats fed a low protein diet prior to 
and during gestation delivered pups with lower body and brain weights, and reduced 
levels of brain DNA and protein than controls.  When these pups themselves had 
offspring, they also had abnormally low brain and body weights (Zamenhof, van 
Marthens et al. 1971).  Additionally, a poor diet before, but not following conception also 
induced low birth weight, slower maturation rate, and poor performance in the Hebb-
Williams maze in offspring two generations downstream from the treatment (Cowley and 
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Griesel 1966).   
 
Clearly, evidence from both animal experiments and epidemiological studies in the 
human population suggest that there are several incidences of transgenerational 
transmission of a disease state induced by the environment.  Recent technological 
advances have identified aberrant DNA methylation resulting from differential 
environments as a possible mechanism underlying this phenomenon.  Furthermore, it 
has been recently demonstrated that a poor postnatal environment, can not only induce 
changes in methylation patterns in the rat brain, but can also result in the 
transgenerational transmission of methylation abnormalities.  Here, pups received 
abusive maternal care, including stepping, dropping, dragging, active avoidance, and  
rough handling, in general, from non-biological dams for a short period daily from 
postnatal day (PND)1-PND7. This treatment results in reduced BDNF expression and 
increased BDNF methylation in the prefrontal cortex in adulthood (Roth, Lubin et al. 
2009).  Moreover, the offspring of females exposed to maltreatment during early life also 
showed increased BDNF methylation in the prefrontal cortex (Roth, Lubin et al. 2009). 
This is especially interesting because, in humans, increased methylation of the BDNF 
gene in the frontal cortex has been previously associated with major psychoses such as 
schizophrenia and bipolar disorder (Mill, Tang et al. 2008).  Thus, this study in rat 
suggests that maltreatment during early development may not only predispose 
individuals to major psychoses, but also their offspring, via transmission of abnormal 
methylation patterns across generations.    
  17 
 
 
 
 
 
 
 
 
 
 
2.0 Persistent Effects of Stress during Early 
Development 
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2.1 Early trauma is a risk factor for psychiatric disorders in adulthood 
 
The extent to which early environment predicts the adult life of an individual is 
controversial, although it is clear that early abuse or trauma continues to affect 
individuals into and throughout their adult life.  Long-term studies have found that infant 
attachment predicts their ability to form appropriate peer relationships, sociability, risk-
taking behaviours, school success and consequently school dropout rate.  This last point 
could be predicted with 77% accuracy based solely on the quality of early care (Sroufe 
2002; Carlson, Sroufe et al. 2004; Harper 2005).  Maltreatment and childhood trauma 
are known to increase the risk of the occurrence of depression and anxiety disorders in 
adulthood (Jaffee, Moffitt et al. 2002; Iversen, Fear et al. 2007; Moffitt, Caspi et al. 2007; 
Heim, Mletzko et al. 2008; Rikhye, Tyrka et al. 2008).  Further, while there is a high level 
of transmission of anxiety disorders and a strong link between parent and child anxiety 
disorders, this can not be explained by parenting alone, but instead can be predicted by 
constitutional factors, like temperament (Weissman, Leckman et al. 1984; Manassis, 
Bradley et al. 1995; Merikangas, Swendsen et al. 1998; Dierker, Merikangas et al. 1999; 
Shamir-Essakow, Ungerer et al. 2005). 
 
The persistence of disorders which may have arisen due to maltreatment in childhood 
drove researchers to investigate whether DNA methylation may play a role.  In the rat, 
the level of maternal care provided has been shown to influence DNA methylation 
patterns in the brain of the pup when adult.  Studies carried out by Meaney and 
colleagues have utilized the naturally occurring individual fluctuation in maternal care 
present in the rat to create two treatment groups, a high licking/grooming and arch-back 
nursing group (ABN-LG) and a low ABN-LG group.  They have shown that pups reared 
with a high ABN-LG dam compared with a low ABN-LG dam have increased 
glucocorticoid receptor (GR) expression in the hippocampus and enhanced 
glucocorticoid feedback sensitivity as adults (Weaver, Cervoni et al. 2004).  This was 
associated with lower DNA methylation in the promoter region of GR and, consequently, 
increased binding of the nerve growth factor-inducible protein-A transcription factor to 
the promoter region of GR (Weaver, Cervoni et al. 2004).  They further showed that all 
effects of high ABN-LG rearing could be reversed in the adult offspring by 
intracerebroventricular infusion of L-methionine, which acts as a methyl-group donor 
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(Weaver, Champagne et al. 2005).  This demonstrates that changes in the epigenome 
established by environment in early development may be reversed by environmental 
stimuli even in adults, emphasizing the plasticity of DNA methylation in the adult brain. 
 
Findings from rodent experiments have led to a recent study in humans which has 
provided evidence that childhood abuse is also associated with abnormal methylation in 
the adult brain (McGowan, Sasaki et al., 2009).  Methylation in the neuron-specific 
glucocorticoid receptor promoter in brains of suicide victims who had undergone 
childhood abuse was significantly higher than both suicide victims who were not abused 
and controls.  This increase in methylation was associated with decreased glucocorticoid 
receptor expression.  Thus, the findings in rodent studies implicating early environment 
in the establishment of methylation patterns has been confirmed in the human 
population.  
 
 
2.2 Maternal separation is a model of early trauma in the rodent 
 
Maternal separation is used as a rodent model of perturbed mother-infant interaction, 
early life deprivation, and/or neglect.  Maternal separation procedures may vary both in 
length (1 to 24 hr), number of separations during the first two weeks following delivery, 
as well as rearing of the control group.  While there are some inconsistencies based on 
the variety of paradigms used, many of these paradigms induce persistent increases in 
anxiety and depressive-like behaviours, as well as changes in the hypothalamic-
pituitary-adrenal axis (HPA axis) response to stressful environments (Huot, Thrivikraman 
et al. 2001; Lehmann, Russig et al. 2002; Romeo, Mueller et al. 2003; Parfitt, Levin et al. 
2004).  Maternal separation has been contrasted with brief periods of separation termed 
handling (10-15 min), which has been found to have the opposite effects of maternal 
separation (i.e., reduced anxiety and HPA axis response) (Boccia and Pedersen 2001; 
Parfitt, Levin et al. 2004).  This has been suggested to be the result of compensatory 
care, including additional licking and grooming, provided to the pups following this brief 
separation. 
 
The effects of maternal separation itself can come from several causes.  Firstly, it may 
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be due to the effect that the separation has directly on the dam.  Evidence for this comes 
from a study demonstrating that the effects of maternal separation on rat pups (in this 
case, HPA axis hypersensitivity) are not present if dams were provided a foster litter 
during the time of the separation (Huot, Gonzalez et al. 2004).  Thus, the stress of the 
separation on the dam may have important implications for her behaviour towards the 
pups upon their reunion, and on stress hormone levels in the milk provided to the pups.  
Secondly, the effects of maternal separation may be due to the effect of maternal 
separation on the pups themselves.  Evidence for this comes from studies showing that 
the effects of maternal separation on rat pups are not present if pups are artificially 
stroked and fed during the separation period (van Oers, de Kloet et al. 1999; Groer, Hill 
et al. 2002).  However, in mice artificial stroking during the maternal separation period 
only partially reversed increased neuronal and glial cell death seen in separated animals 
(Zhang, Levine et al. 2002).  Thus, it is not clear whether the long-lasting effects of 
maternal separation are due to the effect of the separation on the dam, on the pups, or 
perhaps the most likely scenario, some combination of the two. 
 
 
2.3 Adverse Early Environment Induces Increased Risk-Taking Behaviours 
in Adult 
 
While there are conflicting reports as to the effects of maternal separation, several 
studies have demonstrated that maternal separation can lead to increased risk-taking 
and novelty-seeking behaviours: 
• Adult rats previously exposed to six hours of daily maternal separation (PND1 
and PND21) spend more time in the open arm of the elevated plus maze and 
demonstrate lower risk-assessment and increased risk-taking in the concentric 
square field test compared to control rats (Roman, Gustafsson et al. 2006) 
• Adult rats previously exposed to six hours of daily maternal separation (PND6-
21) demonstrate reduced latency to enter into the aversive area of an open field 
compared to control rats (Mathieu, Denis et al. 2008) 
• Adult rats previously exposed to six hours of daily maternal separation (10 days 
during PND1-14) spend more time in the aversive areas of the open field and 
light-dark box compared to control rats (Colorado, Shumake et al. 2006) 
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• Adult rats previously exposed to three hours of daily separation (PND3-15) have 
a reduced latency to leave the closed protected arm of the T-maze compared to 
control rats (Slotten, Kalinichev et al. 2006) 
• Adolescent rats previously exposed to three hours of daily separation (PND1-21) 
spend more time in the open arm of the elevated plus maze than control rats 
(McIntosh, Anisman et al. 1999). 
• Adult mice previously exposed to 24 hr separation on PND9 spend more time in 
the open arms of the elevated plus maze than control mice (Fabricius, Wortwein 
et al. 2008) 
 
 
2.4 Adverse Early Environment Induces Depressive-Like Behaviours in 
Adult 
 
There are many reports of adverse early environment precipitating depressive-like 
behaviours during adulthood.  Rodents exposed to three hours of daily separation during 
either the first two or three weeks post-delivery spend more time floating in the forced 
swim test compared to controls, a depressive-like behaviour in rodents (Ruedi-
Bettschen, Pedersen et al. 2005; Veenema, Blume et al. 2006; Aisa, Tordera et al. 2007; 
Bhansali, Dunning et al. 2007; Lee, Kim et al. 2007; Lambas-Senas, Mnie-Filali et al. 
2009).  Three hours of daily separation during the first two weeks postnatal also induces 
two additional depressive-like behaviours, anhedonia, measured as reduced responsivity 
to pleasurable stimuli (sucrose), and ethanol preference (Huot, Thrivikraman et al. 2001; 
Ruedi-Bettschen, Pedersen et al. 2005). 
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3.1 Rationale 
 
Previous work in our lab has shown that C57Bl6/J mice exposed to a model of early 
stress, chronic maternal separation occurring between postnatal day 1 (PND1) and 
PND14, have long-term behavioural impairments that can be transmitted to the 
following generation (unpublished data).  These are expressed as reduced risk-
assessment and heightened depressive-like behaviours suggestive of a disturbance 
in the regulation of the behavioural response to stressful environments.  Although 
females in litters that were exposed to chronic maternal separation demonstrate 
abnormal responses to novel or aversive environments, they exhibit normal maternal 
behaviour, indicating that transmission of behavioural alterations to their progeny 
occurs irrespective of maternal care.  These results point to  transgenerational 
epigenetic mechanisms underlying the transmission of behavioural traits in female 
pups exposed to chronic maternal separation to their offspring.  
 
 
3.2 Goals of this Study 
 
• To better characterize the behavioural phenotype induced by our maternal 
separation procedure 
 
• To rule out the influence of maternal care as a mechanism for transmission of 
abnormal behaviours to F2 MSUS by performing cross-fostering and preparing 
and testing F2 offspring from males exposed to maternal separation 
 
• To determine the extent to which all aspects of this behavioural phenotype are 
transmitted across generations 
 
• To determine the mechanism behind this transmission by focusing on changes 
in the epigenome in genes related to stress pathways 
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4.1 Animals 
 
C57Bl/6J mice were maintained in standard conditions under a reverse light-dark 
cycle with food and water available ad libitum.  Unless otherwise described, animals 
were housed 3-4 per cage in standard Nalgene cages containing wood chip bedding 
and a small carton house for enrichment.  All experimental manipulations were 
performed during the animalsʼ active cycle and all experiments were performed in 
accordance with guidelines and regulations of the cantonal veterinary office, Zurich. 
 
 
4.2 Maternal Separation Paradigm 
 
Maternal separation with unpredictable stress (MSUS) dams and litters were 
subjected to daily 3-hr proximal separation from PND1 to PND14.  During separation, 
mothers and pups were placed in separate clean cages containing food and water 
(dams only), and bedding.  Litters and dams were placed such that they had visual 
and olfactory contact.  The timing of separation was unpredictable, but always 
occurred during the dark cycle.  Maternal stress consisted of either 20-min restraint in 
a Plexiglas tube or 5-min forced swim in cold water (18°C) applied unpredictably and 
randomly during separation.  Both MSUS and control dams and litters had their 
cages changed on PND1, PND7, PND14, and PND21, during which time the pups 
were also weighed.  Outside of this, control dams and litters were left undisturbed.  
Only dams giving birth within one week of each other were used.  Litters with less 
than 4 pups were excluded from analysis.  Maternal care was scored shortly before, 
shortly after and 2-3 hours after separation and scoring included ABN, LG, ABN-LG, 
nest building alone, ABN + nest building, blanket nursing, carrying pups, and self-
grooming on- or off-nest. 
 
 
4.3 Enriched environment 
 
Control and MSUS male mice were placed in an enriched environment (Marlau©; 
Viewpoint) immediately after weaning for a period of either two weeks (short-term 
enriched environment, ST-EE) or until behavioural testing which occurred during 
adulthood (long-term enriched environment, LT-EE).  In the case of ST-EE, mice 
were returned to standard group-housing following the period of enrichment.  
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Enrichment consisted of group-housing (n=12) in a large box containing two levels.  
The bottom level was separated into two compartments, one containing food pellets, 
and the other containing access to water, running wheels, and a covered/protected 
area.  The top level consisted of a maze which was changed three times per week 
with a total of 12 configurations.  The box was organized such that animals were 
required to go through the maze to get to the food compartment. 
 
 
4.4 Antidepressant administration 
 
Desipramine (Desip.) (Sigma) was dissolved in 0.9% sterile saline immediately prior 
to use and injected intraperitoneally (i.p.) or subcutaneously (s.c.) using a volume of 
10 ml/kg.  
 
 
4.5 Behavioural Tests of Novelty Seeking and Behavioural Control 
 
All behavioural tests were scored blind to treatment group.  To avoid possible litter 
effects, pups from a minimum of 7 litters in the case of non cross-fostered animals, 
and 5 litters in the case of cross-fostered animals were tested in each behavioural 
test.  All data presented is representative data from three independent experiments in 
the case of F1, two independent experiments in the case of F2, and one experiment 
in the case of F3.   
 
4.5.1 Free exploratory paradigm 
 
The test consists of a box (31.5 x 21 x 20.5 cm) with two rows of three-square areas 
which are all connected. Mice were habituated to three connected areas for 24 hours 
with food and water ad libitum. Testing began when mice were allowed access to the 
row of unfamiliar areas for 10 min exploration.  Manual scoring was done to assess 
the latency to enter the unfamiliar areas.   
 
4.5.2 Open field 
 
Mice were placed in the open field (novel, 71 x 71.5 x 31 cm; repeated, 64 x 51 x 
46.5 cm) and allowed free exploration for 10 min or repeatedly across 2 days, for 5 
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min 3 times daily.  Latency to enter the center of the open field, and total distance 
was quantified using an automated scoring system (Noldus).   
 
4.5.3 Elevated plus maze 
 
Mice were placed for 5 min on a 4-arm plus maze made of two open and two closed 
arms (dark grey Plexiglas, 30 x 5 cm) raised 60 cm above the ground. Manual 
scoring was done to assess the first entry into an open arm. 
 
 
4.6 Behavioural tests of depressive-like behaviours 
 
4.6.1 Forced swim test 
 
Mice were placed in a small tank of water (24 cm high, 19 cm diameter, 18±1°C, filled 
up to 18 cm) for 5 min. In order to determine the acute effects of desipramine, mice 
were administered saline or desipramine in three injections over a 24-h period (10 
mg/kg, i.p. 24 h and 5 h, and 20 mg/kg s.c. 1 hr prior to the behavioural testing). For 
chronic experiments, mice continued to receive either saline or desipramine (20 
mg/kg, i.p.) daily for 14 days with the last injection occurring 30 min prior to testing. 
Manual scoring was done to determine when the animal first assumed a floating 
posture, and to determine total floating duration. 
 
4.6.2 Tail suspension test 
 
Mice were suspended by their tail from a hook (35 cm from floor) for 6 min (Steru, 
Chermat et al. 1985).  A plastic cylinder was placed around the tail to prevent tail 
climbing.  In order to determine the acute and chronic effects of desipramine, mice 
were administered saline or desipramine (20 mg/kg, i.p.) daily for 1 (acute) or 14 
(chronic) days with the last injection occurring 30 min prior to testing. Time spent 
immobile was quantified using an automated scoring system (Noldus). 
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4.6.3 Sucrose consumption test 
 
Mice were singly housed and allowed free consumption of a 4 % sucrose solution for 
4 consecutive days. Results were normalized against water intake across the same 
time period. 
 
 
4.7 In vitro methylation2 
 
In vitro methylation assays were carried out as previously described (Levenson, Roth 
et al. 2006). Male C57BL/6J mice were sacrificed, brains were immersed in 
oxygenated ice-cold cutting solution (CS) (110 mM sucrose, 60 mM NaCl, 3 mM KCl, 
1.25 mM NaH2PO4, 28 mM NaHCO3, 0.5 mM CaCl2, 7 mM MgCl2, 5 mM glucose, 0.6 
mM ascorbate), and transverse slices (400 µM) were prepared with a vibratome. 
After isolation, slices were randomized and equilibrated in a mixture of 50% CS and 
50% artificial cerebrospinal fluid (ACSF) (125 mM NaCl, 2.5 mM KCl, 1.25 mM 
NaH2PO4, 25 mM NaHCO3, 2 mM CaCl2, 1 mM MgCl2, 25 mM glucose) at room 
temperature for 45 min. Slices were treated with either vehicle (0.025% DMSO; 3 hrs) 
or zebularine (50 or 100 µM; 3 hrs). Immediately after treatment, cortical structures 
were isolated in ice-cold CS, immediately frozen and stored at -80° C. 
 
 
4.8 DNA methylation assays 
 
4.8.1 Sample preparation and bisulfite treatment3 
 
 
Genomic DNA was prepared from sperm and brain regions (hypothalamus and 
cortex) collected from F1 males, as well as brain, sperm, and lung collected from 
their offspring, and cortex isolated from acute brain slices (DNeasy blood and tissue 
kit; Qiagen). Purified DNA was processed for bisulfite modification (EZ DNA                                                         2 Drug treatment of acute brain slices was performed by Natacha Linder. 3 Sperm collection and brain region dissection was performed by Johannes Gräff. 
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methylation-gold kit, Zymo research).   
 
4.8.2 Pyrosequencing4 
 
 
In F1 and F2 sperm and brain the percentage of methylated alleles at each CG site 
was quantified in bisulfite-converted DNA by pyrosequencing, a method which 
provides quantitative data for the relative proportion of the methylated versus 
unmethylated nucleotides, and known to have an inter-assay variability of 
approximately 5% (Tost and Gut 2007). To quantify methylation in the CpG island of 
corticotropin releasing factor receptor 2 (CRFR2), methyl CpG-binding protein 2 
(MeCP2), cannabinoid receptor 1 (CB1), monoamine oxidase A (MAOA), and 
serotonin receptor 1a (5HT1aR), pyrosequencing appropriate methylation-unbiased 
primer sets (Table 1) were used for PCR amplification of bisulfite-converted DNA, 
with the reverse primer biotinylated to reduce the possibility of self-priming. Relative 
position of the region of interest is summarized for CRFR2 in Fig. 20a, MeCP2 in Fig. 
25a, CB1 in Fig. 26a, MAOA in Fig. 28a, and 5HT1aR in Fig. 29a (represented in 
blue). Pyrosequencing was performed in PSQTM 96MA system and data was 
analyzed using Pyro Q-CpGTM Software (Pyrosequencing AB) using an internal 
sequencing primer (not shown) and the appropriate dispensation order (Table 1). The 
dispensation order is designed to sequence the complementary strand of the 
bisulfite–converted DNA such that the percentage of G/A corresponds to the 
percentage of the methylated nucleotide. To confirm completeness of bisulfite 
conversion, a C nucleotide located in an internal non-CpG site was assessed.  
 
4.8.3 Bisulfite sequencing 
 
PCR amplification of the target region of CRFR2 (as described above; CRFR2124 
Table 1), was performed on bisulfite-converted DNA extracted from F1 sperm.  PCR 
products were cloned into a TOPO TA vector pCRII-TOPO (Invitrogen) and these 
constructs were used to transform TOP10 (Invitrogen) Escherichia coli competent 
cells.  Positive clones were verified by PCR and products were sequenced using 
                                                        4 Pyrosequencing was performed by EpiGenDx. 
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standard methods.5  Sequenced clones were selected for inclusion in the analysis 
only if there was a conversion efficiency of at least 95% (no more than three non-
CpG located cytosines per sequenced clone that remained unconverted by the 
bisulfite reaction). 
 
Table 1.  Methylation unbiased primer sets used for PCR amplification of 
bisulfite treated DNA 
 
Primer 
Name 
Sequence Dispensation Order 
CRFR2124FP 5’-TAGGTGTAGGAGGGTGGTATAGAT -3’ 
CRFR2124RPB 5’-ATCACCCCAAAACCTTAACC -3’ 
GTCGAGATGTCAGTCTGTTCGTATCGGTCGAGATAGATGTT
CAGTTCGTATCAGTCGTATAGTCGTGTGATGTCAGTCGTTA
TGTTCAGTCGATGTTCAGTCGTT 
MeCP2129FP 5’-AGATAGGAATTTTTGTTAATTGAGG-3’ 
MeCP2129RPB 5’-AATTTTACCACAACCCTCTCTC-3’ 
ATGTCGCTATCGTATGTTCGCTATGAGTGATTCGATAGAGT
AGGTGGTCTGTCAGTCTGTCGTGTCAGTCGATGTCGGTCAG
TCGTATCGTAGTCGTAGTCGGTTCGTGATCGTAGTCTGTCA
GTCTGTCAGTTCTGAG 
CB1120FP 5’-TGGTGGTAAAGAGTGAGGATGAT-3’ 
CB1120RPB 5’-CCCTACTTAAAATCCCTACCTCTC-3’  
CTAGTAGTCTGTCGATGTCGTATGTCGTTATGTTCGTATGT
CAGTCTGTCAGTCGTGATCTGTCGTA 
MAOA151FP 5’-AGAATATYGTGAAAGTTTTAGGTTAA-3’ 
MAOA151RPB 5’-TCTCCCACCTACAAACCTCATTTA-3’ 
TCATCTGTCAGTCTGTCGATGTCGTGTATCGTGTATTCGTA
TAGATGATCAGTTCTGTCGTATAGTGTGATCAGTCGTTGAT
CTGTCG 
MAOA152FP 5’-ATGAGGTTTGTAGGTGGGAGAG-3’ 
MAOA152RPB 5’-CCTAAACCACCCCCATCAA-3’ 
GTCGAGTCGTCTGTCAGTCGTGTATCAGTCGTGATTCGTTA
GTAGTCTGTCAGTCGTGTAGTTGAGTAGTCGATGTATATGT
GTTGAGTCGAGTCG 
MAOA153FP 5’-GTAATAAATGGTTGGGTTTTGAA-3’ 
MAOA153RPB 5’-CCTTCTTTTCTAACATAATTCTCAC-3’ AGCTATCTGTCAGTTCTGTCGT 
MAOA154FP 5’-GTGAGAATTATGTTAGAAAAGAAGGT-3’ 
MAOA154RPB 5’-AACTCCCCTACTCCTAAATAAATT-3’ 
TTCAGTAGGTCGTGATCTGTCGTAGTCTGTCGTAGTCGGTC
GTATCGATGTCGAGTGCTATTAGATGATCGTGAGAGTTATG
TAGTAGTAGTAGTTGTATGTCAGTCGAGTTATTAGTCGTCG
ATCGTTGATTCGATCGATCGATCG 
MAOA155FP 5’-TTTTTTGGGTATTTTAGTAAGG-3’ 
MAOA155RPB 5’-CCTCATAATTTAAATAAAATTCTC-3’ 
TACGTTCGTTGAGTCGTTAGTTGTATAGATGTCAGTCTGTT
CGTTAGTCAGTTCGGAGTTCAGTTCGACTTAGTAGGTCGTA
TAGTGTTATTAGTCGTTATATGTTCG 
5HT1aR111FP 5’-GGGAGTGTAGGTAGGTATGGATA-3’  
5HT1arR111RPB 5’-CCATAAACAACACCAACACTAAC-3’  
GATCGTTCGATGTTCGATATGTCGTGATCGATATGTTGATC
GTGATCATTGTGGTATCGTATTAGTCTGTCGTAGTCGTATG
TAGTCGTGTGTGTGATCGTTGATGTCGTTAGATGTGTATAT
TGATCGTTAGTCGTGATCGA 
5HT1aR112FPB 5’-TTTTGGGTTAGGTTATTTGTGATT-3’  
5HT1aR112RP 5’-ACCCCTAATCCTTACTAATAATACA-3’  
GATCGATCAGATATCGACACATACAATATCAAGATACACAC
ACACATCAATCAGATACCGATAGATACAGATCAGATCTACA
AGATATCGACACACATATCAAGATAATAACATACATATCAA
GATCATCGACATCAGATCGATCGATCAAGATCGATCTCTAT
CATCGATATCTATAATACAGATAT 
5HT1aR113FP 5’-TTATTTAGTTTATGTTGGGTTGG-3’  
5HT1aR113RPB 5’-CCTAACTAACCATTCAAACTCTTC-3’  
ATCGTACTATATATTGATTCTGTCGTTATGATTCGTGGTCG
TCAGTCTGTTCGTATCGCTAGATCGTAGAGTGAAGAGAGTC
GTATATGTTCGATGATCAGTCTGTTCG 
 
4.8.4 Methylation-specific qRT-PCR 
 
To quantify methylation changes induced by zebularine, methylation-specific primers 
were designed as follows: forward methylated (5ʼ-
TGTAGTTTCGAGGTTTGTAATTTTC-3ʼ), reverse methylated (5ʼ-
AACTCTATCTCCAACCCCGTC-3ʼ), forward unmethylated (5ʼ-
TAGTTTTGAGGTTTGTAATTTTTGA-3ʼ), reverse umethylated (5ʼ-                                                        5 Sequencing was performed by MicroSynth. 
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AAACTCTATCTCCAACCCCATC-3ʼ). PCRs were performed in a total volume of 25 
µl, consisting of 2 µl of bisulfite-modified DNA, 12.5 µl of SYBR Green Mix (Qiagen), 
0.5 µl of primer (0.2 µM), and 9.5 µl of DEPC-treated double-distilled water.  
Reactions were performed in an ABI 7500 thermal cycler using the following cycling 
conditions: 95°C for 15 min, 45 cycles of 94°C for 15 sec, 52°C for 30 sec, and 72°C 
for 1 min.  Detection of fluorescent products occurred at the end of the 1 min 72°C 
step.  To verify product specificity, a melting curve analysis was performed by 
increasing the temperature in 1°C increments beginning at 60°C.  For further 
verification, the amplified products were analysed by electrophoresis on an agarose 
gel. 
 
 
4.9 Gene expression analysis with quantitative RT-PCR 
 
For detection of CRFR2, MeCP2, and CB1 mRNAs, DNaseI-treated RNA isolated 
from hypothalamus, amygdala or cortex (RNeasy Mini Kit; Qiagen) was used for 
reverse transcription (RT). RT-reactions were carried out using the SuperScript First-
Strand Synthesis System II for RT-PCR (Invitrogen) and quantitative RT-PCR was 
performed in an ABI 7500 thermal cycler using Taqman probes for β-actin, CRFR2, 
MeCP2, and CB1 in a total volume of 20 μL (Applied Biosystems). All probes except 
for CB1, which is a single-exon gene, were designed to span exon boundaries 
ensuring amplification of only mRNA. For each probe, samples were run in triplicate 
and Ct values were normalized to β-actin. Ct values were chosen in the linear range 
of amplification and the comparative Ct method was used to calculate differences in 
gene expression between samples (Livak and Schmittgen 2001; Pfaffl 2001). 
 
 
4.10 CRFR binding6 
 
CRF receptor (CRFR) binding was carried out as previously described (Tezval, Jahn 
et al.). Briefly, brains of control and MSUS adult mice were extracted, embedded in 
Cryomatrix (Shandon) and frozen at -80ºC. Serial coronal sections (20 μm) were cut                                                         6 CRF receptor binding, quantification, and write-up in the Methods section was done by Dr. 
Sandor Vizi. 
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at Bregma -0.58 to -0.94 and -1.22 to -1.46. To confirm Bregma position during 
cutting, occasional sections were Nissl stained, magnified, and examined. 
Appropriate coronal sections were mounted onto APES-coated slides and stored at -
80ºC. Sections were preincubated in incubation buffer (PBS pH 7.2 with 10 mM 
MgCl2, 2 mM EGTA, 0.1% BSA) for 1 min at room temperature. For CRFR1 binding, 
sections were treated in incubation buffer containing 200 pM [125I-Tyr°]Sauvagine (a 
nonspecific CRFR ligand; PerkinElmer Life Sciences) and, for selective 
displacement, 1μM mouse UrocortinII (a CRFR2 specific agonist, Phoenix 
Pharmaceuticals). For CRFR2 binding, the incubation buffer contained 100 pM [125I-
His2]Anti-sauvagine-30 (a CRFR2 specific ligand; GE Healthcare/Amersham). 
Nonspecific binding (NSB) was determined in the presence of 1 μM Sauvagine 
(Phoenix). Sections were washed in ice-cold PBS pH 7.2 0.01% Triton X-100 and in 
ice-cold water then air-dried. As control, CRFR binding was also performed with 200 
pM [125I-Tyr°]Svg (and with 1 μM Svg for nonspecific binding) on sections from 
CRFR1 and CRFR2 knock-out mice (kindly provided by Dr. Jan Deussing) (data not 
shown). Radioactively labeled sections were exposed to SR phosphor screens 
(Packard) for 24 hours at room temperature. After exposure, sections were Nissl 
stained with 2% cresyl violet and brain areas of interest were identified and outlined 
using a mouse brain atlas (Paxinos and Franklin 2001). Photographs of Nissl stained 
sections with outlined regions were then overlapped with corresponding 
phosphoimages in Photoshop CS2 (Adobe) and the phosphorimages were quantified 
using OptiQuant 4.0 (Packard). Labeling values of brain regions were corrected for 
screen background and nonspecific binding and expressed in net dlu/mm2 units. 
Typically, for each animal and each brain region, four measurements were performed 
on two sections. Means of net labeling values were calculated for each brain region 
in each animal. 
 
 
4.11 Statistical Analyses 
 
One-way analysis of variance (ANOVA) followed by Fisherʼs PLSD post-hoc tests 
were used to analyse maternal care and the effect of desipramine, unpaired t-tests 
with Welchʼs correction in the case of unequal variance were used to compare F1 
control and F1 MSUS, F2 control and F2 MSUS, and F3 control and F3 MSUS 
behavioural data, gene expression, and receptor binding data, and repeated 
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measures ANOVA were used to compare maternal care behaviours and weight 
across the postnatal period and to identify region of differential methylation. All 
correlations were performed using a correlation z-test. All data analysed matched the 
requirements for parametric statistical tests. Significance was set at p<0.05 for all 
tests. Error bars represent standard error of the mean (SEM). 
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5.1 Chronic and unpredictable maternal separation alters behaviour in 
the mouse 
 
A model of chronic postnatal stress in the mouse was used to evaluate the extent to 
which early trauma constitutes a risk factor for persistent and transmissible 
behavioural defects.  Primiparous C57Bl/6J females (F0) and males were bred, and 
their litters (F1) were subjected to daily unpredictable maternal separation (3 hours) 
from birth to postnatal day fourteen (PND14) (MSUS).  During the time of the 
separation, dams were also treated with maternal stress, unpredictably (Fig. 1a, b).  
The immediate effect of the manipulation was investigated by daily monitoring of 
maternal care supplied by F0 dams to F1 pups for two weeks after birth.  Among the 
multiple parameters examined, arched-back nursing (ABN) and ABN associated with 
licking-grooming (ABN+ABN-LG) were used as an index of active maternal care (Liu, 
Diorio et al. 1997; Caldji, Diorio et al. 2000), and time off-nest as an index of absence 
of care.  The overall resulting deficit in maternal care was apparent primarily during 
the first postnatal week, when the pups are the most dependent upon maternal 
attention (Fig. 2a, b).  However, despite deficient maternal care the separated F1 
Control! MSUS!
a!
b!
Figure 1.  Postnatal treatment of F1 MSUS mice.   a, Maternal separation 
procedure and (b) experimental design used to study the impact of chronic 
maternal separation on adult behaviour. C57Bl6/J F0 females (black) bred to 
C57Bl6/J males were allowed to raise their offspring in normal conditions 
(Control) (left, blue) or were subjected to MSUS from birth to PND14 (right, 
orange) and maternal care was observed. F1 progeny (females and males) 
were weaned, and then raised normally until adulthood, when they were 
behaviourally tested. The dotted arrow symbolizes separation of dams from 
pups. !
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pups grew normally, and had normal weight at weaning (PND21) (Fig. 2c).    
 
The long-term effect of maternal separation, combined with physical stress, on the 
behaviour of dams who raised F1 MSUS (F0 MSUS) versus dams who raised F1 
control (F0 control) was 
investigated.  Following 
weaning of F1 control and 
MSUS, F0 dams were 
replaced into standard group-
housing for one month before 
being behaviourally tested.  
Both the open field, and 
elevated plus maze were 
used in order to observe their 
response to aversive areas of 
a novel environment.  F0 
MSUS travelled less overall 
distance in the open field and 
made less entries into the 
aversive center of an open 
field, indicative of reduced 
motivation to explore often 
associated with  depressive-
like behaviours induced by 
chronic stress in rodents (Fig. 
3a, b) (Grippo, Beltz et al. 
2003; Lin, Liu et al. 2005; 
Zhao, Wang et al. 2008).  
Despite this general reduction 
in activity, there was a tendency for F0 MSUS to enter the most aversive region of 
the open field, the center, sooner than F0 controls, which may be indicative of 
enhanced novelty-seeking (Fig. 3c).  Moreover, in the elevated plus maze, there was 
a tendency for F0 dams to spend more time in the least safe area of the maze (the 
open arm), make a greater proportion of entries into the open arm, and travel a 
greater proportion of their total path length in the open arm than controls, again 
a! b!
c!
Figure 2. Poor maternal care provided to F1 
MSUS pups did not result in abnormal weights 
during postnatal development.  Dams undergoing 
maternal separation spent (a) less time actively 
nursing (F(1, 13)=7.25, p<0.05) and (b) more time 
off-nest (F(1, 13)=7.69, p<0.05) than control dams 
during the first week post-delivery.  Average of 
maternal care scoring across three 30-min sessions 
per day.  c, F1 MSUS grew similar to control pups 
(F(1, 14)=0.055, ns). *, p<0.05, as indicated by 
Fisher"s PLSD post-hoc tests.!
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suggesting inappropriate response to dangerous or aversive environments and 
reduced behavioural control (Fig. 4a-c).  However, the possibility that this behaviour 
may also be due to reduced anxiety as 
a result of exposure to the phyiscal 
stressors during the MSUS treatment 
can not be ruled out.  Be that as it 
may, in F0 control dams the level of 
maternal care provided to F1 pups 
was correlated with behavioural traits.  
This analysis demonstrated that, on 
the elevated plus maze, increased 
time off-nest was significantly 
associated with risk-seeking 
behaviours in response to the aversive 
area of the elevated plus maze in F0 
control dams (Fig. 4d-f).  This 
correlation was not present in F0 
MSUS, further demonstrating the 
perturbed maternal care induced by 
maternal separation. 
 
To evaluate the long-term and 
multigenerational effects of maternal 
separation on behaviour, adult F1mice 
and two subsequent generations were 
tested using several behavioural 
paradigms with gradually increasing 
levels of stress and aversion.  In order 
to facilitate the reader, a summary of 
the main behavioural findings in F1, 
F2, and F3 control and MSUS mice is provided in Table 2.  Table 2 clearly 
demonstrates transmission of abnormal behavioural traits from F1 MSUS male and 
female mice, to F2 MSUS mice derived from F1 MSUS females, and F2 and F3 
MSUS mice derived from MSUS males.  A further description of these results follows. 
 
0
10
20
30
+
0
10
20
30
40
50
+
Figure 3.  Reduced exploration and 
enhanced novelty-seeking in F0 MSUS 
dams in the open field. In the open field, 
F0 MSUS dams (a) travelled less total 
distance (n=17; t(29)=2.27, p=0.031), (b) 
made less entries into the center (n=18; 
t(30)=1.97, p=0.059), and (c) entered into 
the center sooner (n=17; t(29)=1.68, 
p=0.10) than F0 control dams (n=14). +, 
0.05<p<0.1; *, p<0.05, as indicated by 
unpaired t-tests.!
a!
b!
c!
6
7
8
9
*
F0 Control dam
F0 MSUS dam
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Figure 4.  Increased exploration of aversive areas of the elevated plus maze in 
F0 MSUS dams.  In the elevated plus maze, F0 MSUS dams (a) spent more time in 
the open arm (n=8; t(14)=1.94, p=0.073), (b) made more entries into the open arm 
(n=8; t(14)=1.78, p=0.097), and (c) travelled a greater proportion of total distance in 
the open arm (n=8; t(14)=2.01, p=0.064), than F0 control dams (n=8). d-f, 
Exploration of the open arm is positively correlated with maternal care behaviours in 
F0 control dams, but not F0 MSUS.  d, Significant correlation between time spent in 
an open arm and time spent off-nest (p=0.03), (e) entries into the an open arm and 
time spent off-nest (p=0.03), and (f) distance travelled in  an open arm and time 
spent off-nest (p=0.03) in F0 control, but not F0 MSUS (p=0.45, 0.79, 0.66 
respectively). +, 0.05<p<0.1, as indicated by unpaired t-tests.!
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c!
d!
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Table 2. Summary of behavioural results for F1, F2 and F3 MSUS and control mice.
F1 male F1 female Male line Female line Male line
F3 male
Male line
F3 female
F2 male F2 female F2 male F2 female
FEP latency to 
enter 
unfamiliar 
area
control: 33.4 ± 5.2 (25)
MSUS: 20.4 ± 2.3* (41)
control: 13.3 ± 1.3 (23)
MSUS: 14.5 ± 1.5 (37)
control: 28.4 ± 4.6 (29)
MSUS: 25.4 ± 3.3 (29)
control: 22.7 ± 2.6 (15)
MSUS: 13.2 ± 2.2* (15)
control pup-control dam: 
39.17 ± 9.6  (18)
control pup-MSUS dam: 
48.8 ± 13.8 (13)
MSUS pup-control dam:
24.3 ± 8.4* (10)
MSUS pup-MSUS dam:
22.3 ± 3.9* (16)
control pup-control dam: 
16.3 ± 3.7 (15)
control pup-MSUS dam: 
21.6 ± 8.8 (14)
MSUS pup-control dam: 
35. 1 ± 9.8 (15)
MSUS pup-MSUS dam: 
24.9 ± 3.7 (14)
control: 17.4 ± 3.0 (19)
MSUS: 33.4 ± 7.8 (18)+
control: 23.7 ± 4.3 (18)
MSUS: 13.9 ± 2.0* (16)
OF latency to 
enter center
control: 107.9 ± 18.5 (25)
MSUS: 71.7 ± 11.8+ (38)
control: 52.19 ± 7.7 (24)
MSUS: 36.0 ± 4.9+ (36)
control: 53.5 ± 7.8 (30)
MSUS: 68.6 ± 9.5 (31)
control: 93.8 ± 18.3 (15)
MSUS: 50.0 ± 8.3* (15)
control pup-control dam: 
42.5 ± 7.2  (18)
control pup-MSUS dam: 
58.3 ± 11.1 (13)
MSUS pup-control dam:
83.8 ± 16.6a (11)
MSUS pup-MSUS dam:
49.0 ± 5.6 (16)
control pup-control dam: 
46.9 ± 6.9 (16)
control pup-MSUS dam: 
51.5 ± 10.4 (14)
MSUS pup-control dam:
49.9 ± 7.1 (15)
MSUS pup-MSUS dam:
62.3 ± 10.3 (15)
control: 46.2 ± 10.6 (17)
MSUS: 52.1 ± 8.7(17)
control: 53.4 ± 7.2 (19)
MSUS: 31.2 ± 3.9* (17)
EPM latency to 
enter open 
arm
control: 91.2 ± 20.4 (25)
MSUS: 105.3 ± 15.8 (42)
control: 193.3 ± 24.1 (26)
MSUS: 125.1 ± 17.4* (39)
control: 129.7 ± 17.3 (30)
MSUS: 57.2 ± 8.6* (25)
control: 231.0 ± 28.1 (15)
MSUS: 142.4 ± 29.8* (16)
control pup-control dam: 
117.5 ± 23.7 (20)
control pup-MSUS dam:
134.6 ± 32.8 (14)
MSUS pup-control dam: 
78.5 ± 10.8* (10)
MSUS pup-MSUS dam:
50. 4 ± 15.7* (16)
control pup-control dam: 
160.9 ± 30.4 (16)
control pup-MSUS dam: 
175.9 ± 33.3 (13)
MSUS pup-control dam:
150.9 ± 31.2a (16)
MSUS pup-MSUS dam: 
51.6 ± 10.0* (14)
control: 162.0 ± 22.3 (20)
MSUS: 155.2 ± 19.3 (19)
control: 141.1 ± 21.7 (20)
MSUS: 49.5 ± 10.8* (13)
FST latency to 
float
control: 90.4 ± 7 (14)
MSUS: 73.5 ± 4.7* (29)
control: 86.7 ± 6.4 (23)
MSUS: 105.1 ± 7.1+ (37)
control: 103.7 ± 9.0 (31)
MSUS: 112.7 ± 10.8 (31)
control: 162.4 ± 22.3 (16)
MSUS:102.5 ± 9.5* (15)
control pup-control dam: 
80.4 ± 8.1 (19)
control pup-MSUS dam: 
115.3 ± 10.2 (13)
MSUS pup-control dam: 
144.0 ± 26.5a (11)
MSUS pup-MSUS dam: 
81.6 ± 6.5 (16)
control pup-control dam: 
143.1 ± 22.7 (16)
control pup-MSUS dam: 
172.8 ± 26.0 (15)
MSUS pup-control dam: 
164.9 ± 25.0 (16)
MSUS pup-MSUS dam: 
147.9 ± 21.0 (16)
control: 62.9 ± 4.5 (18)
MSUS: 67.1 ± 3.4 (18)
control: 66.5 ± 5.0 (20)
MSUS: 73.1 ± 8.2 (15)
time spent 
floating
control: 26.7 ± 5.05 (14)
MSUS: 42.0 ± 4.0* (30)
control: 40.2 ± 5.4 (26)
MSUS: 21.5 ± 3.3* (36)
control: 42.6 ± 6.7 (31)
MSUS: 32.6 ± 5.4 (31)
control: 22.9 ± 5 (28)
MSUS: 39.6 ± 6.2* (31)
control pup -control dam:
52.4 ± 8.3 (19)
control pup-MSUS dam: 
25.9 ± 4.7a (13)
MSUS pup control dam: 
33.5 ± 8.0 (10)
MSUS pup- MSUS dam, 
39.1 ± 6.9 (18)
control pup- control 
dam: 27.4 ± 7.2 (16)
control pup-MSUS dam: 
25.5 ± 7.3 (15)
MSUS pup-control dam: 
14.2 ± 3.6 (15)
MSUS pup-MSUS dam: 
31.5 ± 6.6 (16)
control: 36.0 ± 5.3 (20)
MSUS: 54.6 ± 6.4* (22)
control: 41.2 ± 5.4 (19)
MSUS: 30.5 ± 6.3 (18)
Sucr
.
% sucrose 
intake
control: 285.4 ± 19.3 (18)
MSUS: 234.5 ± 13.2* (20)
control: 291.0 ± 24.3 (18)
MSUS: 275.7 ± 18.7 (20)
control: 286.1 ±  19.0 (14)
MSUS: 264.4 ± 14.7 (16)
control: 277.8 ± 17.4 (16)
MSUS: 257.3 ± 12.3 (16)
control pup-control dam: 
275.3 ± 19.0 (19)
control pup-MSUS dam: 
277.2 ± 27.7 (14)
MSUS pup-control dam:
308.8 ± 21.5 (11)
MSUS pup-MSUS dam:
335.2 ± 27.9 (18)
control pup-control dam: 
274.3 ± 18.4  (15)
control pup-MSUS dam: 
337.8 ± 44.2 (14)
MSUS pup-control dam:
332.7 ± 29.4 (16)
MSUS pup-MSUS dam:
311.2 ± 28.5 (16)
control: 264.2 ± 20.5  (20)
MSUS: 281.6 ± 24.9 (19)
control: 290.6 ±  18.2 (20)
MSUS: 274.1 ± 15.6 (19)
FEP, free exploratory paradigm; OF, open field; EPM, elevated plus maze; FST, forced swim test; Sucr., sucrose consumption.  a, significant interaction due to cross-fostering, *, p<0.05, +, 0.05<p<0.1 compared to control.
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Animals were first tested in mildly stressful conditions using the free exploratory 
paradigm (Griebel, Belzung et al. 1993).  This measures novelty-seeking behaviour 
in mice by providing access to an unfamiliar and familiar environment.  Male F1 
MSUS mice entered into unfamiliar areas of the testing arena sooner than control 
mice, indicating increased novelty-seeking behaviour and reduced assessment of the 
novel environment prior to entry compared to control mice (Fig. 5a).  The effect of 
maternal separation on behaviour in the free exploratory paradigm was sex-specific, 
as female F1 MSUS mice demonstrated normal behaviour on this task (F1 control, 
13.3 ± 1.3, n=23; F1 MSUS 14.5 ± 1.5, n=37; t(56)=.64, p=0.53). On a slightly more 
aversive task, the open field (Welker 1957; Dulawa, Grandy et al. 1999), a similar 
tendency to a reduction in latency to enter the aversive area of an arena was 
observed, in both male and female F1 MSUS animals (male: F1 control, 107.9 ± 
!" #"
$" %"
Figure 5. Sex-specific increased novelty-seeking in F1 MSUS in the 
free exploratory paradigm, open field, and elevated plus maze. a, b, d, 
Images of the (a) free exploratory paradigm, (b) open field, and (d) 
elevated plus maze showing representative tracking of position and 
movements in F1 animals. Aversive areas are outlined by blue boxes.  F1  
MSUS mice (red trace) were more likely to enter aversive areas than 
female F1 control mice (black trace) in the (a) free exploratory paradigm, 
(b) open field, and (d) elevated plus maze.  a, Shorter latency to (a) enter 
unfamiliar areas following 24-hour habituation to familiar areas in the free 
exploratory paradigm in female F1 MSUS (n=41) versus F1 control (n=25) 
mice (t(64)=2.62, p<0.05), b, Shorter latency to enter the center of an open 
field in female F1 MSUS (n=36) versus F1 control (n=24) mice (t(58)=1.87, 
p=007). c, Similar total distance covered during 10-min free exploration of 
the open field in female F1 MSUS (n=36) and F1 control (n=24) mice 
(t(57)=1.30, p=0.20, ns). d, Reduced latency to first enter an open arm in 
female F1 MSUS (n=39) (F1, t(63)=2.35, p<0.05) than F1 control (n=26) 
*p<0.05, +=0.07, as indicated by unpaired t-tests.!
0
1
2
3
4
5
6
7
8
+
Chapter 5: Results 
  41 
18.5, n=25; F1 MSUS, 71.7 ± 11.8, n=24; t(61)=1.74, p=0.087; female: F1 control 
52.2 ± 7.7, n=24; F1 MSUS, 36.0 ± 4.9, n=36; t(58)=2.6, p=0.070).  F1 MSUS had a 
shorter latency to enter the center area of an open field, but covered an overall 
similar distance confirming that the behavioural abnormalities demonstrated by F1 
MSUS mice on initial exposure to a novel environment are not due to differences in 
overall arousal levels (Fig 5b, c).  Finally on a highly aversive test, the four-arm 
elevated plus maze (Pellow, Chopin et al. 1985; Lister 1987), female F1 MSUS 
animals had significantly shorter latency to first enter the open arms than control 
animals (Fig. 5d), again indicating a reduction in behavioural control (Rodgers and 
Dalvi 1997).  Here again the effect was sex-specific; male F1 MSUS mice 
demonstrated normal behaviour in the elevated plus maze (F1 control, 91.2 ± 20.4, 
n=25; F1 MSUS, 105.3 ± 15.82, n=42; t(65)=0.54). 
 
We further tested the animals on paradigms classically used to examine depression.  
In a forced swim test 
(Porsolt, Le Pichon et al. 
1977), male F1 MSUS 
animals adopted a floating 
posture significantly sooner 
than control mice and 
spent significantly more 
time floating (Fig. 6a, b), 
indicating altered stress-
coping when faced with an 
inescapable stressor.  
Moreover, on a sucrose 
consumption test (Cryan 
and Mombereau 2004), 
they consumed less 
sucrose than control mice 
(Fig. 6c), reflecting 
anhedonia, a symptom 
commonly associated with 
depression in humans 
(Wong and Licinio 2001).  
Figure 6. Depressive-like behaviours in male F1 
mice. a, b, On the forced swim test, (a) shorter latency 
to float in male F1 MSUS (n=29) versus F1 control mice 
(n=14) (t(41)=2.03, p<0.05), and (b) increased time 
spent floating in male F1 MSUS (n=30) versus F1 
control mice (n=14) (t(42)=2.25, p<0.05). c, Lower 
sucrose intake normalized to water intake over 4 days in 
male F1 MSUS (n=20) versus F1 control mice (n=18) 
(t(36)=2.22, p<0.05) due t=o (d) reduced overall sucrose 
consumption . *, p<0.05 as indicated by unpaired t-test. !
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In contrast to the depressive-like behaviours present in male F1 MSUS mice, female 
F1 MSUS demonstrated a tendency for increased latency to float (F1 control, 86.7 ± 
6.4, n=23; F1 MSUS, 105.1 ± 7.1, n=37; t(56)=0.06), as well as a significant 
decrease in time spent floating in the forced swim test (F1 control, 40.2 ± 5.4, n=26; 
F1 MSUS, 21.5 ± 3.3, n=36; t(63)=2.12, p=0.038), but no change in sucrose 
consumption (F1 control, 291.0 ± 24.34, n=18; F1 MSUS 275.7 ± 18.69, n=20; 
t(36)=0.51, p=0.62) compared to female F1 control mice.  Altogether, these results 
indicate that chronic and unpredictable postnatal stress induces novelty-seeking 
behaviours in both male and female mice, and sex-specific depressive-like 
behaviours, with male MSUS mice demonstrating enhanced depressive-like 
behaviours, and female MSUS mice demonstrating decreased depressive-like 
beaviours in a forced swim test. 
 
In order to see if depressive-like behaviours induced by maternal separation could be 
reversed in adulthood, male MSUS and control mice were placed in enriched 
environment immediately after weaning for a period of either two weeks (ST-EE) or 
until behavioural testing (LT-EE).  Mice were tested on both the forced swim test and 
the tail suspension test, two behavioural tests which use time spent immobile when 
faced with an inescapable situation as a measure of depressive-like behaviours.  
Mice exposed to maternal separation living in standard housing exhibited depressive-
like behaviours (more time immobile) in both the forced swim test and tail suspension 
test, confirming previous results (Fig. 7).  Additionally, in the forced swim test, control 
mice exposed to 2-weeks of enrichment post-weaning spent more time floating than 
standard-housed control mice (Fig. 7a).  This increase in depressive-like behaviour 
following short-term enrichment was unexpected, but is most likely the result of 
reinstatement into standard housing, a comparatively impoverished environment.  
Interestingly, this induction of depressive-like behaviours was not observed in ST-EE 
MSUS mice, suggesting that MSUS mice may be resistant to certain types of 
environmental stressors (Fig. 7a).  In the forced swim test, either short-term or long-
term enrichment had no effect on MSUS mice (Fig. 7a).  In contrast, in the tail 
suspension test, both short-term and long-term enrichment had no effect on control 
mice but reversed the effect of maternal separation in MSUS mice (Fig. 7b).  This 
suggests that while the behavioural response to the stressful condition (either 
immobility in the tail suspension, or floating in the forced swim) may appear 
outwardly similar, different neurochemical pathways underlie these behaviours.  This 
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has been previously suggested by pharmacological studies demonstrating that, in 
control animals, selective serotonin-reuptake inhibitors (SSRIs) can reduce immobility 
in the tail suspension test, but not in the forced swim test.  In contrast, atypical 
antidepressants tend to reduce immobility in the forced swim test, and not the tail 
suspension test (Bai, Clay et al. 2001; Cryan, Mombereau et al., 2005). 
 
 
5.2 Behavioural alterations are transmitted to the subsequent two 
generations 
 
To examine whether the behavioural traits induced by maternal separation are 
heritable, both adult F1 MSUS females and males were bred with wild-type animals 
to generate F2 MSUS offspring.  These animals were reared under normal conditions 
(no maternal separation or stress involved) (Fig. 8).  To ensure that rearing 
conditions were normal in these animals, maternal care in F1 MSUS females bred 
with wild-type males, and in wild-type females bred with F1 MSUS males, was 
monitored.  In addition, cross-fostering was performed on PND0 such that the F2 
offspring of F1 females include four treatment groups: F2 MSUS raised by F1 MSUS 
dams, F2 MSUS raised by F1 CON dams, F2 CON raised by F1 CON, and F2 CON 
raised by F1 MSUS.  Maternal care was monitored during three 30-min periods within 
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Figure 7.  Differential effects of enriched environment on 
depressive-like behaviours induced by early stress in male mice in 
the forced swim test and tail suspension test. a, In the forced swim 
test, standard housed MSUS mice (n=16) spend more time floating than 
control (n=16), and this is not reversed by enrichment. Short-term, but 
not long-term enrichment, induces more floating behaviour in control 
mice (ST-EE, LT-EE, n=12), but not MSUS mice (ST-EE, n=12, LT-EE 
(n=11) (F(1, 74)=4.684, p=0.03).   b, In the tail suspension test, 
standard housed MSUS mice (n=15) spend more time immobile than 
control (n=15), and this is reversed by both short-term and long-term 
enrichment (ST-EE, n=12, LT-EE, n=11) (F(1, 71)=5.96, p=0.0041).  
Enrichment has no effect on time spent immobile in control mice (ST-
EE, LT-EE, n=12). *, p<0.05, **, p<0.01, ***, p<0.001, as indicated by 
Fisher"s PLSD post-hoc tests.!
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their active cycle each day for one week after delivery (PND0-PND6 in cross-fostered  
female line, PND1-PND7 in male line).  F1 MSUS females had normal fertility and 
provided adequate maternal care, not only to their own biological offspring (Fig. 9a) 
but also to the offspring of control dams after cross-fostering (Fig. 9b). Wild-type 
dams bred to F1 MSUS males also provided normal maternal care as expected (Fig. 
10).   Increased nursing observed in the female versus the male line is most likely 
Figure 8. Generation of F2 MSUS and control mice.  
Experimental design to study transmission of the effect of 
MSUS on adult behaviour. Following behavioural testing, 
adult F1 control (blue, left) and F1 MSUS (orange, right) 
females and males were bred to C57Bl6/J animals (black) 
and F2 offspring was raised in normal conditions (no 
maternal separation or maternal stress). !
Maternal 
care scoring!
Behavioral 
Testing!
F1!
F2!
Breeding!
Figure 9.  Similar levels of maternal care provided to F2 
MSUS and control mice derived from experimental F1 
females.  a, b, Normal maternal care provided by F1 MSUS 
dams. Daily scoring of maternal care from birth to PND7 (three 
30-min sessions/day) showing (a) similar ABN+ABN-LG, and (b) 
similar time off-nest in F1 control and MSUS dams raising their 
own offspring (F2 control and MSUS pups respectively) (control, 
n=9; MSUS, n=12) or cross-fostered offspring (F2 MSUS and 
control pups respectively) (n=3) (a, F(1, 23)=0.22, ns; b, F(3, 
21)=0.26, ns). 
Control dams!
MSUS dams!
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due to the earlier developmental period 
(PND0-PND6 versus PND1-PND7) during 
which scoring took place.  Consistently, F2 
MSUS offspring from both groups of 
females grew normally and had body 
weight comparable to control animals at 
weaning (PND21) (Fig. 11).   
 
Behaviour in F2 offspring was then tested 
using the same paradigms and conditions 
as in F1 animals.  Strikingly, despite being 
adequately reared, F2 MSUS offspring 
from F1 MSUS males exhibited similar 
behavioural alterations as F1 MSUS 
animals.  Interestingly, female mice seem 
more susceptible to transmission, as 
female F2 MSUS mice demonstrate similar 
behavioural alterations in all behavioural 
tests described above, while male F2 
MSUS mice show similar alterations only 
in the elevated plus maze.  On the free 
exploratory paradigm, F2 MSUS female 
mice derived from F1 MSUS males, had a 
Control sires 
MSUS sires 
Figure 10.  Similar levels of maternal care provided to F2 MSUS 
and control mice derived from experimental F1 males. a, b, 
Normal maternal care provided by wild-type mothers raising offspring 
of F1 MSUS or F1 control sires.  Daily scoring of maternal care from 
birth to PND7 (three 30-min sessions/day) showing similar (a) level of 
active nursing (ABN+ABN-LG, in %) (t(17)=1.10, ns) and (b) time off-
nest (F(1,17)=1.06, ns) (n=9-10).!
Control sires!
MSUS sires!
a b 
(%
) 
a!
b!
Figure 11.  Normal weight during 
development in F2 MSUS compared 
to F2 control.  a, b, Average litter 
weight of offspring of F1 MSUS (a) 
males (litter n=9) and (b) females (litter 
n=8) grew normally compared to control 
(a, litter n=10; b, litter n=17).!
!"#$%"&'
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shorter latency to enter unfamiliar areas compared to F2 control mice (Fig. 12a).  
Similarly, they had increased propensity to enter into the aversive areas of the open 
field and elevated plus maze (Fig. 12b, d).  Again, these behaviours were not due to 
increased activity or arousal since F2 MSUS mice covered a comparable total 
distance in the open field (Fig. 12c).  In the free exploratory behaviour and open field, 
this altered behaviour was specific to females and was not observed in male F2 
MSUS mice (free exploratory paradigm: F2 control, 28.4 ± 4.6, n=29; F2 MSUS, 25.4 
± 3.3, n=29; t(56)=0.54; open field: F2 control, 53.5 ± 7.82, n=30; F2 MSUS, 68.6 ± 
9.52, n=31; t(59)=1.22, p=0.23). However, male F2 MSUS mice demonstrated similar 
behavioural alterations as female F2 MSUS mice in the elevated plus maze (elevated 
plus maze; control, 129.67 ± 17.34, n=30; MSUS, 57.2 ± 8.6, n=25; t(41)=3.74, 
p=0.0006).   
 
Remarkably, whether derived from F1 MSUS males (Fig. 12) or F1 MSUS females 
(Fig. 13), either male or female MSUS offspring exhibited similar behavioural 
abnormalities when exposed to aversive environments, indicating a comparable 
transmission of this trait in both sexes.      The transmission was sex-specific, as 
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Figure 12. Increased novelty-seeking in the free exploratory paradigm, open field, and 
elevated plus maze in female F2 MSUS mice. a, b, d, Images of the (a) free exploratory 
paradigm, (b) open field, and (d) elevated plus maze showing representative tracking of 
position and movements in F2 animals. Aversive areas are outlined by blue boxes. F2 MSUS 
mice (red trace) were more likely to enter aversive areas than F2 control mice (black trace) in 
the (a) free exploratory paradigm, (b) open field, and (d) elevated plus maze. a, Shorter latency 
to enter unfamiliar areas following 24-hour habituation to familiar areas in the free exploratory 
paradigm in female F2 MSUS (n=15) versus F2 control (n=15) mice (t(28)=7.75, p<0.01). b,  
Shorter latency to enter the center of an open field in female F2 MSUS (n=15) than F2 control 
(n=15) mice (t(28)=2.19, p<0.05). c, Similar total distance covered during 10-min free!
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Female F2 MSUS mice had reduced latency to first enter an open arm (n=16) (t(29)=4.66, 
p<0.05) compared to F2 control (n=15). *p<0.05, **p<0.01 as indicated by unpaired t-tests. !
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transmission of abnormal behaviour in the free exploratory paradigm was seen in the 
male offspring of female MSUS mice, even though behaviour was normal in F1 
MSUS females in this particular behavioural test.  Abnormal behavioural traits in the 
offspring of F1 MSUS females was observed in both the free exploratory paradigm 
and the elevated plus maze, but not the open field, in male F2 MSUS mice (Fig. 13). 
Moreover, cross-fostering had no effect on the offspring of F1 MSUS dams in the free 
exploratory paradigm or elevated plus maze confirming that early environment 
provided by F1 MSUS dams does not contribute to the abnormal behavioural traits 
exhibited by male F2 MSUS (Fig. 13).  While male F2 MSUS derived and raised by 
F1 MSUS females behaved normally in the open field, cross-fostering itself   had a 
significant effect on these mice; male F2 MSUS derived from F1 MSUS females but 
raised by F1 control females demonstrated increased latency to enter the center of 
the open field (F2 control pup raised by F1 control dam, 42.5 ± 7.2, n=18; F2 control 
pup raised by F1 MSUS dam, 58.3 ± 11.1, n=13; F2 MSUS pup raised by F1 control 
dam, 83.8 ± 16.6, n=11; F2 MSUS pup raised by F1 MSUS dam, 49 ± 5.6, n=16;  
F(1, 54)=2.65, p=0.013).  This effect of cross-fostering was not seen in male F2 
control mice, suggesting that male F2 MSUS mice may be more susceptible to 
certain aspects of differential early environments.  Female F2 MSUS mice derived 
from female F1 MSUS mice displayed normal behaviour in the free exploratory 
paradigm and open field, (free exploratory paradigm: F2 control pup raised by F1 
Free Exploratory Paradigm Elevated Plus Maze 
Figure 13.  Similar behavioural abnormalities in F2 MSUS derived from F1 MSUS 
females, whether raised with F1 control or F1 MSUS dams. a, Decreased latency to 
enter the unfamiliar areas in the free exploratory paradigm in male F2 MSUS offspring 
derived from F1 MSUS females, regardless of whether they were raised by F1 control 
(n=10 from 5 litters) or F1 MSUS dams (n=16 from 7 litters), compared to F2 controls 
(n=18 from 11 litters, 13 from 5 litters respectively) (F(1,53)=4.52, p<0.05). b, In the 
elevated plus maze, decreased latency to enter the open arms in male F2 MSUS 
offspring derived from F1 MSUS females, regardless of whether they were raised by F1 
control (n=10 from 5 litters) or F1 MSUS dams (n=16 from 9 litters), compared to F2 
controls, regardless of whether they were raised by F1 control (n=20 from 12 litters) or F1 
MSUS dams (n=14 from 5 litters) (F(1,56)=6.24, p<0.05). * p<0.05, +=0.05 F2 control 
versus F2 MSUS within MSUS dams according to Fisher!s PLSD post-hoc tests."
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control dam, 16.3 ± 3.7, n=15; F2 control pup raised by F1 MSUS dam, 21.6 ± 8.8, 
n=14; F2 MSUS pup raised by F1 control dam, 35.1 ± 9.8, n=15; F2 MSUS pup 
raised by F1 MSUS dam, 24.9 ± 3.7, n=14; F(1, 54)=0.12, p=0.73; open field: F2 
control pup raised by F1 control dam, 46.9 ± 6.9, n=16; F2 control pup raised by F1 
MSUS dam, 51.5 ± 10.4, n=14; F2 MSUS pup raised by F1 control dam, 49.9 ± 7.1, 
n=15; F2 MSUS pup raised by F1 MSUS dam, 62.3 ± 10.3, n=15;  F(1, 56)=0.62, 
p=0.43) but similar to male F2 MSUS mice, female F2 MSUS mice had reduced 
latency to enter an open arm in the elevated plus maze when raised by MSUS dams.  
This abnormal behaviour was not present in F2 control mice cross-fostered to F1 
MSUS dams, but was also not observed in F2 MSUS pups raised by control dams, 
demonstrating that while the environment provided by F1 MSUS dams can not 
induce the abnormal behaviour observed in the EPM, the environment provided by 
F1 control dams may be able to reverse some of the transmissible effects in a sex-
specific manner (F2 control pup raised by F1 control dam, 160.9 ± 30.4, n=16; F2 
control pup raised by F1 MSUS dam, 175.9 ± 33.3, n=13; F2 MSUS pup raised by F1 
control dam, 150.9 ± 31.2, n=16; F2 MSUS pup raised by F1 MSUS dam, 51.6 ± 
10.0, n=14; F(1, 55)=4.06, p=0.049).   
 
In order to confirm that increased propensity to enter the aversive areas observed in 
female F2 MSUS mice are not due to an overall reduction in the level of anxiety, but 
instead an enhancement in novelty-seeking, F2 MSUS and control were placed 
repeatedly in an open field for two days.  In this experiment, the center of the open 
field continues to be an aversive area within the arena, but the aspect of novelty is 
eliminated across time.  While F2 MSUS initially covered a larger proportion of their 
total distance in the aversive center of the arena, on repeated exposure to the same 
arena, this proportion decreased to a similar level as in control mice (Fig. 14).  Thus, 
F2 MSUS demonstrate a propensity to explore the aversive environment only in 
novel environments, demonstrating that it is not a general reduction in anxiety, but 
rather enhanced novelty-seeking associated with increased risk-taking.   
 
We next tested whether depressive-like behaviours present in male F1 MSUS 
animals can also be transmitted to F2 animals.  On the forced swim test, female F2 
mice derived from F1 MSUS males adopted a floating posture significantly earlier 
than F2 control animals, and spent more time floating (Fig. 15 and saline in Fig. 16a, 
b, d, e), indicating depressive-like behaviours comparable to their F1 MSUS sires. 
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Female F2 MSUS animals 
also spent more time 
immobile in the tail 
suspension test (Steru, 
Chermat et al. 1985), 
further confirming the 
transmission of depressive-
like behaviours from F1 
males to their female 
offspring (saline in Fig. 16c, 
f). Notably, the behavioural 
alterations observed in the 
forced swim test and the 
tail suspension test in F2 
MSUS animals could be 
fully reversed by both acute 
and chronic injection of the 
tricyclic antidepressant 
desipramine, consistent 
with their depressive-like 
nature (desip. in Fig. 16).  
The transmission of 
depressive-like behaviours 
is specific to F2 female 
mice, and is not observed 
in the male offspring of F1 
MSUS sires (latency to 
float: F2 control, 103.7 ± 
9.0, n=31; F2 MSUS, 112.7 
± 10.8, n=31; t(60)=0.64; time spent floating: F2 control, 42.6 ± 6.7, n=31; F2 MSUS, 
32.6 ± 5.41, n=31; t(60)=1.16, p=0.25).  While immobility was clearly transmitted to 
female F2 animals, anhedonia was not present in F2 MSUS mice, as demonstrated 
by a non-significant decrease in sucrose consumption in male (F2 control, 277.8 ± 
17.4, n=16; F2 MSUS, 257.3 ± 12.3, n=16; t(30)=0.97) and female F2 MSUS 
compared to F1 MSUS animals (Fig. 17).  This suggests a lack of penetrance of this 
Figure 14. Increased exploration of the aversive 
area of an open field on initial exposure, but 
normal exploration after repeated exposures, in 
F2 MSUS compared to F2 control mice.  Female 
F2 MSUS mice cover more distance in the center of 
the open field than F2 control animals on the first 
two trials of the first day (left) but cover similar 
distances on the third trial of the first day and all 
three trials of the second day (right) (control, n=10, 
MSUS, n=8; day 1, F(1,15)=6.98, p<0.05; day 2, 
F(1,15)=.30, ns). *, p<0.05 according to Fisher!s 
PLSD post-hoc test."
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Figure 15. Enhanced depressive-like 
behaviours in F2 MSUS mice. a, b, On the 
forced swim test, (a) shorter latency to float 
in female F2 MSUS (n=15) versus F2 
control mice (n=16) (t(20)=2.47, p<0.05), 
and (b) increased time spent floating in 
female F2 MSUS (n=31) versus F2 control 
mice (n=28)(t(57)=2.07, p<0.05). *, p<0.05 
as indicated by unpaired t-test.!
a! b!
Control!
MSUS!
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behavioural trait.  Moreover, unlike the abnormalities observed in F2 MSUS when 
exploring aversive environments, transmission of changes in depressive-like 
behaviours was not demonstrated in the female line, as F2 MSUS derived from F1 
females demonstrated normal behaviours in the forced swim test and sucrose 
consumption (not shown).  This difference in transmission may result from the fact 
that distinct mechanisms operate in female and male gametogenesis. . 
 
Cross-fostering, itself, induced alterations in depressive-
like behaviours demonstrated in the forced swim test in 
males derived from F1 MSUS dams.  In the forced swim 
test,  both male control and MSUS cross-fostered pups 
demonstrated increased latency to float and decreased 
time spent floating (latency to float: F2 control pup raised 
by F1 control dam, 80.4 ± 8.1, n=19; F2 control pup with 
F1 MSUS dam, 115.3 ± 10.2, n=13; F2 MSUS pup raised 
with F1 control dam, 144.0 ± 26.5, n=11; F2 MSUS pup 
raised by F1 MSUS dam, 81.6 ± 6.5, n=16; F(1, 
55)=14.52, p=0.004; time spent floating: F2 control pup 
Figure 16. Reversal of depressive-like behaviours in F2 MSUS mice with acute and chronic 
antidepressant treatment. In the forced swim test (a, d) lower latency to float and (b, e) increased 
time spent floating in saline-treated female F2 MSUS (n=17) versus F2 control (n=14) was reversed 
by both (a, b) acute (1 day) and (d, e) chronic (14 day) treatment with desipramine (F2 MSUS 
n=14, F2 control, n=11) (a, F(3,52)=3.01, p<0.05; b, F(3,52)=2.93, p<0.05; d, F(3,48)=3.51, p<0.05; 
e, (F(3,47)=3.22, p<0.05). In the tail suspension test, (c, f) increased time spent immobile in saline-
treated female F2 MSUS (n=16) versus F2 control (n=14) was reversed by both (c) acute and (f) 
chronic treatment with desipramine (F2 MSUS, n= 14, F2 control, n=11) (c, F(3,50)=5.93, p<0.001; 
f, F(3, 48)=7.29, p<0.001). *, p<0.05, MSUS versus control within generation/drug treatment, #, 
p<0.05, saline versus desipramine within MSUS or control as indicated by Fisher!s PLSD post-hoc 
tests. "
a" b" c"
d" e" f"
Control"
MSUS"
Figure 17.  Anhedonia 
in F2 mice. Lower 
sucrose consumption 
normalized to water 
intake over 4 days in 
female F2 MSUS (n=16) 
versus F2 control mice 
(n=13) t(27)=1.50, ns).!
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raised by F1 control dam, 52.4 ± 8.3, n=19; F2 control pup raised by F1 MSUS dam, 
25.9 ± 4.7, n=13; F2 MSUS pup raised by F1 control dam, 33.5 ± 8.0, n=10; F2 
MSUS pup raised by F1 MSUS dam, 39.1 ± 6.9, n=18; F(1, 56)=4.28, p=0.043).  The 
effect of cross-fostering was specific to males and was not observed in cross-
fostered female F2 mice (latency to float: F2 control pup raised by F1 control dam, 
143.1 ± 22.7, n=16, F2 control pup raised by F1 MSUS dam, 172.8 ± 26.0, n=15; F2 
MSUS pup raised by F1 control dam, 164.9 ± 25.0; F2 MSUS pup raised by F1 
MSUS dam, 147.9 ± 21.0, n=16; F(1, 59)=0.97, p=0.33); time spent floating: F2 
control pup raised by F1 control dam, 27.4 ± 7.2, n=16; F2 control pup raised by F1 
MSUS dam, 25.5 ± 7.3, n=15; F2 MSUS pup raised by F1 control dam, 14.2 ± 3.6, 
n=15; F2 MSUS pup raised by F1 MSUS dam, 31.5 ± 6.6, n=16; F(1,58)=2.16, 
p=0.15).  Both males and females derived from F1 MSUS dams consumed normal 
levels of sucrose, whether raised by control or MSUS dams (male: F2 control pup 
raised by F1 control dam, 275.3 ± 19, n=19; F2 control pup raised by F1 MSUS dam, 
277.2 ± 27.7, n=14; F2 MSUS pup raised by F1 control dam, 308.8 ± 21.5, n=11; F2 
MSUS pup raised by F1 MSUS dam, 335.2 ± 27.9, n= 18; F(1,57)=3.305, ns; female: 
F2 control pup raised by F1 control dam, 274.3 ± 18.4, n=16; F2 control pup raised 
by F1 MSUS dam, 337.8 ± 44.2, n=14; F2 MSUS pup raised by F1 control dam, 
332.7 ± 29.4, n=16; F2 MSUS pup raised by F1 MSUS dam, 311.2 ± 28.5, n=16; 
F(1,57)=1.89, ns). 
 
Due to the increase in novelty-seeking behaviours present in F1 MSUS male and 
female mice, and the sex-specific transmission of these behaviours to their male and 
female offspring, as well as the increased depressive-like behaviours seen in F1 
MSUS males and their female offspring, we wanted to determine the persistence of 
the transmission and confirm that it is germline-dependent, by further testing whether 
the behavioural phenotype could be transmitted to F3 generation. We bred F2 MSUS 
males with wild-type females and generated F3 MSUS offspring under normal rearing 
conditions (Fig. 18). Remarkably, adult F3 MSUS demonstrated similar behavioural 
alterations when exposed to aversive environments as F1 and F2 MSUS mice.   
Female F3 MSUS mice had increased novelty-seeking behaviour in the free 
exploratory paradigm (Fig. 19a), and increased propensity to enter into the aversive 
areas of the open field and elevated plus maze (Fig. 19b, c).  Again, this effect is sex-
specific; F3 MSUS males demonstrate normal behaviour in the open field and 
elevated plus maze, and a tendency towards increased latency to enter the 
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unfamiliar area in the free 
exploratory paradigm 
(latency to enter unfamiliar 
area in the free exploratory 
paradigm: F3 control, 17.4 
± 3.0, n=19; F3 MSUS, 
33.4 ± 7.8, n=18; 
t(21)=1.91, p=0.07; latency 
to enter the center area of 
an open field: F3 control, 
46.2 ± 10.6, n=17; F3 
MSUS, 52.1 ± 8.7, n=17; 
t(32)=0.43; latency to enter 
open arm in the elevated 
plus maze: F3 control, 162.0 ± 22.3, n=20; F3 MSUS, 155.2 ± 19.3, n=19; 
t(37)=0.23).  Despite the fact that female, but not male F2 MSUS demonstrated 
increased depressive-like behaviours in the forced swim test, male F2 MSUS 
transmitted aspects of this enhanced depressive-like behaviour to their male 
offspring.  Male F3 MSUS animals spent overall more time floating in the forced swim 
test than F3 controls, although their latency to float was normal, indicating 
transmission of only some aspects of the immobility response to inescapable stress 
(Fig. 19d, e).  Female F3 MSUS mice demonstrated normal behaviour in the forced 
swim test (latency to float; F3 control, 66.5 ± 5.0, n=20; F3 MSUS, 73.1 ± 8.2, n=15; 
t(33)=0.72, p=0.55; time spent floating; F3 control, 41.2 ± 5.4, n=18, F3 MSUS, 30.5 
± 6.3, n=18; t(35)=1.29, p=0.20).   Both male and female F3 MSUS consumed 
normal levels of sucrose solution, confirming the lack of transmission of this 
behavioural trait (Fig. 19f) (male: F3 control, 264.2 ± 20.5; F3 MSUS, 281.6 ± 24.9, 
n=15; t(37)=0.54, p=0.60; female: F3 control, 290.6 ± 18.2; F3 MSUS, 274.1 ± 15.6, 
n=19; t(37)=0.69, p=0.47). 
 
 
5.3 Aberrant DNA methylation in F1 germ cells and F2 brain 
 
We next investigated the potential mechanisms underlying the inheritance of these 
behavioural traits.  Since transmission occurs independently of maternal care, it is 
Figure 18.  Generation of F3 MSUS and control 
mice. Following behavioural testing, adult F2 
control (blue, left) and F2 MSUS (orange, right) 
males were bred to C57Bl6/J females (black) and 
F3 offspring was raised in normal conditions (no 
maternal separation or maternal stress). !
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likely to be mediated by epigenetic mechanisms in the germline.  DNA methylation is 
a process that can persistently alter chromatin remodeling and gene expression and, 
importantly, can be inherited (Roemer, Reik et al. 1997; Morgan, Sutherland et al. 
1999; Rakyan, Chong et al. 2003; Anway, Cupp et al. 2005; Klose and Bird 2006; 
Nilsson, Anway et al. 2008). To determine whether DNA methylation is involved in 
the observed transmission, we examined the level of methylation in F1 MSUS 
germline of five candidate genes: corticotropin-releasing factor receptor 2 (CRFR2), 
!" #"
$"
Figure 19. Increased novelty-seeking, and depressive-like behaviours in F3 MSUS mice. 
a, b, d, Images of the (a) free exploratory paradigm, (b) open field, and (d) elevated plus maze 
showing representative tracking of position and movements in F3 animals. Aversive areas are 
outlined by blue boxes. F3 MSUS mice (red trace) were more likely to enter aversive areas than 
F3 control mice (black trace) in the (a) free exploratory paradigm, (b) open field, and (d) 
elevated plus maze. a, Shorter latency to enter unfamiliar areas following 24-hour habituation to 
familiar areas in the free exploratory paradigm in female F3 MSUS (n=16) versus F3 control 
(n=18) (t(24)=2.07, p<0.05) mice. b, Shorter latency to enter the center of an open field in 
female F3 MSUS (n=17) than F3 control (n=19) mice (t(27)=2.71, p<0.05). c, Shorter latency to 
first enter into an open arm in the elevated plus maze in female F3 MSUS mice (n=13) 
compared to F3 control mice (n=20) (t(27)=3.77, p<0.01). d, e, On the forced swim test, (d) 
Similar latency to float in male F3 MSUS (n=18) versus F3 control mice (n=18) (t(34)=00.75, 
ns), and (e) increased time spent floating in male F3 MSUS (n=22) versus F3 control mice 
(n=20) (t(40)=2.1, p<0.05). c, Similar sucrose consumption normalized to water intake over 4 
days in male F3 MSUS (n=19) versus F3 control mice (n=19) (t(36)=0.32, ns). *, p<0.05, 
**p<0.01 as indicated by unpaired t-test."
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methyl CpG-binding protein 2 (MeCP2), cannabinoid receptor-1 (CB1), monoamine 
oxidase A (MAOA), and serotonin receptor 1a (5HT1aR).  These five genes were 
selected for their known involvement in emotional processing and have all been 
previously demonstrated to play a regulatory role in behavioural responses to 
stressful situations and in depressive-like behaviours (see discussion 6.2.3 and 6.3). 
To quantify the level of methylation of these genes, MSUS and control mice were 
randomly chosen after behavioural testing, and tissue samples were collected.  Due 
to the prevalence of behavioural abnormalities demonstrated across behavioural 
tests, males were used for molecular analysis in the brain in the case of F1 and 
females in the case of F2.  Genomic DNA was extracted from F1 MSUS male sperm 
cells and subjected to bisulfite conversion followed by pyrosequencing analyses. 
These analyses revealed that methylation in the CpG island surrounding the 
transcription initiation site of CRFR2 was significantly decreased in F1 MSUS sperm 
(Fig. 20a, b). Hypomethylation was prominent in a stretch of the CpG island 
(representing about 25% of CpGs) located 5ʼ of the transcription initiation site. The 
results were verified with bisulfite sequencing of individual sperm cells, which 
demonstrated an increase in the proportion of germ cells with lower methylation 
profiles (Fig. 20c). Next, to examine whether the aberrant methylation was 
transmitted to the offspring, similar analyses were performed in the brain of adult 
female F2 animals derived from F1 males. A comparable DNA hypomethylation in 
the same stretch of the CRFR2 CpG island was detected in female F2 MSUS brain 
(Fig. 20d). Notably, despite the fact that DNA hypomethylation is most commonly 
associated with increased gene expression (Jaenisch and Bird 2003; Caiafa and 
Zampieri 2005; Levenson, Roth et al. 2006; Lubin, Roth et al. 2008, but see also 
Polesskaya, Aston et al. 2006; Kangaspeska, Stride et al. 2008; Metivier, Gallais et 
al. 2008) CRFR2 CpG island hypomethylation was associated with decreased 
CRFR2 expression. Expression was decreased in brain areas involved in emotional 
processing (significantly in cortex and hypothalamus) in female F2 MSUS animals 
(Fig. 20e), and was associated with reduced CRFR2 binding in the lateral 
hypothalamus, a region involved in the regulation of emotional states activated by 
chronic stress (Matsuda, Peng et al. 1996; Winsky-Sommerer, Yamanaka et al. 
2004; Chaki, Funakoshi et al. 2005) (Fig. 21). To test whether the relationship 
between hypomethylation and decreased CRFR2 mRNA expression is causal and 
not correlative, we conducted an in vitro methylation assay using the DNA 
methyltransferase (DNMT) inhibitor, zebularine. Zebularine decreased both DNA 
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methylation and CRFR2 gene expression in a dose-dependent manner (Fig. 22a), 
and the change in CRFR2 gene expression strongly correlated with the change in 
DNA methylation, both in vivo and in vitro (r2=0.979) (Fig. 22b). This confirms the link 
between CRFR2 promoter hypomethylation and reduced CRFR2 expression.  The in 
vitro assay was further validated by demonstrating the effect of zebularine on BDNF 
gene expression, a gene previously demonstrated to be increased following 
hypomethylation (Lubin, Roth et al. 2008; Roth, Lubin et al. 2009) (Fig. 22c).  
 
Figure 20. Hypomethylation of CRFR2 CpG island in F1 MSUS germ line and F2 MSUS brain, 
and decreased CRFR2 expression in F2 MSUS brain. a, Schematic representation of CRFR2 
gene showing the CpG island and transcripion initiation site. Base-pair (bp) annotations are relative 
to the location of the initiation site. Target region used for pyrosequencing to quantify methylation 
represented in blue. b, Reduced methylation in the CRFR2 CpG island in sperm of F1 MSUS mice 
(n=6) compared to F1 control (n=6) mice (F(1,10)=5.31, p<0.05). c,  Increased proportion of 
unmethylated and low-level methylation DNA profiles following bisulfite sequencing in F1 MSUS 
compared to F1 control sperm (n=95 clones for F1 MSUS, n=91 clones for F1 control). Two clones 
different by a single position were treated as having the same methylation profile. Open circles 
represent unmethylated and closed circles represent methylated CG dinucleotides. d, e, Reduced 
methylation (d) in female F2 MSUS brain (cortex) (n=4, F(1,6)=20.66, p<0.05) and (e) reduced 
CRFR2 mRNA expression in female F2 MSUS cortex,  amygdala, and hypothalamus (n=11, 4, 8, 
relatively) compared to F2 control mice (n=12, 7, 8 relatively) (cortex, t(21)=2.31, p<0.05; amygdala, 
t(9)=1.59, ns; hypothalamus, t(14)=2.26, p<0.05). Horizontal bar represents position of sequence 
with significantly reduced methylation in both F1 germ cell and F2 brain as indicated by repeated 
measures ANOVA, *, p<0.05.!
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Since CRFR2 is an important component of stress pathways and plays a key role in 
the integration of neuroendocrine and behavioural responses to stress (Takahashi 
2001), it is likely to contribute to the observed behavioural phenotype. Thus, we 
examined whether its expression is also changed in the brain of F1 MSUS animals, 
and whether any change is associated with altered methylation. Quantitative RT-PCR 
revealed that CRFR2 mRNA expression was normal in cortex, amygdala and 
hypothalamus in male F1 animals (Fig 23b). Consistently, CRFR2 CpG island 
methylation was also not altered in the brain of male F1 animals (Fig. 23a). But 
despite normal CRFR2 mRNA expression and methylation levels, the behavioural 
abnormalities observed in F1 MSUS animals suggested that CRFR2 protein might be 
altered in these animals as well. Therefore, we examined the regional abundance of 
CRFR2 by quantifying receptor-binding. Despite the relatively mild phenotype 
observed in F1 MSUS females, CRFR2 binding was decreased in several brain 
areas including the hypothalamus and the amygdala in female F1 animals (Fig. 24). 
This decrease was specific to these structures and was not observed in 
hippocampus or cortical areas (data not shown). It was also specific for CRFR2, as 
the expression of CRFR1 was not altered in F1 MSUS brain (data not shown). The 
mechanisms involved in CRFR2 down-regulation in hypothalamus and amygdala are 
not known but most likely involve posttranscriptional regulatory processes. These 
results overall suggest that CRFR2 is likely to contribute to the behavioural traits 
observed in MSUS animals. 
 
Figure 21. Reduced CRFR2 binding in female F2 MSUS brain.  a, Reduced CRFR2 
binding in F2 MSUS hypothalamic subnuclei (LH, n=11; PVN, n=10) (LH, t(15)=2.42, 
p<0.05; PVN, t(15)=1.46, ns) compared to control mice (n=9). b, Images of brain 
sections showing Nissl staining and autoradiograms from total and nonspecific (NSB) 
CRFR2 bindings in F2 MSUS and control mice. Number in top right corner of Nissl 
section indicates Bregma position; scale bar 1 mm.* p<0.05 as indicated by unpaired t-
test. Abbreviations: LH, lateral hypothalamus; PVN, paraventricular nucleus. 
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In addition to CRFR2, 
methylation of the CpG 
island surrounding the 
transcription initiation site 
of both MeCP2 and CB1 
genes was altered in male 
F1 MSUS germline but, 
unlike CRFR2, methylation 
was increased (Fig. 25a, b, 
Fig. 26a, b). Importantly, 
hypermethylation of the 
same stretch of CpGs was 
observed in the brain of F2 
MSUS animals, and 
hypermethylation was 
associated with reduced 
mRNA expression of both 
MeCP2 and CB1 genes 
(Fig. 25c, d, Fig. 26c, d).  
 
To investigate whether the 
transmission of aberrant 
methylation profile is 
specific to brain tissue or is 
present across tissues, 
lung and sperm was taken 
from naive randomly 
chosen F2 MSUS  and 
control mice.  Decreased 
methylation of CRFR2 and 
increased methylation of MeCP2 and CB1 was also observed in sperm and lung cells 
of F2 MSUS animals, with some apparent correction in methylation level of CB1 in F2 
MSUS sperm (Fig. 27). 
 
This strongly suggests a broad transmission of the altered methylation profile, and is 
Figure 22.  In vitro assay of the effects of 
hypomethylation on gene expression.  a, Reduced 
CRFR2 methylation (n=5; t(8)=2.63, p<0.05) and 
CRFR2 mRNA expression (right) (n=8; t(13)=2.19, 
p<0.05) in cortex after treatment of acute mouse brain 
slices with 100 µM zebularine.  b, High correlation 
(r2=0.979) between changes in CRFR2 CpG island 
methylation and CRFR2 expression induced by 
zebularine in vitro, and MSUS in vivo (in cortex). The 
MSUS data point represents the average change in 
DNA methylation across the target region.  c, 
Increased BDNF mRNA expression in cortex after 
treatment of acute mouse brain slices with 100 µM 
zebularine (t(5)=2.60, p<0.05). *, p<0.05 as indicated 
by unpaired t-test.!
b!
a!
c!
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consistent with behavioural data from F3 MSUS showing that most, but not all 
behavioural alterations were sex-specifically transmitted to the F3 generation  (e.g., 
latency to float in the forced swim test, and anhedonia in sucrose consumption) (Fig. 
19). It further demonstrates that DNA methylation changes in sperm are not the result 
of environmental factors occurring during behavioural testing, as F2 sperm was taken 
from naive mice.  These data overall indicate that DNA methylation in the germline is 
Figure 24. Reduced CRFR2 binding in F1 MSUS brain.  a, Reduced CRFR2 binding 
in female F1 MSUS hypothalamic subnuclei (n=12) (LH, t(15)=2.44, p<0.05; PVN 
t(17)=3.25, p<0.01) compared to control mice (n=6). c, Reduced CRFR2 binding in 
female F1 MSUS amygdalar subnuclei (BMA, t(13)=2.38, p<0.05; MePV/D, t(14)=3.05, 
p<0.01; CeA, t(14)=2.00, p=0.06), but not in limbic association areas (n=12) (Ect, 
t(10)=1.00, ns; PRh, t(14)=1.04, ns) compared to control mice (n=6). b, d, Images of 
brain sections showing Nissl staining and autoradiograms from total and nonspecific 
(NSB) CRFR2 bindings in (b, d) female F1 MSUS and control mice. Number in top 
right corner of Nissl section indicates Bregma position; scale bar 1 mm.* p<0.05, ** 
p<0.01, as indicated by unpaired t-test. Abbreviations: LH, lateral hypothalamus; PVN, 
paraventricular nucleus; BMA, basomedial amygdala; MePV/D, medial posteroventral 
and medial posterodorsal amygdala; CeA, central amygdala; Ect, ectorhinal cortex; 
PRh, perirhinal cortex.!
a! b!
c! d!
a!
Figure 23. Normal CRFR2 methylation and gene expression in F1 MSUS brain.  a, b, 
Normal CRFR2 gene methylation (a) (n=4, F(1,6)=0.13, ns) and (b) mRNA expression in 
cortex, amygdala, hypothalamus in F1 MSUS brain (n=8) compared to male F1 control mice 
(n=7, 7, 6 relatively) (cortex, t(13)=.015, ns; amygdala, t(13)=0.051, ns; hypothalamus, 
t(12)=1.864, ns).!
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altered bidirectionally by early stress, and that these alterations are transmitted to 
several tissues in the offspring. Notably, the aberrant methylation was specific to 
particular genes, since the methylation profile of MAOA or 5HT1aR was not altered in 
F1 MSUS sperm (Figs. 28, 29). 
 
 
Figure 25. Hypermethylation of MeCP2 CpG island in F1 MSUS germ line 
and F2 MSUS brain, and decreased mRNA expression in F2 MSUS brain. 
a, Schematic representation of (a) MeCP2 showing the CpG island and 
transcription initiation site. Base-pair (bp) annotations are relative to the 
location of the initiation site. Target sequences used for pyrosequencing to 
quantify methylation are represented in blue. b, c, Increased methylation of 
MeCP2 CpG island in (b) sperm of F1 MSUS mice (F(1,7)=6.19, p<0.05) and 
(c) brain of female F2 MSUS mice (F(1,6)=13.31, p=0.01) (sperm, n=4-5; 
brain, n=4).  d, Reduced MeCP2 mRNA expression in female F2 MSUS (n=7) 
compared to F2 control (n=5) brain (t(10)=2.80, p<0.05). For methylation data, 
horizontal bar highlights sequence significantly altered in F1 germ cell and F2 
brain as indicated by repeated measures ANOVA, * p<0.05, ** p<0.01.  For 
gene expression data (d), *, p<0.05, as indicated by unpaired t-test.!
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Figure 26. Hypermethylation of CB1 CpG island in F1 MSUS germ line and F2 
MSUS brain, and decreased mRNA expression in F2 MSUS brain.  a, 
Schematic representation of (a) CB1 showing the CpG island and transcription 
initiation site. Base-pair (bp) annotations are relative to the location of the initiation 
site. Target sequences used for pyrosequencing to quantify methylation are 
represented in blue.  b, c, Increased methylation of CB1 CpG island in (b) sperm 
of F1 MSUS mice (F(1,9)=15.57, p<0.01) and (c) brain of female F2 MSUS mice 
(F(10, 40)=5.26, p<0.01) (sperm, n=5-6, brain, n=3). d, Reduced CB1 mRNA 
expression in female F2 MSUS (n=8) compared to F2 control (n=8) brain 
(t(14)=2.21, p<0.05).  Horizontal bar highlights sequence significantly altered in F1 
germ cell and F2 brain as indicated by repeated measures ANOVA, * p<0.05.  For 
gene expression data (d), *, p<0.05, as indicated by unpaired t-test.!
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Figure 27.  Aberrant methylation in the promoter-associated CpG island of CRFR2, 
MeCP2, and CB1 in F2 MSUS germ line and lung. a, b, Reduced methylation of CRFR2 
CpG island in (a) sperm and (b) lung of male F2 MSUS mice compared to F2 control mice.  
c, d, Increased methylation of MeCP2 CpG island in (c) sperm and (d) lung of male F2 
MSUS mice compared to F2 control mice. e, f, Increased methylation of CB1 CpG island in 
(e) sperm and (f) lung of male F2 MSUS mice. sperm, n=7 MSUS, n=7 control; lung, n=3 
MSUS, n=3 control. !
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Figure 28. Normal methylation of MAOA CpG islands in F1 MSUS germ line. a, 
Schematic representation of MAOA gene showing two CpG islands and transcription 
initiation site. Base-pair (bp) annotations are relative to the location of the initiation site. b, c, 
Absolute level of methylation within identified regions of MAOA in sperm of F1 MSUS and F1 
control mice in (b) CpG island 1 and (c) CpG island 2 (n=6).!
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Figure 29. Normal methylation of 5HT1aR CpG islands in F1 MSUS germ line. a, Schematic 
representation of 5HT1aR gene showing two CpG islands and transcription initiation site. Base-pair 
(bp) annotations are relative to the location of the initiation site. b, c, Absolute level of methylation 
within identified regions of MAOA in sperm of F1 MSUS and F1 control mice in (b) CpG island 1 and 
(c) CpG island 2 (n=6).!
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The present results provide evidence that chronic and unpredictable stress 
experienced during early postnatal development in mice leads to persistent and 
transmissible stress-induced behaviours.  Further, that the transgenerational 
transmission may result from epigenetic inheritance, more specifically the 
transmission of abnormal DNA methylation patterns through the germ line.  Aberrant 
DNA methylation in the CpG islands of several genes have been demonstrated, both 
in the germline of animals exposed to stress, and the female brain and male germ 
cell of their progeny, and this is additionally associated with changes in gene 
expression in the female brain.  The present findings are the first to demonstrate that 
postnatal stress in mice can persistently alter DNA methylation in the germline and 
affect behaviour across generations.  This extends previous findings in plants, 
Drosophila, and mammals, that environmental manipulations or genetic mutations 
can induce epigenetic reprogramming and transmission of disease states (Roemer, 
Reik et al. 1997; Anway, Cupp et al. 2005; Molinier, Ries et al. 2006; Xing, Shi et al. 
2007).  These results demonstrate that unfavourable environmental factors during 
early development can negatively influence behaviour across generations in a sex-
specific manner.  Further, results presented here suggest a mechanism for a 
phenomenon that is well documented in humans and animals but, to this point, has 
been poorly understood (Chong and Whitelaw 2004; Harper 2005; Tsankova, 
Renthal et al. 2007).  
 
 
6.1 Early stress induces transmission of abnormal behaviours across 
generations 
 
Stress during postnatal development induced abnormal behavioural responses on 
initial exposure to aversive environments, as well as depressive-like behaviours in 
adulthood.      The behavioural alterations induced by early stress were sex-specific, 
such that enhanced novelty-seeking was observed in both female and male mice, 
while increased depressive-like behaviours were only observed in male mice.  The 
behavioural effects of the maternal separation itself were mild, in that a somewhat 
large number of animals were behaviourally tested in order to observe significant 
results.  However, some of these behavioural deficits were clearly transmitted to the 
subsequent two generations without any additional environmental manipulation or 
changes in maternal care  through both males and females exposed to the initial 
treatment. Transmission of behavioural alterations was again sex-specific; males 
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transmitted behavioural alterations primarily to female offspring. Moreover, while both 
males and females transmitted enhanced novelty-seeking behaviours similarly, 
depressive-like behaviours were only transmitted through the male line (for summary 
of behavioural data, see Table 2).  Furthermore, depressive-like behaviours were 
only seen in F2 MSUS females and F3 MSUS males, demonstrating that F2 MSUS 
male mice can carry alterations responsible for enhanced depressive-like behaviours 
without, themselves, expressing the aberrant behaviour (Table 2).  Taken together, 
behavioural data suggests the presence of an epigenetic mechanism underlying the 
robust transmission of behavioural abnormalities across generations.   
 
6.1.1 Reduced anxiety or increased risk-taking? 
 
The free exploratory paradigm, open field, and elevated plus maze, were used to 
challenge the animalsʼ response to novel and aversive environments.  These tests 
take advantage of the approach-avoidance conflict naturally occurring in mice when 
exploring a novel area (Cryan and Holmes, 2005).  On the one hand, mice are 
naturally curious and, thus, are motivated to explore a novel environment.  On the 
other hand, they feel fear at the potential dangers associated with the novel arena.  
Additionally, open and unprotected areas are particularly aversive areas of a novel 
arena (Cryan and Holmes, 2005).  Thus, there are two possible interpretations to 
reduced responsiveness to the dangers associated with an aversive  area; either the 
animal feels less stress or anxiety when considering the challenge ahead, or the 
animal displays enhanced novelty-seeking and risk-taking which results in an 
inappropriate assessment of the dangers within the environment prior to exploration 
(Cryan and Holmes, 2005).  The first interpretation is seen as beneficial, while the 
latter is a negative behavioural trait associated with a wide range of personality 
disorders in humans (Hinshaw, 2003).  While perhaps the first explanation is most 
widely published, both interpretations are equally valid when considering the reduced 
latency to enter into the novel or aversive areas demonstrated by maternal separated 
animals and their offspring.  Therefore, in order to make an important discrimination 
between these two interpretations, F2 mice were placed repeatedly in an open field 
to negate the factor of novelty within the environment.  One would expect that if the 
abnormal behaviour in MSUS mice was the result of decreased anxiety they would 
continue to explore the aversive area of an open field more than control mice, despite 
multiple exposures.  However, if the phenotype results from abnormal novelty-
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seeking, MSUS would have normal levels of center exploration when the novelty of 
the environment is no longer a factor.  Here, F2 MSUS mice explored the aversive 
area of the open field more than control mice on initial exposure, but this behaviour 
decreased to normal levels across repeated exposure, confirming that the 
transmissible abnormality in behaviour induced by early stress is indeed a deficit in 
behavioural control, and not reduced anxiety (Fig. 14).  This additional experiment 
highlights the need for caution when interpreting animal behaviour.   
 
6.1.2 Multiple neurochemical pathways involved in transmissible depressive-
like behaviours 
 
Aspects of depressive-like behaviours were also clearly induced by early stress and 
transmitted across generations.  Animals exposed to early stress adopted an 
immobile posture more than control animals (Figure 6), and this was seen across two 
subsequent generations (Figs. 15, 19).  However, traits such as anhedonia (as 
measured by sucrose consumption) and latency to enter into an immobile posture (as 
measured by the forced swim test) showed less penetrance (Figs. 6, 17, 19).  This 
suggests that different molecular mechanisms with altered susceptibility to epigenetic 
inheritance across generations are responsible for the expression of these 
behavioural traits. 
 
The observed depressive-like behaviour in both the forced swim test and tail 
suspension test is immobility, a behaviour which has been associated with an 
absence of escape-directed behaviours and, therefore, has been termed 
“behavioural despair” (Porsolt, Le Pichon et al. 1977).  An alternative theory is that 
immobility represents a coping strategy, similar to the concept of “entrapment” often 
described in depressive patients (Thierry, Steru et al. 1984; Dixon, 1998; Gilbert and 
Allan, 1998; Cryan, Mombereau 2004).  Consequently, immobility may be seen as a 
passive, rather than an active coping strategy, used to deal with stressful stimuli.  In 
fact, animals with high immobility early in the forced swim test stay afloat, while 
animals which continue to struggle become unable to swim, and sink following 
extended exposure to the inescapable stress, providing evidence for the possible 
advantages of immobility as a coping strategy (Nishimura, Tsuda et al. 1988).  Thus, 
here again caution must be used when interpreting this behavioural measure.  
However, whether the floating behaviour observed in MSUS mice is an indication of 
despair or coping, the clear effect of chronic antidepressant treatment (Fig. 16) does 
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suggest that similar neurochemical pathways are being affected by early stress in 
MSUS mice, as in depressive patients. 
 
The tail suspension test has often been termed the “dry” version of the more popular 
forced swim test, as both tests measure time immobile induced by an inescapable 
situation.  However, while the observed behaviour is similar, they are differentially 
affected by antidepressant administration, suggesting the involvement of different 
neurochemical pathways (Bai, Clay et al. 2001; see review Cryan, Mombereau et al., 
2005).  In contrast to the tail suspension test, the forced swim test is not generally 
seen as sensitive to selective serotonin reuptake inhibitors and is ineffective in a 
large proportion of mouse strains (Lucki, Dalvi et al. 2001).  Furthermore, several 
atypical antidepressants, like rolipram (a type 4 cyclic adenosine monophosphate-
specific phosphodiesterase inhibitor) and levoprotiline (a histamine H1 receptor 
antagonist), affect depressive-like behaviour in the forced swim test, but not in the tail 
suspension test (Maj, Rogóź et al., 1990; Noguchi, Fukuda et al., 1992).  Additionally, 
there are also differences in sensitivity and in dose response curves to 
antidepressants between the two tests.  While in the forced swim test, increasing 
doses of antidepressants tend to have a bi-phasic or U-shaped dose response, they 
have a linear response in the tail suspension test (Porsolt, Le Pichon et al. 1977; Bai, 
Clay et al 2001; Li, Tizzano et al. 2001; Cryan, Mombereau et al. 2005).  As well, 
decreased gamma-aminobutyric acid (GABA)-B signaling via administration of an 
antagonist or with genetic knockout reduces depressive-like behaviours in the forced 
swim test, but not in the tail suspension test (Mombereau, Kaupmann et al. 2004).   
 
Due to the volume of evidence suggesting the involvement of different neurochemical 
pathways in the immobility response to the forced swim test and the tail suspension 
test, it may not be surprising that a differential effect of enriched environment on 
MSUS and control mice was observed in the forced swim test and tail suspension 
test.  Thus, in the present study, both short-term and long-term enrichment 
completely reversed the depressive-like behaviours in maternal separated animals in 
the tail suspension test, but had no effect in the forced swim test (Fig. 7).  This 
suggests that depressive-like behaviours in MSUS mice are the result of changes in 
several neurochemical pathways, of which enriched environment may only affect 
one.  The clear reversal of immobility in the tail suspension task by enriched 
environment suggests that enriched environment may be altering the serotonergic 
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pathway, similar to the effect seen with selective serotonin reuptake inhibitors in the 
tail suspension test. 
 
6.1.3 Maternal care and environmental factors do not play a role in the 
transmission of behavioural traits 
 
While there was a clear transmission of an abnormal response to stressful situations, 
F2 MSUS dams did not provide abnormal maternal care to their offspring (Fig. 9).  
This, despite the fact that they themselves received poor maternal care during the 
maternal separation procedure (Fig. 2a, b).  This is in contrast to studies done in rats 
that have shown behavioural transmission of differential maternal care (Francis, 
Diorio et al. 1999; Champagne, Francis et al. 2003; Weaver, Cervoni et al. 2004; 
Weaver, Chapagne et al. 2005).  The difference between these previous studies and 
the one presented here may be due to the fact that previous studies observing a 
transmission of chronic (permanent) poor mothering results from a natural trait in 
female rats (high ABN-LG dams versus low ABN-LG dams). Such poor mothering, 
here characterized by low licking/grooming, is much more severe than the MSUS 
manipulation because it results in a persistent deficit in maternal behaviours 
experienced by the pups consistently throughout the day and throughout postnatal 
development until weaning. Our manipulation is restricted to only two weeks 
postnatal, with maternal care returning to normal levels during the second week of 
treatment (Fig. 2a, b).  Consequently, the two-week treatment mainly perturbs the 
natural rhythm and regularity of care rather than its overall amount, as some 
compensation has previously been observed immediately after separation (data not 
shown).  Additionally, care is reduced approximately five-fold, both in duration and 
number of licking/grooming bouts, in low licking/grooming rat dams compared to high 
licking/grooming dams (see for instance Champagne, Francis et al., 2003) in rat 
studies, while it was reduced by only 10-15% in MSUS mice compared to controls 
(Fig. 2a, b). The milder impact of MSUS on maternal behaviours most likely explains 
why maternal care is not a transmissible behaviour in the case of our maternal 
separation paradigm. 
 
Observation of maternal care provided to F2 is necessary to ensure that postnatal 
environment is not a factor in the behavioural transmission demonstrated.  Many 
measures of maternal care were observed, including several types of nursing 
behaviours and time spent off-nest, and F1 MSUS provided normal maternal care in 
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all measures.  However, despite careful monitoring of maternal care it is clear that 
not all changes in postnatal environment can be observed externally.  Nevertheless, 
several additional pieces of evidence suggest that behavioural transmission is not 
due to differential rearing environments.  Cross-fostering studies demonstrated that 
F2 control animals raised by F1 MSUS did not display any of the behavioural 
abnormalities present in F2 MSUS (Fig. 13).  Perhaps the strongest piece of 
additional evidence is that F1 MSUS males also transmit the environmentally-
induced behavioural abnormalities, even to a greater extent than F1 MSUS females, 
despite being separated from females immediately after breeding.    
 
Furthermore, it is important to note that chronic and unpredictable separation induces 
behavioural abnormalities two generations downstream of the original manipulation.  
This is important for reasons often overlooked in transgenerational epigenetic 
research (reviewed in Skinner, 2008).  While transmission to F2 alone does suggest 
epigenetic, and not environmental factors, it does not completely rule out 
environmental influence, since the germ line which will ultimately generate F2 is 
present in F1 during the time of the postnatal treatment (Fig. 30).  Although this may 
be unlikely, transmission to F3 is nonetheless important to demonstrate that the 
phenotype is indeed transgenerational, germ line dependent, and not the direct effect 
of the treatment itself (Skinner 2008).  Here, early stress induces a phenotype which 
is transmitted through the paternal line at least two generations downstream, thereby 
ruling out any environmental basis for this transmission. 
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6.2 Early stress induces abnormal DNA methylation in the germline and 
in the brain of the subsequent generation 
 
DNA methylation is an important mechanism for transcriptional regulation, and its 
establishment and maintenance are dynamically controlled during development 
(Klose and Bird 2006).  In germ cells, it is acquired over successive prenatal and 
postnatal stages and is completed after birth (Chong and Whitelaw 2004; Trasler 
2006).  Aberrant DNA methylation is associated with multiple diseases including 
cancer, psychiatric disorders, immune and metabolic diseases (Egger, Liang et al. 
2004; Anway, Cupp et al.; Jirtle and Skinner; Tsankova, Renthal et al. 2007; Wilson, 
Power et al. 2007).  Further, environmental factors such as chemicals, nutritional 
Figure 30.  F1 MSUS germ cells are present at time of treatment.  
Schematic demonstrating the presence of F1 MSUS germ cells during 
the treatment of F1 MSUS with maternal separation, thus making the F3 
generation the first generation not directly exposed to the the treatment.  
Adapted from Skinner 2008. !
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factors, hormonal manipulations and aging are known to contribute to abnormal DNA 
methylation (Rakyan, Chong et al. 2003; Anway, Cupp et al. 2005; Weaver, 
Champagne et al. 2005; Blewitt, Vickaryous et al. 2006; Nilsson, Anway et al. 2008).  
The present findings newly demonstrate that early life stress can also alter DNA 
methylation in sperm cells, and that the alterations persist and are transmitted to 
subsequent generations.  These findings significantly extend previous data showing 
that DNA methylation in the brain is influenced by environmental factors such as 
maternal care, and recent evidence that early stress can result in transgenerational 
transmission of abnormal methylation in the brain (Weaver, Cervoni et al. 2004; Roth, 
Lubin et al. 2009).  Additionally, these findings provide novel evidence that maternal 
care and inheritance of behavioural traits can be dissociated. Notably, the present 
findings indicate that the sensitivity to early stress is locus-dependent, since only 
three of the five genes investigated are affected, and suggest a differential sensitivity 
within the genome to stress-induced epigenetic regulation.  Furthermore, the affected 
loci are perturbed differently, with some being hypomethylated (CRFR2) and others 
hypermethylated (MeCP2 and CB1) suggesting locus-specific regulation of 
methylation levels.  Finally, it should be noted that even if only examined in the male 
germline, aberrant DNA methylation may also occur in oocytes since some of the 
MSUS-induced behavioural traits were similarly transmitted by F1 females and 
males. 
 
6.2.1 Aberrant DNA methylation and associated gene expression changes 
 
It is particularly interesting to note that the subtle change in DNA methylation (1-5% 
absolute value) is associated with a proportionally greater reduction of CRFR2 
expression (12-45%) in female F2 MSUS brain. This amplifying effect on gene 
expression was true for both F2 MSUS mice (in vivo) and acute brain slices (in vitro) 
and was present to a similar extent in both conditions (Fig. 22b).  This suggests that 
differential methylation at any (or a few) CpGs within the identified region is sufficient 
to affect gene expression.  This extends previous evidence demonstrating that it is 
the density of DNA methylation rather than the pattern of DNA methylation itself 
which is most important for regulating gene transcription (Boyes and Bird, 1992; 
Lorincz, Schubeler et al, 2002).  Evidence from MSUS mice suggest that a change in 
methylation at a subset of CpGs within the identified regions is sufficient to alter local 
chromatin structure and thereby modify the access that transcription factors have to 
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the underlying DNA strand (Jaenisch and Bird 2003; Wang, Wysocka et al. 2004; 
Richards 2006).   
 
A single nucleosome consists of approximately 145 bp wrapped around an octamer 
of histones.  Here, differential methylation was found across stretches of 
approximately 110-120 bp for CRFR2 and MeCP2, and 60 bp for CB1.  Thus, it is 
possible that abnormal methylation at a subset of these CpGs may affect the 
wrapping within a particular nucleosome important for establishing the rate of gene 
transcription.  Furthermore, the relatively large change in gene expression and the 
modest change in DNA methylation is associated with altered behaviour of the 
animal, however the extent to which each gene contributes to the behavioural 
phenotype is not known (discussed below in 6.3).   
 
It is also important to realise that while the effect on DNA methylation is small in 
absolute terms, due to the low levels of overall methylation, when calculated in 
relative terms these changes are quite substantial and likely to have a considerable 
biological impact.  Thus in F1, an overall 10% decrease in DNA methylation is 
observed for CRFR2, 40% increase for MeCP2, and 30% increase for CB1 in sperm.  
The finding that CpG islands are minimally methylated under normal conditions is 
consistent with previous data, and the biological impact of small changes in 
methylation has already been demonstrated for several genes in the context of 
cancer (Wilson, 2007).  
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The difference in CRFR2 methylation 
demonstrated by Pyrosequencing in 
F1 sperm was confirmed by repeating 
the methylation assays using 
classical bisulfite sequencing. These 
assays showed a comparable 
reduction in DNA methylation on the 
CRFR2 promoter of approximately 
10% in MSUS germ cells compared to 
control (Fig. 31).  Pyrosequencing 
data presented here also shows that 
the absolute value of DNA 
methylation is overall similar in brain, 
sperm, and lung although the profile 
of methylation differs slightly across 
tissues. This suggests the possibility that different mechanisms of establishment 
and/or maintenance of DNA methylation may be recruited in different tissues, as has 
been previously reported in the literature (Latham, 1995; Hanel and Wevrick, 2001; 
Raiche, Rodriguez-Juarez, et al., 2004; Ohgane, Hattori et al. 2005; Watanabe, 
Uchiyama, et al. 2006).  
 
 
6.2.2  Aberrant germ cell methylation is associated with a high transmission 
rate of behavioural abnormalities 
 
The subtle change in DNA methylation in the germline is also associated with a high 
degree of behavioural transmission of specific traits induced by maternal separation.  
Consequently, while the behavioural effects of the maternal separation itself are 
relatively mild, the transmission of these subtle behavioural abnormalities is robust 
across generations in a sex-specific manner.   Thus, while there is correction of 
anhedonia across generations, there is no reduction in abnormal behaviours resulting 
from initial exposure to an aversive environment or in time spent immobile when 
faced with inescapable stress observed in the male line.    Considering that altered 
DNA methylation at a subset of CpGs in the identified region is sufficient to induce 
changes in gene expression, this implies that MSUS alters DNA methylation not only 
in 1-5% of germ cells, which would result in 1-5% of inheritance, but rather at 
Figure 31. Comparison of Pyrosequencing 
and bisulfite sequencing of CRFR2 in F1 
sperm.  Similar reduction in DNA methylation 
at the CRFR2 promoter in germ cells between 
MSUS and control samples whether 
assessed by pyrosequencing (Pyro.) or 
bisulfite sequencing (Bisulf.) (Pyro. n=5-6; 
Bisulf., n=91-95 clones from 1 F1 control and 
1 F1 MSUS). !
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individual CpG sites in the identified region with a 1-5% probability (Fig. 32). This is 
further demonstrated by bisulfite sequencing of individual sperm cells that 
demonstrated an increase in the proportion of germ cells with DNA profiles 
characterized by lower levels of methylation (Fig. 20c). In addition, since F2 MSUS 
are only inheriting one affected allele, the high rate of transmission further suggests 
two possibilities for the underlying mechanism of transmission, of which one or both 
may be occurring. The first possibility is that maternal separation induces aberrant 
expression of factors which regulate DNA methylation inside the sperm head. These 
factors may act to alter methylation on the paternal allele within the sperm cell, and 
can be transferred on fertilization, to act on methylation on the maternal allele.  The 
second possibility is that there is a mechanism by which methylation patterns from 
one allele is copied to the homologous allele after fertilization.  Epigenetic 
mechanisms through which either situation can occur have been previously 
proposed.  The first may occur by paramutation, in which the epigenetic state at one 
allele is conferred to the homologous allele in a meiotically heritable manner and the 
second, by transvection, in which the epigenetic state at one allele is conferred to the 
homologous allele in a mitotically heritable manner (Rassoulzadegan, Magliano, et 
al. 2002; Herman, Lu et al. 2003; Rassoulzadegan, Grandjean et al. 2006; Ashe and 
!"#$%&'()%
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Figure 32.  Two possible explanations for transmission of behavioural traits due to 
aberrant DNA methylation in germ cell.  Representation of two sperm samples with 
identical levels of overall methylation at each of the five CG sites (80% methylation; black 
circles). If only one unmethylated CG site (white circle) is necessary for transmission of a 
certain behavioural trait (purple mice), then example 1 results in a low transmission rate, 
and example 2 results in a high transmission rate to the next generation.  !
Example 1  
(low transmission rate) 
Example 2  
(high transmission rate) 
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Whitelaw, 2007; Wagner, Wagner et al. 2008).  Both phenomena have been 
demonstrated in mice and paramutation have been demonstrated to be RNA-
mediated (see also 1.3.2). 
 
While the precise nature of the mechanism underlying the high transmission rate of 
environmentally-induced transgenerational epigenetic effects is not known, this 
phenomenon has been observed previously in several rodent studies.  Similar to the 
present findings, a model of early abuse induced DNA methylation changes to a 
similar degree in the brain of both male and female animals exposed to early trauma 
and the  male and female offspring of females exposed to the early abuse (Roth, 
Lubin et al. 2009).  Likewise, chemicals in the pre- and postnatal environment induce 
a wide range of adult-onset disease states and fertility abnormalities to a similar 
magnitude from F1 through F4 offspring, also as a result of the transmission of 
abnormal levels of DNA methylation (Anway, Cupp et al. 2005; Anway, Leathers et 
al. 2006; Anway, Memon et al., 2006; Anway, Rekow et al. 2008; Nilsson, Anway et 
al. 2008).  Thus, it is likely that there are many circumstances in which one or both of 
these mechanisms occur and result in a high rate of transmission of environmentally 
induced abnormalities.  However, further research is required to better understand 
the extent to which these mechanisms are occurring in mammals. 
 
Female offspring of male F1 MSUS mice appear to be more susceptible to 
transmission of aberrant behavioural traits induced by early trauma than male 
offspring, except for behaviors on the elevated plus maze which were consistently 
transmitted to both F2 females and F2 males. The reason for the sex-biased 
expression of the behavioral traits induced by early trauma is not yet known.  One 
potential mechanism may involve sex steroids, in particular, 17β-estradiol and 
testosterone. Both have been previously associated with altered level of methylation 
in a gene-specific manner in the mouse brain (Mani and Thakur, 2006; Singh and 
Prasad, 2008), and estradiol has also been suggested to decrease DNMT activity 
(Singh and Prasad, 2008).  Thus, it is possible that the presence of male sex steroids 
may correct transmissible methylation in the brain of male offspring (only in the brain, 
not in the germline), and/or the presence of female sex steroids may act in concert 
with altered DNA methylation present in MSUS mice resulting in the observable sex-
specific behavioural abnormalities.  If the former is occurring, then the data also 
suggests that the presence of male sex steroids cannot correct abnormal methylation 
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of DNA in the germ cell (Fig. 27a, c, e), thus resulting in the transmission of 
behavioural abnormalities to the F3 generation, despite normal behavior in the male 
F2 MSUS mice. Indeed, changes in DNA methylation were consistently observed in 
both F1 and F2 sperm despite the fact that aspects of the behavioral traits were not 
fully expressed by males. This strongly indicates transmission of the profile of DNA 
methylation in the germline, with potential correction in the brain. Parent-of-origin 
susceptibility to transmission of methylation patterns has been previously suggested 
by sex-dependent effects of imprinted genes (Hager, Cheverud et al. 2008).  While 
such sex-linked epigenetic mechanism is not yet determined, it has been suggested 
that sex-dependent trans control of expression, i.e., differential expression at a sex-
specific modifier locus during gametogenesis, may be responsible (Hager, Cheverud 
et al. 2008).  If females are indeed more susceptible to epigenetic inheritance of 
stress-induced behavioural traits, this may be a contributing factor to the increased 
incidence rate of stress-induced affective disorders in the female population. Finally, 
a bias towards a transmission to females from fathers has been recently 
corroborated by a new study in mice showing an association of paternal open-field 
activity with the open-field activity of female but not of male offspring (Alter, Gilani et 
al. 2009). This data strongly suggests an epigenetic mode of transmission.  
 
6.2.3 Differential methylation resulting from early stress is gene-specific 
 
The high proportion of genes with methylation abnormalities (three of five candidates) 
results from the fact that these genes were carefully selected, and are not 
representative of the entire genome.  New advances made towards high-throughput 
analyses across the epigenome will help better establish the extent of methylation 
changes induced by early stress, as well as the extent of transmission of aberrant 
methylation to the brain of the offspring.  The two genes which did not demonstrate 
changes in DNA methylation in their CpG islands were both chosen as candidate 
genes because of the well-known link between the serotonergic system and 
depression-like behaviours.  MAOA is an enzyme that catalyzes the degradation of 
the neurotransmitter serotonin.  A deficiency in MAOA enhances emotional learning 
(Kim, Shih et al. 1997), and decreases time spent floating in the forced swim test in 
mice (Cases, Seif et al. 1995). It is also known that MAOA is increased following 
chronic stress (Filipenko, Beilina et al. 2002).  5HT1a receptors are present both 
presynaptically as autoreceptors in the dorsal and median raphe nuclei, and 
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postsynaptically throughout the forebrain including the hippocampus and amygdala.  
Mice deficient for 5HT1aR demonstrate enhanced fear responses (Klemenhagen, 
Gordon et al. 2006; Tsetsenis, Ma et al. , 2007).  Additionally, the 5HT1aR is a 
known target for antidepressants (for a review see Cryan, Valentino et al. 2005), and 
in vivo studies in humans have shown that patients with panic disorder or major 
depression have a reduction in 5HT1aR receptor binding in many areas of the brain 
(Sargent, Kjaer et al., 2000; Nash, Sargent et al. 2008).  While it has been generally 
accepted that methylation levels in the promoter-associated CpG island of a gene is 
most likely to cause gene expression changes, it is now clear that methylation levels 
elsewhere within the gene may also have an effect (Flanagan and Wild, 2007; Song, 
Mahmood et al., 2009).  Thus, the possibility that methylation levels may be altered 
elsewhere within these genes and that this may also affect gene expression of 
MAOA or 5HT1aR can not be ruled out at this time. 
 
6.2.4 Alterations in CRFR2 protein levels in the brain of F1 MSUS are 
associated with changes in CRFR2 methylation in the germline 
     
It is interesting that there was no difference in CRFR2 methylation in male F1 MSUS 
brain, but reduced CRFR2 binding in the hypothalamus and amygdala in the F1 
MSUS female brain, and reduced CRFR2 methylation in F1 MSUS sperm.  Since 
female F1 MSUS displayed a relatively milder behavioural phenotype than male F1 
MSUS mice, it is likely that male F1 MSUS also demonstrate reduced CRFR2 
binding.  While this can not be confirmed, it is nonetheless important to consider a 
possible mechanism by which changes induced by maternal separation in F1 MSUS 
brain at the protein level may be associated with changes in sperm at the level of the 
epigenome.  It is well known that the central nervous system can regulate gonadal 
function via the neuroendocrine system, and it has been recently established that 
there are certain brain areas directly connected with the gonads in a pituitary-
independent manner (Gerendai, Toth et al. 2000).  Importantly, there are descending 
connections from the amygdala, and regions of the hypothalamus important in 
emotional response, including the lateral hypothalamus and paraventricular nucleus 
of the hypothalamus, to the testis.  These connections are known to exert a direct 
effect on local endocrine release, and have been suggested to be responsible for 
mediating subtle regulation of gonadal function (Gerendai, Banczerowski et al. 2005). 
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6.3 Early stress induces changes in gene expression in the subsequent 
generation 
 
The present findings show that changes in DNA methylation affect several genes 
involved in stress coping in different brain areas, only a small number of which were 
identified in this study, and suggest that the observed behavioural phenotype results 
from the combination of alterations in these genes. The extent to which each 
individual gene contributes to the behavioural phenotype is not known and is difficult 
to evaluate at this point.  However, all candidate genes were chosen based on their 
known involvement in stress and emotional pathways.  Below is a brief description of 
these genes and evidence for their involvement in stress-related behavioural 
responses. 
 
6.3.1 CRFR2 
 
CRFR2 is a seven-transmembrane G-protein coupled receptor, which signals mainly 
by coupling to Gs, thereby activating adenylyl cyclase and protein kinase A.  There 
are four known ligands for CRFR2: corticotropin releasing factor, urocortin I, urocortin 
II, also know as stresscopin-related gene, and urocortin III, also known as 
stresscopin.  Corticotropin-releasing factor has a much higher affinity for CRFR1, 
urocortin I has equal affinites for CRFR1 and CRFR2, and urocortin II, and urocortin 
III appear to be selective for CRFR2 (for reviews, see Perrin and Vale 1999; 
Dautzenberg and Hauger 2002; Bale and Vale 2004).  In rodents, CRFR2 has two 
splice-variants, CRFR2α and CRFR2β, which are produced by alternate 5ʼ exons 
(Chen, Perrin et al. 2005).  CRFR2α is the predominant splice variant in rodent brain 
and CRFR2β is the predominant isoform in the periphery (Chen, Perrin et al. 2005). 
This differs from humans in which CRFR2α and not CRFR2β is the predominant 
isoform in the periphery (Kostich, Chen et al. 1998).  In the present study, 
methylation levels were quantified in the CpG island 5ʼ to the start site of CRFR2α. 
 
In contrast with CRFR1, CRFR2 is thought to reduce the stress response and has 
previously been associated with exploration in aversive environments and 
depression-like behaviours (Bale and Vale, 2004). Pharmacological antagonists to 
CRFR2 increase exploratory activity in aversive environments in mice 
(Pelleymounter, Joppa et al. 2002; Pelleymounter, Joppa et al. 2004), and CRFR2 
deficient mice spend more time floating in the forced swim test (Pelleymounter, 
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Joppa et al. 2002; Bale and Vale 2003; Pelleymounter, Joppa et al. 2004).  These 
findings mimic the behaviours demonstrated by MSUS mice, which also display 
reduced CRFR2 gene expression and receptor binding.   
 
6.3.2 MeCP2 
 
MECP2 binds both methylated DNA and transcriptional repressor complexes, and 
thus was previously thought to function as a global transcriptional repressor (Lewis, 
Meehan et al. 1992; Nan, Campoy et al. 1997).  However, recently it was 
demonstrated, with the use of MeCP2-null and overexpressing mice, that the majority 
of genes are activated by MeCP2 and thus, that MeCP2 acts as both an activator 
and a repressor (Chahrour, Jung et al. 2008).  MeCP2 has also been suggested to 
interact with DNMT1, suggesting that it may guide DNMT1 to sites which require 
methylation following replication (Kimura and Shiota 2003).  Furthermore, biophysical 
studies have suggested that MECP2 may act in a methylation- and HDAC-
independent fashion to induce chromatin condensation via a chromatin-condensing 
domain (Georgel, Horowitz-Scherer et al. 2003).  While the majority of studies 
involving the functional relevance of MeCP2 have focused on Rett syndrome, a 
neurodevelopmental disorder resulting from mutations in MeCP2, it has also been 
demonstrated that mice deficient for MeCP2, demonstrate increased aggression and 
have a heightened behavioural and physiological response to stress (Gemelli, Berton 
et al., 2006; McGill, Bundle et al. 2006; Fyffe, Neul et al. 2008).    Additionally, 
MeCP2 has been demonstrated to bind the CRF promoter suggesting that MeCP2 
can modulate CRF expression (McGill, Bundle et al. 2006).  Furthermore, MeCP2 
protein levels in the hippocampus are decreased by chronic stress (Dyuzhikova, 
Savenko et al. 2006). 
 
6.3.3 CB1 
 
CB1 is a presynaptic receptor which binds to endocannabinoids released into the 
synapse by the postsynaptic neuron.  Once activated they inhibit the release of 
neurotransmitters.  Pharmacological blockade of CB1 or elimination by gene knock-
out also alters emotionality in mice (Haller, Bakos et al. 2002; Martin, Ledent et al. 
2002; Griebel, Stemmelin et al. 2005; Rutkowska, Jamontt et al. 2006; Steiner, 
Wanisch et al. 2007).  CB1 knockout mice have increased expression of CRF mRNA 
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in the hypothalamus, decreased expression of GR mRNA in the CA1 subregion of 
the hippocampus, and release higher levels of ACTH and glucocorticoids during a 
stressful event (Haller, Varga et al. 2004; Cota, Steiner et al. 2007).  Thus, CB1 has 
been linked with basal HPA-axis function. 
 
6.3.4 The effect of maternal separation is multigenic 
 
Due to the multigenic effect of the maternal separation treatment, the extent to which 
these genes are mediating the behavioural effects observed can not be determined 
at this time.   It is likely that it is the interaction of many genes that induces the 
behavioural phenotype seen in MSUS.  This is clearly demonstrated by data from 
bisulfite sequencing of CRFR2 in the F1 sperm cell in which there is a range of 
different profiles of DNA methylation in both F1 control and F1 MSUS mice.  While 
there is an overall shift towards unmethylated DNA in F1 sperm cells, each F2 MSUS 
comes from a single sperm cell.  Thus, the high rate of behavioural transmission 
suggests that the behavioural phenotype is not the result of altered methylation in 
CRFR2 alone, but is likely to involve interactions between several genes in a sex-
specific manner.  Data from genome-wide methylation and gene expression assays 
will help to discern the extent of the transmissible changes induced by maternal 
separation.  However, behavioural results from gene-targeting and pharmacological 
studies do suggest that alterations in the expression levels of CRFR2, MeCP2, and 
CB1 in MSUS mice are a contributing factor to the aberrant response to stressful 
environments observed in MSUS mice. 
 
 
6.4 The use of environmental manipulations as animal models for 
human situations 
 
6.4.1 Maternal separation involves multiple factors which could contribute to 
behavioural and methylation abnormalities 
 
Unlike the pharmacological or gene manipulation studies described above, maternal 
separation induces widespread and global changes in mice exposed to the 
treatment.  This points to both the benefits and disadvantages using differential 
environments, such as maternal separation, or enriched environment, in animal 
research.  Thus, environmental manipulations like maternal separation offer the 
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benefit of applying ethogically valid environments to mice, with easy-to-draw parallels 
to human situations and disorders.  For example, mice exposed to MSUS are reared 
in a stressful and unpredictable environment during the time when they are most 
dependent on dams for care, clearly mimicking aspects of detachment or poor 
parental relationships which may occur during childhood in humans.  Unfortunately, 
due to the global nature of this treatment, it is difficult to evaluate the precise cause 
of the induction of abnormalities in animals exposed to maternal separation.  For 
instance, from the data presented here, it is clear that maternal care provided to pups 
undergoing maternal separation is perturbed.    However, maternal separation in 
combination with maternal stress has multiple long-term effects on the behavioural 
response of the dam, including reduced motivation to explore and inappropriate 
behaviours towards aversive environments, suggesting that a variety of 
neurochemical and hormonal pathways may be affected  in F0 MSUS dams during 
the treatment (Figs. 3, 4).  Interestingly, in F0 control dams, the natural fluctuation in 
caregiver traits which occurs across animals is correlated with their innate 
behavioural responses to the aversive areas of the elevated plus maze (Fig. 4d-f).  
However, this was not the case in F0 MSUS dams, further demonstrating that 
behaviour in F0 MSUS dams is greatly perturbed by the maternal separation 
paradigm used here.  Therefore, considering the obvious stress which the dams 
undergo during maternal separation, and its long-term ramifications, it is especially 
important to consider that there are factors other than maternal care received, which 
may be the cause of the behavioural abnormalities and associated methylation 
changes observed in F1 MSUS mice.  In particular, along with abnormal maternal 
care, the effect of the stress on the dam is likely to alter milk content, including stress 
hormone levels present in the milk that is provided to the pups.   
 
Additionally, the effects of the maternal separation paradigm may be due to factors 
which occur during the period of separation itself. For instance, during the period of 
separation, the nest temperature of the pups is not regulated.  Nest temperature has 
previously been shown to be important for healthy development in mice, most likely 
due to the additional energy expenditure, and brown fat thermogenesis required for 
survival at reduced temperatures (Haidmayer and Hagmüller 1981; Schneider, 
Hamilton et al. 1987; Bult and Lynch 2000).  This additional energy expenditure may 
be especially difficult for the pups as milk is not provided during the three-hour 
separation.  Furthermore, we have observed that licking/grooming activity occurs 
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quite frequently (10-15% of the time) during the first postnatal week under normal 
conditions (data not shown), and this important aspect of postnatal environment is 
absent during the three-hour separation.  Previous findings have suggested 
licking/grooming to be a particularly important aspect of the effects of maternal 
separation as several studies have shown that the effects of maternal separation on 
rat pups are not present if pups are artificially stroked and fed during the separation 
period (van Oers, de Kloet et al. 1999; Groer, Hill et al. 2002).  Due to the number of 
factors likely to contribute to the phenotype presented here, it is not possible to 
pinpoint at this time which are involved, and to what extent their involvement is 
necessary for the induction of the behavioural phenotype or for behavioural 
transmission to occur.  However, it is likely that a combination of these factors 
induced by the severity of the treatment is required for such persistent 
transgenerational changes to occur. 
 
6.4.2 Extrapolating postnatal manipulations from mouse to human 
 
Another limitation to postnatal manipulations in mice occurs when drawing parallels 
between the animal model and human circumstances due to differences in 
developmental rate.  This is because mice are born extremely immature; anatomical 
studies have suggested that humans are born at a stage of development similar to 
that of third postnatal week in the mouse (Clancy, Darlington et al. 2001).  That being 
said, mice are able to live independent from the dam as early as two to three weeks 
post-delivery (soon after eye-opening), while humans are dependent on their parents 
for many years following birth.  Thus, the maternal separation treatment occurs 
during the entire two week period, from a time of extreme immaturity which might 
parallel prenatal development in humans, to a time of near independence from the 
litter, making it difficult to extrapolate, from the mouse data, a critical period for the 
effects of differential environment in humans.   
 
6.4.3 Enriched environment as a means of reversing disease states 
 
Similarly, many factors are known to be involved in the effect of enriched 
environment.  Mice living in enriched environment have greater somatosensory, 
olfactory, and visual input, as well as increased cognitive stimulation due to 
enhanced spatial complexity, object recognition, and novelty within the environment.  
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These enhancements to the environment are known to affect various cortical areas, 
the cerebellum, and the hippocampus (for reviews, see Nithianantharajah and 
Hannan 2006; Laviola, Hannan et al. 2008).  In particular, enriched environment is 
thought to increase the  expression of genes which promote cellular plasticity and 
reduce cell death, such as the neurotrophins (Faherty, Raviie Shepherd et al. 2005; 
Franklin, Murphy et al. 2006; Wolf, Kronenberg et al., 2006; Spires, Grote et al. 
2004).  Enriched environment has also been effective in rodent models of 
Alzheimerʼs disease, Parkinsonʼs disease, Huntingtonʼs disease, and traumatic brain 
injury (Passineau, Green et al. 2001;  Spires, Grote et al. 2004; Faherty, Raviie 
Shepherd et al. 2005; Wolf, Kronenberg et al. 2006).   
 
In addition to its effectiveness in the above-stated disease models, enrichment has 
also been shown to be beneficial in ameliorating the symptoms of stress-induced 
depression.  In rats exposed to juvenile stress (PND27-29), living in enrichment 
during adulthood reversed depressive-like behaviours in two-way shuttle avoidance 
learning (Ilin and Richter-Levin, 2009).  Further, several studies have shown that 
enriched environment post-weaning is effective in reversing depressive-like 
behaviours in the forced swim test induced by either prenatal or postnatal stress 
(Yang, Li et al. 2006; Bhansali, Dunning et al. 2007).  However, similar to the present 
experiment, it has also been reported that post-weaning enrichment can not reverse 
the depressive-like behaviours in the forced swim test induced by postnatal stress 
(Cui, Yang et al. 2006).  Such conflicting reports of the effect of enriched environment 
is frequent due to the lack of standardization of enrichment protocols across labs and 
experiments.  In fact, Donald Hebb first used the term when comparing observations 
he had made about the behavioural differences in rats allowed to roam freely in his 
home versus those in the laboratory (Hebb 1947).  While enriched environment 
experiments run currently are more controlled than this, there are still several factors 
which remain variable from lab to lab.  For instance, many enriched environments 
involve the placement of objects which are rotated during the treatment.  These 
objects, as well as the number of times these objects are changed, are not standard 
and the objects themselves are often not well described in published accounts.  The 
use of running wheels in the enriched environment is also not standardized, neither 
in their usage or in the number of running wheels available.  Enrichment can also 
involve housing one strain of mice with a strain of mouse less susceptible to stress 
(Holmes, le Guisquet et al. 2005; Bhansali, Dunning et al. 2007).  The protocol itself 
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may vary in whether the animals are housed permanently in an enriched 
environment, or placed in an enriched environment for a period of time each day.   
 
Due to the variety of enrichment protocols currently in use, a standardized version of 
enriched environment, called the Marlau cage (Viewpoint) was used in the present 
experiment.  This cage was created to reduce variation and increase reproducibility 
across laboratories.  The enriched environment provided by the Marlau cage 
provides increased social interaction (12 mice per cage, instead of 4), increased 
somatosensory and visual input, voluntary exercise and increased motor stimulation 
provided by the running wheels and larger cage size, as well as increased novelty 
and cognitive stimulation due to the rotation of maze configurations which need to be 
learned or recalled several times during the week.  Thus, reversal of the depressive-
like behaviour demonstrated in the tail suspension test may be the result of one, or a 
combination of these factors.  Despite this, it is interesting to note that reversal due to 
housing in the Marlau cage is only present in the tail suspension test, and not in the 
forced swim test, suggesting some specificity in its effects. 
 
 
6.5 Changing views on the impact of methylation on gene transcription 
 
The findings presented here bring attention to a common perception of DNA 
methylation which has recently been called into question.  Traditionally, DNA 
methylation has been viewed as a silencing mechanism for gene expression.  Here, 
reduced methylation of CRFR2 and increased methylation of CB1 and MeCP2 have 
all been associated with decreased gene expression.  This is consistent with several 
recent reports that provide evidence that DNA methylation in the promoter region is 
associated with, not only decreased gene expression, but also increased gene 
expression.  For instance, in the human brain, DNA methylation in the promoter 
region of the 5HT2A gene was shown to correlate with higher gene expression 
(Polesskaya, Aston et al. 2006).  In human somatic cells, many active genes were 
shown to have methylated promoters, while many inactive genes had unmethylated 
promoters (Weber, Hellmann et al. 2007). Additionally, recent evidence that a methyl 
Cpg-binding protein, MeCP2, acts as both an activator and a repressor of gene 
transcription, further suggests that decreased methylation can be mechanistically 
associated with decreased gene expression (Chahrour, Jung et al. 2008). Thus, 
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while there are several examples to support the traditional view that increased 
promoter methylation is associated with gene silencing, there is growing evidence 
that the opposite also does occur.  
 
Further, DNA methylation has been recently shown to be highly dynamic and rapidly 
cycling.  Cyclical methylation and demethylation of CpG dinucleotides was found in 
the promoter region of five different transcriptionally active genes, including estrogen 
receptor α, with a periodicity of approximately 100 minutes (Kangaspeska, Stride, et 
al. 2008).  Importantly, increased methylation at the promoter region coincides with 
the initiation of transcription (Kangaspeska, Stride, et al. 2008), suggesting that DNA 
hypomethylation can be mechanistically associated with decreased transcription.  
Furthermore, DNMT3a/b was found to be recruited to the DNA strand when cyclical 
demethylation occurs demonstrating that it can have both methylating and 
demethylating activities (Metivier, Gallais et al. 2008).  In vitro, DNMT3a/b was 
demonstrated to have deamination activity (Metivier, Gallais et al. 2008).  Thus, the 
induction of deaminated cytosines by DNMT3a/b, and their repair via base excision 
repair, are a proposed mechanism for cyclical demethylation in promoter regions 
(Metivier, Gallais, et al. 2008).  These very recent findings have greatly changed the 
prior view of DNA methylation as generally permanent, and demonstrates the need to 
better define the factors mediating the effects of DNA methylation on gene 
transcription. 
 
 
6.6 Conclusions 
 
Early stress induces behavioural deficits which are transmissible to two generations 
downstream.  Male MSUS mice demonstrate a significant increase in propensity to 
enter into aversive areas in the free exploratory paradigm and elevated plus maze, a 
tendency to enter into the aversive center of the open field, as well as enhanced 
depressive-like behaviours in the forced swim test and sucrose consumption test.  
Female MSUS mice demonstrate a significant increase in propensity to enter into 
aversive areas in the elevated plus maze.  The offspring of male MSUS mice also 
exhibit aspects of these behavioural abnormalities in a sex-specific manner: male 
offspring exhibit similar behavioural effects in the elevated plus maze, and female 
offspring exhibit similar behavioural effects in the free exploratory paradigm, open 
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field, elevated plus maze, and forced swim test.  Comparably, the offspring of female 
MSUS mice exhibit similar behavioural abnormalities in a sex specific-manner: male 
offspring in the free exploratory paradigm and both male and female offspring in the 
elevated plus maze.  F3 MSUS mice derived from F2 MSUS males also demonstrate 
similar behavioural abnormalities in a sex-specific manner: females in the free 
exploratory paradigm, open field, and elevated plus maze, and males in the forced 
swim test.  This behavioural transmission is associated with aberrant DNA 
methylation in the germ line of male animals exposed to maternal separation and in 
the female brain and male germ line of their offspring.  Aberrant methylation is 
associated with changes in gene expression which are likely to contribute to the 
behavioural abnormalities present in the offspring of animals exposed to maternal 
separation. This provides evidence for a rapid form of environmentally-driven 
evolution distinct from traditional views that the evolutionary process is driven solely 
by random mutations in the DNA sequence itself.  Instead, it suggests the prospect of 
a mechanism for the environment to, not only directly influence the organism, but its 
offspring as well.  The extent to which this occurs, as well as the persistence and 
plasticity of the mechanism, has yet to be determined.  However, due to the 
multigenerational transmission demonstrated here, and suggested by previous 
epidemiological studies in humans, transgenerational epigenetic inheritance is likely 
to continue to be of interest to people across scientific spectrums in the coming 
years. 
 
Lastly, the transmissible behavioral traits induced by our early stress model, such as 
inappropriate response to stressful environments and depressive-like behaviours, are 
reminiscent of symptoms of major neuropsychiatric disorders such as borderline 
personality disorder and depression.  Thus, the present findings may be relevant 
when considering the underlying mechanisms and incidence rate of diseases within 
clinical psychiatry and may ultimately provide the basis for research into novel 
therapeutic strategies to prevent or treat these disorders.   
 
 
6.7 Future directions 
 
The results discussed here lead to several important experimental questions which 
may be developed in future studies.  Evidence presented here suggests that 
abnormal DNA methylation patterns are responsible for the transmission of 
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behavioural abnormalities across generations.  Although the mechanisms that alter 
DNA methylation in the present model are not known, they may involve changes in 
DNMTs, non-coding RNAs, and/or chromatin remodeling complexes (Kawasaki and 
Taira 2004; Siedlecki and Zielenkiewicz 2006; Aravin, Sachidanandam et al. 2007; 
Carmell, Girard et al. 2007), or a combination of these processes.  One intriguing 
possibility for the mechanism underlying germ line abnormalities in DNA methylation 
has come from the recent discovery of sperm/oocyte specific non-coding small 
RNAs, termed Piwi-interacting RNAs (piRNAs).  piRNAs are dynamically expressed 
during the development of germ cells, and are thought to be key to the establishment 
of methylation patterns in the germ cell (Aravin, Sachidanandam et al. 2008). This is 
particularly interesting in regards to the present study because aberrant RNA content 
has been shown to be transmitted through meiosis to the fertilized embryo 
(Rassoulzadegan, Grandjean, et al., 2006; Wagner, Wagner, et al., 2008).  Further, 
abnormal piRNA expression would alter methylation in a locus-specific and gene-
specific manner, similar to that observed in the present study.  This possibility is 
currently under investigation. 
 
Additionally, both short-term and long-term housing in enriched environment was 
able to reverse one aspect of depressive-like behaviours demonstrated in mice 
exposed to maternal separation.  It is expected that this reversal in one depressive-
like behaviour would also be associated with an absence in the observed 
transmission of increased immobility in the tail suspension test to F2 MSUS.   It 
would also be expected that blockade of one aspect of the transmitted behavioural 
phenotype would be associated with partial correction in aberrant DNA methylation in 
germ cell from maternal-separated mice. 
 
It is also interesting that short-term enriched environment induced increased time 
spent floating in the forced swim test in control mice, but not in MSUS mice.  This 
suggests that MSUS mice may be resistant to certain forms of stress in adulthood.  
Resistance to chronic stress (chronic social defeat stress) has also been induced 
with chronic systemic treatment with histone deacetylase (HDAC) inhibitors 
(Tsankova, Berton et al. 2006).  This raises the question of whether aberrant DNA 
methylation is also associated with changes in histone acetylation in adult mice 
subjected to maternal separation as pups.   
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Finally, due to the volume of human studies suggesting the presence of 
transgenerational epigenetic inheritance, and the number of disorders already linked 
with aberrant methylation of specific genes, it would be interesting to quantify 
methylation in germ cells of patients with and without stress-induced affective 
disorders across generations to determine if aberrant methylation in genes previously 
associated with these disorders may indeed be observed across generations.  This 
type of evidence in the human population will draw these findings closer to clinical 
relevance and help shift the focus towards the epigenome as a target for novel 
pharmaceuticals in the future.  
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Abstract 
The epigenome is the overall epigenetic state of a cell, and represents the ensemble of 
chromatin modifications. It is an essential mechanism for the regulation of the genome 
that depends on modifications of DNA and histones, but does not involve any change of 
the DNA sequence. It was previously assumed that in order for appropriate cellular 
development and differentiation to occur in mammals, the epigenome was fully erased 
and reestablished between generations.  However, several examples of incomplete 
erasure at specific genes have been reported, and this is suggested to be associated 
with the epigenetic inheritance of gene profiles. Although the existence of such a mode 
of inheritance has been controversial, there is increasing evidence that it does occur in 
rodents and humans.  In this review, we discuss the evidence that adverse 
environmental factors can affect not only the individuals directly exposed to these 
factors, but also their offspring.  Because the epigenome is sensitive to environmental 
influence and, in some cases can, in part, be transmitted across generations, it provides 
a mechanism for the transgenerational transmission of the impact of environmental 
factors.  Environmental factors examined include exposure to toxicants, diet, and 
postnatal care.  DNA methylation is the main mechanism discussed in this review. 
 
Keywords: epigenetic, DNA methylation, transmission, nutrition, chemical toxicants, 
postnatal environment 
 
 
 
  
It is commonly accepted that heritable information is transmitted to offspring through 
sequences of DNA, and that any change of the DNA sequence during transmission is 
random, and not influenced by environmental factors (except for mutagens).  However, 
recent work in the field of epigenetics has proposed that inheritance of DNA sequences 
is not the only mechanism underlying the transgenerational transmission of physical, 
behavioural, and emotional traits in mammals. Further, it is now known that the 
epigenome can be modulated by a variety of environmental factors, including chemicals, 
nutrition and early environment, as well as by aging (Anway et al., 2005; Anway et al., 
2006; Roth et al., 2009; Waterland et al., 2006; Weaver et al., 2004; Weaver et al., 2005; 
Wilson and Jones, 1983).  The epigenome therefore provides an important interface 
between genes and the environment, and may provide a mechanism for a rapid form of 
environmentally-driven transgenerational adaptation. 
 
Conrad Waddington coined the term “epigenetics” in the 1940s to describe gene-
environment interactions that ultimately lead to a particular phenotype (Waddington, 
1942).  Waddington originally used this term in a developmental context to depict the 
permanent changes in gene activation and deactivation required for cellular 
differentiation.  While the mechanisms for these changes were unknown at the time, they 
are now considered to be the result of altered DNA methylation and/or post-translational 
chemical modifications of the chromatin (Holliday and Pugh, 1975; Riggs, 1975; 
Scarano, 1971).  Thus, the current use of the term has shifted to emphasize mitotically 
or meiotically heritable changes in gene expression, that are not due to any alteration in 
the nucleotide sequence, but rather to modifications of the DNA molecule itself and of 
the chromatin.  These modifications on the DNA include biochemical alterations of 
specific base pairs on the DNA, in particular methylation of CpGs (cytosines immediately 
followed by a guanine), or of core or variant histone proteins, as well as DNA looping or 
  
chromatin structure (Mager and Bartolomei, 2005).   
 
In mammals, the most common epigenetic modification of the DNA strand involves the 
enzymatic transfer of a methyl group to the fifth position of cytosine residues in CpG 
dinucleotides (Richards, 2006).  DNA methylation has many well-known roles in the 
mammalian organism.  During development, it is necessary to establish tissue-specific 
patterns of gene expression (Scarano, 1971). It is also crucial for X-chromosome 
inactivation, in which one X-chromosome is silenced in females, and parental imprinting, 
in which one parental allele is inactivated (Delaval and Feil, 2004; Riggs, 1975). The 
pattern of DNA methylation in CpG islands located within or near promoter regions is 
known to affect the transcription rate of the gene by altering local chromatin structure 
and thereby modifying the access of transcription factors to DNA (Richards, 2006; Wang 
et al., 2004). DNA methylation patterns are established and maintained by DNA 
methyltransferases (DNMTs), methyl CpG-binding proteins and, as recently 
demonstrated, small RNA molecules (Chahrour et al., 2008; Cheng, 1995a; Cheng, 
1995b; Fan and Hutnick, 2005; Matzke and Birchler, 2005; Ooi et al., 2009; 
Wassenegger, 2005; Zemach and Grafi, 2007). 
 
Transgenerational transmission of epigenetic information 
RNA-mediated paramutation in the mouse 
 
A well-characterized example of transmission of epigenetic information across 
generations is paramutation.  Paramutation is a phenomenon by which the silencing of 
one allele is meiotically inherited by interaction in trans with the homologous allele (Ashe 
and Whitelaw, 2007).  Most examples of paramutation reported to date are in plants 
(Ashe and Whitelaw, 2007; Bond and Finnegan, 2007; Chandler, 2007), but 
  
paramutation has also now been demonstrated in the mouse, firstly at the Kit locus that 
codes for a tyrosine kinase receptor (Rassoulzadegan et al., 2006; Wagner et al., 2008).  
Mice heterozygous for Kit mutations have reduced Kit mRNA expression, and an altered 
pigment pattern (white spots).  However, some of the offspring from heterozygous Kit 
mice have a similar altered pigmentation, despite carrying two wild-type alleles 
(Rassoulzadegan et al., 2006).  Abnormal RNA in the sperm of Kit mutant mice was 
suggested to be responsible for this phenomenon because microinjection of sperm RNA 
from Kit mutant mice, or injection of miRNAs targeting Kit mRNA reproduce this effect 
(Rassoulzadegan et al., 2006).  These results suggested that functional information not 
encoded in the DNA sequence itself, but likely to be carried by RNA, can be transmitted 
through the germ line. This idea was corroborated by a recent study demonstrating that 
injection of a miRNA targeting cyclin-dependent kinase 9 (Cdk9), a regulator of cardiac 
growth, in fertilized mouse eggs induces cardiac hypertrophy in adult animals (Wagner 
et al., 2008). This correlated with the presence of trace amounts of the miRNA in sperm 
cells. Importantly, the cardiac hypertrophy was inherited across at least three 
generations, and mimicked human hypertrophic cardiomyopathy, a disease that is often 
familial (Wagner et al., 2008). The injection of a miR-124 microRNA into fertilized eggs 
resulting in a giant phenotype in the progeny of transgenic males was also recently 
reported as a model of RNA-mediated heritable epigenetic modifications (Grandjean et 
al., 2009). 
 
Epigenetic inheritance at endogenous alleles Agouti viable yellow (Avy) and axin-fused (AxinFu) 
 
The agouti viable yellow (Avy) and axin-fused (AxinFu) alleles are metastable epialleles, 
characterized by an inter- or intra-individual variability in expression state. Here, 
variations in expression are not the result of any genotypic alteration, but result from 
  
modifications in the level of DNA methylation of an intra-cisternal A particle (IAP) long 
terminal repeat. This IAP is a retrotransposon located upstream of the coding sequence 
in the case of Avy, and within intron 6 in the case of AxinFu (Morgan et al., 1999; Rakyan 
et al., 2003).  These variations in DNA methylation and gene expression induce a 
diversity in phenotypes that occur despite the genetic identity (isogenic Avy or AxinFu 
mice). The ectopic expression of the Avy protein results in yellow fur, obesity, and 
diabetes and increases tumor susceptibility, while the ectopic expression of AxinFu 
induces a kinked tail (Duhl et al., 1994; Reed, 1937). These naturally occurring variable 
phenotypes resulting from differential methylation can be transmitted to the subsequent 
generation, paternally for Avy, and both maternally and paternally for AxinFu (Blewitt et al., 
2006; Morgan et al., 1999; Rakyan et al., 2003). 
 
Further, the level of methylation of Avy and AxinFu DNA methylation and gene expression 
can also be modulated by environmental factors, in particular maternal diet. 
Administration of a methyl-rich diet to pregnant mouse females was shown to increase 
the level of DNA methylation at the Avy and AxinFu genes in the offspring, and induce the 
associated variability in phenotype (Waterland et al., 2006; Waterland and Jirtle, 2003).  
This is most likely mediated by in utero effects occurring as a result of the methyl 
supplement.  Somewhat unexpectedly, diet-induced changes in Avy methylation are not 
transmitted maternally to the next generation (Waterland et al., 2007). Thus, while the 
differential methylation of IAPs in Avy and AxinFu genes can induce variable phenotypes 
across generations in isogenic mice, data from Avy mice suggest that the impact of 
maternal diet on these phenotypes may be reset between generations.   
 
The Avy case provides an additional example of transgenerational mechanisms that are 
independent of epigenetic variation at the Avy gene (Waterland et al., 2008).  Avy mice 
  
have a tendency to become obese when adult, even when fed regular mouse diet ad 
libitum (Duhl et al., 1994; Waterland et al., 2008).  Interestingly, the interindividual 
variation in maternal obesity demonstrates a transgenerational amplification of body 
weight across generations, which is independent of methylation at Avy (Waterland et al., 
2008). Furthermore, diet-induced hypermethylation blocks the transgenerational effect of 
maternal adiposity on the body weight of their offspring (Waterland et al., 2008).  Thus, 
while diet-induced hypermethylation at Avy is not transmitted, methyl supplementation 
may interact with epigenetic mechanisms at other genomic loci, in particular those 
involved in body weight regulation (Waterland et al., 2008).   
 
DNA methylation and familial cancer 
 
Aberrant genome-wide changes in DNA methylation have been consistently observed in 
cancer cells.  Although a global hypomethylation is often detected in tumors, localized 
increases in DNA methylation in the promoter-associated CpG islands of genes also 
occur (Fleming et al., 2008; Wilson et al., 2007).  The cause of such concomitant hypo- 
and hypermethylation is not known, but could result from local alterations in DNMTs, 
which are expressed at higher levels in tumor cells (Fleming et al., 2008; Jones and 
Baylin, 2002).  Global hypomethylation is linked to carcinogenesis because it can induce 
aberrant gene expression, chromosomal instability, reactivation of retrotransposons, 
and/or loss of imprinting (Fleming et al., 2008; Wilson et al., 2007). In contrast, 
hypermethylation in CpG islands may lead to a deactivation of tumor suppressor genes 
that should normally be active (Ahuja and Issa, 2000; Fraga et al., 2007). These 
mechanisms provide a potential treatment strategy in preventive and therapeutic 
medicine. Indeed, hypomethylating agents like decitabine 6 and 5-azacytidine are 
currently used for the treatment of cancer (Kurkjian et al., 2008). 
  
 
Hypermethylation at the promoter of two tumor suppressor mismatch repair genes, 
MLH1 and MSH2, has been associated with hereditary non-polyposis colorectal cancer 
(Chan et al., 2006; Herman et al., 1998; Hitchins et al., 2007).  Hypermethylation of both 
MLH1 and MSH2 was also observed in the germline, albeit in a low proportion of cells 
(Chan et al., 2006; Suter et al., 2004).  Intriguingly, the MLH1 epimutation appears to be 
more easily transmitted through the maternal line, raising the possibility that epigenetic 
errors may be more likely to occur during oogenesis than spermatogenesis (Fleming et 
al., 2008). The heritable germline epimutation described here suggests 
transgenerational epigenetic inheritance. However, because the subjects are not 
genetically identical, it is possible that DNA variants are present within the family, and 
may predispose the individuals to an atypical epigenetic state at each generation (Chong 
et al., 2007).  Indeed, it was recently demonstrated that a deletion in the last exons of a 
gene located directly upstream of MSH2 correlates with epigenetic inactivation of the 
MSH2 allele. This suggests that, at least in the case of MSH2, DNA variants and not 
epigenetic inheritance, may lead to epigenetic alterations present in each generation 
(Ligtenberg et al., 2009). 
 
Transgenerational transmission of environmental effects 
Epigenetic inheritance and environmental toxicants 
 
There is accumulating evidence that chemical toxicants have detrimental effects not only 
on individuals directly exposed to the toxicant, but also on their offspring.  One of the 
most dramatic examples is with diethylstilbestrol, a synthetic nonsteroidal estrogen 
prescribed in the 1970s to prevent miscarriage in women with prior history.  While the 
drug helped pregnancies to go to term, it induced severe developmental abnormalities 
  
and increased the risk of developing breast cancer and a rare form of adenocarcinoma 
in girls whose mothers was exposed to diethylstilbestrol during the first trimester of 
pregnancy (Palmer et al., 2006). Further, the risk of cancer appeared to be transmitted 
to the following generation. A clinical study reported that a 15 year-old girl, whose 
maternal grandmother was exposed to diethylstilbestrol during pregnancy, was 
diagnosed with a very rare case of small cell carcinoma in the ovary (Blatt et al., 2003). 
A larger number of maternal granddaughters than expected also developed ovarian 
cancer (Titus-Ernstoff et al., 2008). Although these findings are among the first and need 
to be confirmed by further transgenerational studies, they suggest that the detrimental 
effect of a drug can be transmitted across generations.  Such transgenerational effect of 
diethylstilbestrol was also observed in mice.  Similar to humans, perinatal exposure to 
diethylstilbestrol induced abnormalities in uterine development and uterine cancer in 
both F1 and F2 generations. These abnormalities were suggested to result from 
aberrant DNA methylation in a gene that controls uterine development (homeobox gene 
HOXA10) and in uterine cancer genes (Bromer et al., 2009; Li et al., 2003; Newbold et 
al., 2006; Walker and Haven, 1997). 
 
Transgenerational transmission of the detrimental effects of endocrine disruptors present 
in our environment was also demonstrated in rats, through both females and males.  
Rats exposed to the endocrine disruptor vinclozolin, a fungicide commonly used for 
agricultural fruit crops, or the pesticide methoxychlor, during the period of gonadal sex 
determination (embryonic stage E8-E15, F1), have reduced epididymal sperm counts 
and sperm motility, and increased spermatogenic cell apoptosis (Cupp et al., 2003; 
Uzumcu et al., 2004).  These drug-induced traits are transmitted to the male offspring 
through the male germline down to three generations from exposure to the toxicant (F2-
F4), and were associated with aberrant DNA methylation in sperm (Anway et al., 2005).  
  
Exposure to vinclozolin from E8 to E14 was also found to induce pregnancy 
abnormalities, including uterine hemorrhage and/or anemia, down to two generations in 
females (Nilsson et al., 2008).  Further to affecting fertility, vinclozolin was also found to 
increase the incidence rate of tumor formation in aging males exposed to vinclozolin 
prenatally (F1) and their offspring (F2-F4) (Anway et al., 2006).  Thus, it is now apparent 
that exposure to chemical toxicants during key periods of development impacts fertility 
and tumor development across multiple generations via transmission through both 
females and males.  These effects persist across the lifespan and are still present in 
aged animals.  The mechanism of transmission itself is suggested to be the result of 
aberrant DNA methylation in the germline. 
 
Epigenetic inheritance and diet 
 
It is now becoming clear that poor nutrition or reduced food availability can have 
detrimental effects across several generations. A marked example of such effect is of 
women subjected to severe food restriction during the last trimester of pregnancy, due to 
Nazi embargo on food supplies in Western Holland during World War II. Babies born 
from these women were reported to have lower birth weight, and this was also observed 
in the subsequent generation despite no further dietary restriction during conception or 
rearing. These observations suggest a transgenerational effect of diet on birth weight 
(Susser and Stein, 1994).  A recent study also reported that paternal grandmother’s and 
grandfather’s food supply is linked to the risk of mortality in granddaughters and 
grandsons respectively. This was observed when food supply was insufficient during the 
slow growth period in mid-childhood in both grandparents, or during early pre- and 
postnatal life of the grandmother (Pembrey et al., 2006).   
 
A similar phenomenon was observed in experimental animals, in particular in rats 
  
malnourished before or during gestation (Cowley and Griesel, 1966; Zamenhof et al., 
1971).  Like for the Dutch famine, female rats fed a low protein diet prior to and during 
gestation delivered pups with lower body and brain weight, an effect that correlated with 
reduced level of DNA and protein in the brain. This reduction was not observed when 
food restriction occurred after delivery. But the effect was inherited by the offspring of the 
malnourished pups which also had abnormally low brain and body weight (Zamenhof et 
al., 1971).  Second generation offspring had comparable low birth weight, slower 
maturation rate, and displayed poor cognitive performance in the Hebb-Williams maze 
(Cowley and Griesel, 1966).  Since these studies in rodents were carried out prior to 
molecular advances in epigenetics, the mechanisms underlying the transmission of the 
effects of a poor diet remain unknown, but would be interesting to investigate. 
 
Due to the increase in obesity in Western countries, the transgenerational effect of a 
maternal high-fat diet on subsequent generations has also been studied.  Maternal high-
fat diet exposure increases body length and reduces insulin sensitivity two generations 
downstream from the initial exposure (Dunn and Bale, 2009).  These abnormalities can 
be transmitted both maternally and paternally, and the effect is further amplified when 
female and male offspring of maternal high-fat diet exposure are bred (Dunn and Bale, 
2009).  
 
These findings in human and rodent suggest that epigenetic and environmental factors 
are involved in the transmission of the effect of insufficient or excessive diet, but these 
factors remain unknown.  They are likely to be multiple, but a recent study showed that 
alterations in DNA methylation of the gonadotrophin hormone secretagogue receptor 
(GHSR) promoter in the brain of offspring of mice exposed to a high-fat diet (Dunn and 
Bale, 2009).  More research is required to determine the extent of the contribution of 
  
epigenetic mechanisms. 
 
Epigenetic inheritance and poor early environment 
The influence of the quality of the environment early in life has been under intense 
research. It is now largely recognized that early abuse or trauma strongly affects 
individuals throughout their adult life.  Long-term studies revealed that infant attachment 
predicts the ability of the child to form appropriate peer relationships, and his/her 
sociability, risk-taking behaviors, school success or dropout rate.  Success in school is 
indeed an important factor that can be predicted with 77% accuracy, based solely on the 
quality of early care (Harper, 2005; Sroufe, 2002).  Further, maltreatment and childhood 
trauma are known to increase the risk of depression and anxiety disorders in adult 
individuals (Iversen et al., 2007).  While there is a high level of transmission of anxiety 
disorders and a strong link between parent and child anxiety disorders, this can not be 
explained by parenting alone, but instead can be predicted by constitutional factors, like 
temperament (Dierker et al., 1999; Manassis et al., 1995; Merikangas et al., 1998; 
Shamir-Essakow et al., 2005; Weissman et al., 1984). 
 
The persistence of disorders that may have arisen from maltreatment in childhood drove 
researchers to investigate whether DNA methylation plays a role.  In rat, the amount of 
maternal care provided during early development has been shown to influence the 
pattern of DNA methylation in the pup’s brain when adult. Based on naturally occurring 
individual fluctuations in maternal care provided by female rats, Michael Meaney and 
colleagues explored the mechanisms that may underlie such fluctuations. Female rats 
were selected based on their nurturing ability and placed in two treatment groups, high 
licking/grooming and arch-back nursing (ABN-LG), and low ABN-LG.  Studies of pups 
  
reared by high ABN-LG dams showed that these pups have higher glucocorticoid 
receptor (GR) expression in the hippocampus and glucocorticoid feedback sensitivity 
than pups from low ABN-LG dams, when adult (Weaver et al., 2004).  These effects 
were associated with lower DNA methylation in the promoter region of GR and an 
associated increase in binding of the nerve growth factor-inducible protein-A 
transcription factor to the promoter region of GR (Weaver et al., 2004).  They further 
showed that all effects of high ABN-LG rearing could be reversed in the adult offspring 
by intracerebroventricular infusion of L-methionine, which acts as a methyl-group donor 
(Weaver et al., 2005).  This demonstrates that changes in the epigenome established by 
the environment during early development may be reversed by environmental stimuli 
even in adults, emphasizing the plasticity of DNA methylation in the adult brain. 
 
Findings from rodent experiments were recently corroborated by a study in humans, and 
implicated the early environment in the establishment of methylation patterns. This study 
provided evidence that childhood abuse is also associated with abnormal methylation in 
the adult human brain (McGowan et al., 2008).  Methylation in the neuron-specific 
glucocorticoid receptor promoter in the brain of suicide victims who experienced 
childhood abuse was significantly higher than in suicide victims who were not abused, or 
in controls.  The increase in methylation was associated with decreased glucocorticoid 
receptor expression (McGowan et al., 2008).  
 
Further to altering methylation, a poor postnatal environment was also recently 
demonstrated to result in transgenerational transmission of methylation anomalies in the 
rat brain. Pups receiving daily abusive maternal care including stepping, dropping, 
dragging and active avoidance, from non-biological dams during postnatal day (PND) 1 
to 7 have reduced BDNF expression and increased methylation of the BDNF gene in the 
  
prefrontal cortex when adult (Roth et al., 2009).  The offspring of females exposed to 
maltreatment during early life also showed increased BDNF methylation in the prefrontal 
cortex (Roth et al., 2009). The findings are particularly interesting because, in humans, 
increased methylation of the BDNF gene in the frontal cortex is associated with major 
psychoses such as schizophrenia and bipolar disorder (Mill et al., 2008).  Thus, this 
study in rat suggests that maltreatment during early development may not only 
predispose individuals to major psychoses, but also their offspring via transmission of 
abnormal methylation patterns across generations. Importantly, maltreatment during 
early development induced poor maternal care in the female offspring when they 
themselves, had pups (Roth et al., 2009). Thus, the alterations in BDNF methylation in 
the brain of the offspring from abused dams may result from either transmission of 
methylation via the gametes, or changes in methylation elicited by the transmission of 
poor maternal care across generations.  Interestingly, cross-fostering did not fully 
reverse alterations in methylation levels, suggesting that postnatal experience is not the 
only factor contributing to this transmission (Roth et al., 2009).  
 
Conclusions 
 
A growing number of reports describe transmission of complex behavioral traits and 
adult-onset disease states across multiple generations that are non-genomic.  The 
extent to which transgenerational epigenetic inheritance occurs, as well as the 
persistence and plasticity of this mechanism, still need to be determined.  A point 
sometimes overlooked in transgenerational epigenetic research is the need for 
transmission two generations downstream from the original manipulation (reviewed in 
Skinner, 2008).  While transmission to the offspring of perturbed animals may suggest 
epigenetic and not environmental factors, it does not completely rule out environmental 
  
influence, because the cells that ultimately generate the offspring are present at the time 
of treatment. Thus, transmission to a subsequent third generation is important to 
demonstrate that the phenotype is indeed transgenerational, germline dependent, and 
not a direct effect of the treatment itself (Skinner, 2008). Several studies have taken this 
point in consideration and provided evidence for transgenerational transmission across 
several generations.  Further, growing interest in the field also provided new 
experimental evidence that alteration in DNA methylation in germ cells may underlie 
epigenetic inheritance.  Because a wide range of environmental factors are known to be 
associated with changes in DNA methylation in both humans and rodents, it is now clear 
that epigenetic inheritance may be occurring on a much broader scale than previously 
thought.  Finally, further to DNA methylation, other epigenetic mechanisms such as RNA 
interference, histone posttranslational modifications or DNA repair may also contribute to 
epigenetic inheritance (Godmann et al., 2009).  
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The brain is one of the most complex and most complexly regulated organs in the 
human body and its proper functioning requires that regulatory networks are tightly 
controlled. Over the past decade, it has become increasingly apparent that 
epigenetic mechanisms are an essential part of these networks and largely 
contribute to higher-order brain processes such as synaptic plasticity, and learning 
and memory. Not surprisingly, therefore, can a dysfunction thereof lead to severe 
brain disorders including neuro-developmental diseases such as Rett syndrome, 
Fragile X syndrome and Rubinstein Taybi syndrome, neurodegenerative disorders 
such as Huntington’s and Alzheimer’s disease, as well as autism. Moreover, 
dysregulated epigenetic mechanisms also underlie psychiatric disorders such as 
depression and schizophrenia, and they can also determine, in part, how the brain 
deals with stressful situations in infancy and adulthood. 
 
In this chapter, we will describe the evidence that suggests how a dysregulation of 
epigenetic mechanisms is a major factor in the etiology and occurrence of Rett 
syndrome and Alzheimer’s disease as examples of neurodevelopmental and 
neurodegenerative diseases, respectively. Further, we will also cover the 
involvement of epigenetic mechanisms in depression and schizophrenia to illustrate 
the role of the epigenome in psychiatric disorders. Where applicable, we will describe 
animal models that reproduce human pathophysiological features and that are 
currently explored to test potential therapeutic treatments targeting the epigenetic 
machinery. Finally, this chapter ends with a description of how early-life stress can 
have life-long influence on emotional behaviors. 
Introduction 
 
Epigenetics is most commonly defined as the study of alterations in gene function 
which are heritable through both mitosis and meiosis, but which cannot be explained 
by changes in the DNA sequence itself [1] (reviewed in [2, 3]). On the molecular 
level, epigenetic mechanisms encompass first and foremost chemical modifications 
of the DNA and of the histone proteins, the two constituents of chromatin. In 
extension, RNA interference and prion mechanisms can also constitute epigenetic 
mechanisms [4], however, in this chapter we will concentrate our focus on direct 
chemical modifications of the chromatin. Such modifications entail on the one hand 
methylation of the DNA at cytosine-guanine dinucleotides, which are often found in 
sequences called CpG islands being characterized by a high incidence of CG 
repeats. DNA methylation is most commonly associated with transcriptional silencing 
either by directly inhibiting the binding of transcription factors or by indirectly 
recruiting methyl-CpG binding proteins (MBPs) and their associated repressive 
chromatin-remodeling activities [5, 6]. However, since DNA methylation has also be 
found in the promoter and the coding region of actively transcribed genes, the 
relationship between this epigenetic mark and transcriptional activity is not clear-cut 
[7, 8].   
 
 
On the other hand, epigenetic modifications at the chromatin refer to 
posttranslational modifications of histone proteins. Histones are basic proteins that 
function to condensate and to regulate the accessibility of the chromatin. They 
consist of a globular histone core and an N-terminal histone tail, a loosely structured 
sequence of amino acids protruding out of the core. Posttranslational histone 
modifications most prominently occur on this N-tail, and involve acetylation, 
methylation, phosphorylation, ubiquitination in mammals (reviewed in [4]), and 
sumoylation in yeast [9]. Due to their chemical properties, these epigenetic 
modifications are capable of altering the condensation of the chromatin and, as a 
consequence, the accessibility of the DNA to the transcriptional machinery.  
 
Both the acetylation and the phosphorylation of histones, occurring on lysine (K) as 
well as on serine (S), threonine (T) and tyrosine (Y) residues, respectively, have 
been linked to transcriptional activation. This is because the addition of the partially 
negatively charged acetyl- and phospho- groups results in a repulsive force between 
the histone tail and the DNA, itself being negatively charged, which relaxes the 
chromatin structure [10]. In contrast, histone methylation has been shown to 
associate with both actively transcribed but also with silenced genes [11, 12], 
depending on which residue they occur. What is more, these residues can be mono-, 
di-, and trimethylated, the combination of which can have differing roles in the 
regulation of gene expression [13]. Histone methylation can also occur on arginine 
(R) residues in both a mono- or dimethylated form, with its effect on the organization 
of chromatin not being clearly understood [13]. Next, protein ubiquitination (also 
called ubiquitylation), the attachment of the highly conserved 76 amino acid-long 
polypeptide group ubiquitin, is most commonly associated with marking proteins for 
degradation by the proteasome, but has also been found to occur on histone tails, 
where it serves a different, yet not well characterized purpose. The ubiquitination of 
histone tails has been identified to be a prerequisite for subsequent histone 
methylation and it has also been shown to be a correlate of both transcriptional 
activation and nucleosome loosening [13, 14]. Finally, histone sumoylation is the 
least known posttranslational histone modification. In yeast, it has been shown to 
occur on all four core histones and to negatively regulate transcription, possibly by 
interfering with histone acetylation and ubiquitination [9, 15].  
 
The repertoire of DNA and histone modifications is insured by specific enzymes 
including DNA methyltransferases (DNMTs), histone acetyltransferases (HATs) and 
deacetylases (HDACs), histone methyltransferases (HMTs), protein kinases and 
phosphatases, and ubiquitin- and SUMO-associated enzymes [4, 13, 15]. These 
enzymes operate both independently and in synergy to establish a “histone code”, a 
highly dynamic and variable chromatin marking that in combination with chromatin-
associated proteins determines the pattern of gene expression [16, 17].  
 
1. Epigenetic dysregulation in neurodevelopmental disorders - Rett Syndrome 
 
Neurodevelopmental disorders commonly define impairments of the central nervous 
system that occur during development. Such impairments can have their onset 
during the development as such, for instance in the case of fetal alcohol syndrome, 
whereas others are genetically predisposed, for instance in Down Syndrome. Several 
genetically predisposed neurodevelopmental disorders have been documented to 
involve at least in part an epigenetic dysregulation of physiological functions. These 
disorders include Fragile-X syndrome, Rett Syndrome and Rubinstein-Taybi 
Syndrome. In this chapter we will focus exclusively on Rett Syndrome, as it 
implicates both aberrant DNA methylation and posttranslational histone 
modifications. For a recent review of epigenetic dysregulation in other 
neurodevelopmental disorders the reader is referred to [18]. 
 
Rett Syndrome (RS) is a relatively common cognitive disorder characterized by an 
arrest of neurological development leading to decelerated head growth and cognitive 
impairment. RS is caused by a loss-of-function mutation in the X-linked methyl-CpG-
binding protein 2 (MeCP2) gene [19] (Table 1), which is lethal when heterozygous. 
This disease thus develops exclusively in females with a worldwide prevalence of 
1:10’000. Because MeCP2 is a transcriptional regulator that binds specifically to 
methylated DNA, its deficiency alters chromatin remodeling and induces a general 
dysregulation of gene transcription. Although MeCP2 is a member of the 
transcriptional repressors methyl-binding proteins (MBP) (for a review see [5]), it was 
recently found to play also a role in the activation of transcription, and can therefore 
act both as a transcriptional silencer and activator [20].  
 
In mice, both MeCP2-null mutation and neuron-specific deletion of MeCP2 
recapitulate some of the symptoms of RS. MeCP2-deficient mice have reduced brain 
weight and impaired neuroanatomical structures (smaller neuronal cells). They 
exhibit an overall decrease in exploratory activity [21, 22], and have cognitive deficits 
and impaired synaptic plasticity [23]. The cognitive deficits can be reversed by 
overexpression of wild-type human MeCP2 protein (by two-fold) in young animals 
(10-week old) [23]. Intriguingly, however, in 20-week old mice, human MeCP2 
overexpression induces seizures, suggesting that an overdose of MeCP2 can have 
deleterious effects, presumably by silencing genes that - under physiological 
conditions - are active and required for a proper brain functioning.  
 
One identified target of MeCP2 is brain-derived neurotrophic factor (Bdnf). Calcium-
dependent phosphorylation of MeCP2 reduces MeCP2 binding to the Bdnf promoter, 
and thereby decreases promoter methylation and increases Bdnf expression [24-26], 
an effect similar to that observed in RS-related mutations of MeCP2. This would 
suggest that RS is associated with increased Bdnf expression. However, this 
appears not to be the case [27] as MeCP2 mutant mice have reduced BDNF levels. 
This reduction and the neuronal atrophy characteristic of RS can be reversed by 
forebrain-specific overexpression of Bdnf in vivo [27]. This beneficial effect of Bdnf 
overexpression was recently confirmed in cultured hippocampal neurons [28]. It is 
therefore thought that the substantial lack of neuronal activity in MeCP2 mutant mice 
is more important as to determine the levels of Bdnf than what would be caused by 
the lack of MeCP2 binding [29]. Alternatively, since MeCP2 is also expressed in 
astrocytes [30], it is conceivable that MeCP2 affects the levels of Bdnf in a cell-type 
specific manner, which might explain the apparent discrepancy between the two lines 
of evidence. More refined analyses are required to solve this issue.  
 
In addition to Bdnf, a recent study identified seven other genes as direct binding 
targets of MeCP2 in the mouse brain [31], including myelin-associated proteins and 
dopamine decarboxylase. Yet more genes are likely to be discovered, as MeCP2 
phosphorylation is associated with dendritic growth and spine maturation [26], which 
is thought to occur through the de-repression of target genes involved in 
development processes [20, 32].  
  
Further to regulating DNA methylation, MeCP2 also influences posttranslational 
modifications of histone protein, in particular histone acetylation and methylation. At 
the promoter region of Bdnf, this is mediated by the formation of a complex between 
MeCP2 and HDAC1 [25], which reduces the acetylation of both histone H3 and H4. 
This is paralleled by increased dimethylation of H3K9 but decreased dimethylation of 
H3K4, two post-translational histone modifications that inhibit and promote gene 
transcription respectively [33]. This suggests a cooperative contribution of epigenetic 
modifications for gene silencing, and is consistent with the observation that mice with 
deficient MeCP2 have hyperacetylated H3 [34]. Taken together, these results 
strongly argue for an overall increase in gene transcription in RS, due to loss of 
MeCP2-mediated gene silencing. However, in light of the recent observation that 
MeCP2 also acts as a transcriptional activator, it is essential to determine whether 
the transcription of specific genes is also decreased. In animal models and in 
patients, the effect of MeCP2 deficiency may be pharmacologically attenuated by 
direct administration of exogenous MeCP2, or with drugs targeting transcriptional 
processes, DNA methylation, histone acetylation and/or histone methylation. 
However, such drugs can have significant side effects and unspecific targets, and 
thus need to be further investigated for potential future use.  
 
2. Epigenetic dysregulation in neurodegenerative disorders -  Alzheimer’s disease 
 
Neurodegenerative diseases are conditions in which cells of the central nervous 
system are lost. Since cells in the central nervous system are only marginally 
regenerated, cell loss will have devastating consequences on cognition and 
locomotion. Alzheimer’s Disease (AD) and Huntington’s Disease are two 
neurodegenerative diseases for which there is ample evidence that they are caused - 
at least in part - by epigenetic dysregulation. For an extensive overview of the 
implication of epigenetic mechanisms in Huntington’s, the reader is referred to [35]. 
 
AD is one of the most common neurodegenerative diseases worldwide, and has an 
estimated prevalence of 1:100 in the population over 65 of age in Western countries. 
Despite years of intense research and multiple clinical trials, AD remains a non-
curable brain disease [36]. It is primarily characterized by a progressive cognitive 
decline that gradually develops with age. Its pathophysiology in the brain is 
manifested by the presence of two major hallmarks: extracellular amyloid plaques 
and intracellular neurofibrillary tangles [37]. Amyloid plaques are deposits of the 
amyloid β (Aβ) peptide, produced through enzymatic cleavage of the amyloid 
precursor protein (APP) by β and γ secretase. Neurofibrillary tangles (NFTs) are 
intraneuronal aggregates of hyperphosphorylated tau protein, a microtubule-binding 
protein.  
 
Several epigenetic modifications such as aberrant histone acetylation and DNA 
methylation are present in the APP-Aβ pathway and may contribute to AD. One line 
of evidence suggests that histone acetylation is increased in AD. A potential 
mechanism for this increase is thought to involve the formation of a complex between 
the APP intracellular domain (AICD), produced from APP by γ secretase, and the 
nuclear adaptor protein Fe65 and the histone acetyltransferase (HAT) TIP60, a 
transcriptional activator [38]. At the same time, presenilin 1 (PS1), a gene coding for 
the γ secretase complex, was also shown to contribute to histone hyperacetylation in 
AD pathology. Loss-of-function mutations in PS1 or mutations associated with 
familial AD, an early onset form of AD affecting genetically predisposed individuals, 
inhibit the proteasomal degradation of the HAT cAMP-responsive element binding 
protein (CBP), and result in increased CREB-mediated gene expression in neurons 
in culture [39]. Consistently, in a mouse model of AD with severe neurodegeneration 
and memory loss due to cyclin-dependent kinase 5 (Cdk5) hyperactivation (CK-p25 
mouse model), lentivirus-mediated overexpression of the HDAC SIRT1 (silent mating 
type information regulation 2 homolog) confers substantial protection against AD-
related neurodegeneration and memory loss [40]. Although in this case it is not 
known whether SIRT1 acts via the epigenetic machinery or rather via cytoplasmic 
substrates, these findings suggest that pharmacological treatment activating SIRT1 
such as the polyphenol resveratrol might be beneficial for treating AD.  
 
In contrast, a parallel line of evidence suggested that a decrease in histone 
acetylation is causally linked to AD. In cultured cortical neurons, the overexpression 
of APP leading to cell death is accompanied by a decrease in the level of CBP, and 
in H3 and H4 acetylation [41]. Similarly, loss-of-function mutations in PS1 and PS2 
genes in mice reduce the expression of CBP, and of CBP/CREB target genes such 
as c-fos and Bdnf. They also result in impaired synaptic plasticity, and defective 
spatial and contextual memory [42]. Moreover in CK-p25 mice, the 
intracerebroventricular injection of sodium butyrate, a potent HDAC inhibitor, rescues 
memory and synaptic connectivity [43], suggesting that HDAC inhibitors might be 
used for potential treatment of AD-related pathologies. Notably, several inhibitors are 
currently being tested in pre-clinical or phase I/II trials for the treatment of AD. 
However, since histone acetylation appears to be dysregulated bidirectionally and 
possibly, in a gene-specific fashion, more research is required to fully evaluate the 
potential of HDAC inhibitors. 
 
Interestingly, besides pharmacological treatment, natural manipulations such as 
environmental enrichment may also represent a promising means to treat AD. In 
wild-type mice, exposure to an enriched environment for four weeks was shown to 
improve synaptic connectivity and cognitive abilities in mice [43]. The improvement 
was comparable to that achieved with HDAC inhibitors [43], which highlights the 
potential of environmental stimulation for the reversal of cognitive deficits in AD.  
 
Further to histone acetylation, DNA methylation is also involved in the etiology of AD. 
In cell culture, hypomethylation of the promoter region of PS1 increases presenilin 
expression, which enhances β-amyloid formation [44]. This effect can be reversed by 
application of the methyl donor S-adenosylmethionine (SAM) that rescues 
methylation, increases presenilin expression and reduces β-amyloid formation. 
These observations therefore suggest that methyl donors or drugs targeting the 
methyl metabolism may be potential therapeutic agents to treat AD [45]. The finding 
that DNA hypomethylation underlies some aspects of AD pathology was also 
recently confirmed in mouse and primate models of AD. In these models, exposure 
to lead (Pb) was found to reduce the enzymatic activity of DNMT1 in cortical neurons 
and is associated with increased APP expression [46]. Further, a recent post mortem 
study in human also reported hypomethylation of the presenilin promoter region in 
late-onset AD patients when compared to age-matched healthy subjects [47]. These 
findings therefore support the hypothesis that DNA hypomethylation, at least in the 
presenilin promoter, is causally associated with AD. However, other AD-related 
susceptibility genes such as BACE1, which codes for β-secretase, or the gene 
coding for apolipoprotein E that facilitates amyloid plaque formation, are 
hypermethylated in late-onset AD [47]. This suggests that alteration in DNA 
methylation is presumably bidirectional and gene-specific altered in AD, similar to 
histone acetylation. Further studies are thus needed to identify genes with an altered 
DNA methylation profile, and the direction and extent of their expression changes. 
 
3. Epigenetic dysregulation in psychiatric disorders - Depression 
 
Psychiatry disorders range from personality and anxiety disorders to addiction and 
depression, which are often difficult to define and even more so to treat. One of the 
most prominent psychiatric disorders is depression, for which a substantial body of 
evidence now suggests that several depressive-like phenotypes are partly caused by 
epigenetic mechanisms.  
 
Depression is a common mental disease characterized by pessimistic thoughts, lack 
of enthusiasm and vitality, feelings of sadness and anhedonia. This chronic illness 
affects roughly five per cent of the population worldwide, although this number is 
likely to underestimate the actual prevalence rate. Depression is difficult to treat. 
Indeed, only half of depressed patients show complete remission [48, 49]. One of the 
major issues with therapeutic treatment of depression is that the beneficial effect of 
anti-depressant drugs is delayed, and symptoms are usually ameliorated only after a 
couple of weeks. The reasons for such delay are not known but are thought to result 
from the fact that the mechanisms underlying the etiology of depression are of 
epigenetic nature. Initial evidence for this hypothesis came from studies examining 
the effect of electroconvulsive therapy, a treatment effective only after repeated 
administration. Chronic electroconvulsive seizures (ECS) were shown to increase 
Bdnf and CREB expression, and BDNF protein in the hippocampus [50-52]. This 
increase is associated with H3 hyperacetylation at BDNF promoter 3 [53], suggesting 
that chromatin remodelling contributes to the beneficial effects of chronic ECS.  
 
The importance of histone posttranslational modifications in depression was further 
demonstrated in a model of social defeat in rodent. This model of chronic stress 
induces symptoms of depression that can be reversed by chronic, but not acute, 
antidepressant treatment, mimicking what is observed in human patients [54]. In 
mice, chronic social defeat decreases the expression of two splice variants of Bdnf 
(Bdnf III and Bdnf IV) in the hippocampus, and is associated with increased 
dimethylation of H3K27 [54], a mark for transcriptional repression [33] (Figure 1). 
While behavioural abnormalities induced by chronic stress can be reversed by 
chronic antidepressant treatment, the increase of H3K27 dimethylation can not [54]. 
Instead, antidepressant treatment appears to reverse the downregulation of Bdnf 
expression by increasing H3 acetylation, and H3K4 methylation, both marks of 
transcriptional activation [33] at the same promoters  [54, 55]. Additionally, chronic 
antidepressant treatment downregulates the expression of HDAC5, specifically in 
animals exposed to chronic stress [56]. Thus, chronic stress-induced histone 
modifications at the Bdnf gene in the hippocampus are likely to be an important 
mechanism for the development of depressive behaviours, and may also be a target 
for antidepressant treatments.  
 
In addition, there is evidence for the influence of antidepressant treatments on DNA 
methylation. Chronic antidepressant treatment was demonstrated to increase methyl 
MeCP2 and MBD1, two proteins which bind methylated CpG dinucleotides and act 
as either a transcriptional activator or repressor in the rodent brain [57]. The 
antidepressant-dependent increase in MeCP2 was specific to gamma aminobutyric 
acid (GABA)-ergic interneurons [57]. This finding is of particular interest, since 
abnormal GABAergic transmission and abnormalities in GABA-related gene 
methylation have been linked to major depression and suicide. Depressed patients 
who committed suicide have higher level of methylation in the GABA-A α1 receptor 
subunit promoter, and increased DNMT3b mRNA and protein in the prefrontal cortex 
when compared to control individuals who died of other causes [58]. This suggests 
the intriguing possibility that antidepressant treatments specifically target the 
epigenetic machinery in cell types affected by depression.  
 
4. Epigenetic dysregulation in psychotic disorders - Schizophrenia  
 
Psychotic disorders refer to mental illnesses that are characterized by distorted 
perceptions of reality. The most common form of psychosis is Schizophrenia, with an 
approximate prevalence of one percent worldwide among people 18 years old or 
more  [59]. Schizophrenia is characterized by two main types of symptoms: positive 
symptoms such as delusions and hallucinations, and negative symptoms such as 
social withdrawal, lack of motivation, and overall apathy. While the causes of 
schizophrenia are not well understood, they are likely to involve a genetic 
predisposition and environmental factors during pre- and postnatal development. The 
importance of the environment is indeed illustrated by the fact that the concordance 
rate for schizophrenia in monozygotic twins is of only 50 percent [60]. But the 
question of how environmental factors influence the development of schizophrenia is 
still open.  
 
There is now increasing evidence that schizophrenia is associated with aberrant 
epigenetic profiling, and abnormal GABAergic neurotransmission in cortical areas 
[61]. The first line of evidence involves reelin, a glycoprotein expressed in GABAergic 
neurons during development and adulthood, and which contributes to neuronal 
migration [61, 62]. Post-mortem analyses in schizophrenic patients revealed that 
reelin mRNA and protein expression is significantly reduced in several brain regions, 
despite an overall normal number of neuronal cells [63, 64]. This reduction may be 
caused by an alteration of the methylation profile, possibly hypermethylation, at the 
reelin promoter since this promoter contains a large CpG island [49, 65]. Reelin 
expression is indeed sensitive to pharmacological manipulations of DNA methylation. 
In vivo, repeated methionine administration increases methylation of the reelin 
promoter, induces binding of MeCP2 to the reelin promoter, and downregulates 
reelin expression [66] [67]. Consistently, in vitro administration of the DNMT inhibitor, 
5-aza-2’-deoxycytidine, increases reelin expression [65].  
 
Further evidence for the involvement of DNA hypermethylation in GABAergic 
dysfunction observed in schizophrenic patients involves glutamate decarboxylase 
(GAD67), an enzyme that catalyzes the production of GABA. GAD67 mRNA and 
protein expression is downregulated in cortical structures of schizophrenic patients 
[63, 64], which correlates with increased methylation of the GAD67 promoter in 
prefrontal cortical samples from post-mortem brains of schizophrenic patients [68].  
 
In addition to the GABAergic system, increased methylation of the CpG island of an 
oligodendrocyte-specific transcription factor, sex-determining region Y-box containing 
gene 10 (SOX10), and decreased expression of SOX10  [69], was observed in the 
brains schizophrenic patients. This may provide a possible mechanism for the 
abnormalities in oligodendrocytes observed in schizophrenic patients.  
 
The mechanisms that underlie the abnormal hypermethylation of promoters such as 
reelin, GAD67, and SOX10 in the brain of schizophrenic patients are suggested to be 
caused by elevated levels of SAM, and increased expression of DNMT1 mRNA [70, 
71]. Indeed, the administration of SAM can induce psychotic episodes in some 
schizophrenic patients [72]. Due to the involvement of aberrant hypermethylation in 
schizophrenic patients, DNMT inhibitors have been suggested as potential 
therapeutic agents for this disease [4, 65, 73]. 
 
While in the GABAergic system and in oligodendrocytes, several instances of 
hypermethylation were observed in schizophrenic patients, hypomethylation was 
detected in the dopaminergic system. Increased activation of catechol-O-
methyltransferase (COMT), an enzyme involved in the degradation of 
neurotransmitters such as dopamine, epinephrine, and norepinephrine, is associated 
with impaired attention, executive cognition, and working memory, and with an 
increased risk to develop diseases such as schizophrenia [74]. Reduced methylation 
of the COMT promoter is detected in the frontal lobe of schizophrenic patients, and is 
associated with increased activation of the gene [75]. Moreover, aberrant methylation 
of genes within the dopaminergic system has also been observed in monozygotic 
twins. In one study, methylation upstream of the locus for dopamine D2 receptor was 
investigated in two sets of twins, one concordant and one discordant for 
schizophrenia. Of the discordant twins, the epigenetic profile of the affected twin was 
more similar to that in twins concordant for schizophrenia than to his own unaffected 
brother [76], confirming the implication of DNA methylation in schizophrenia.   
 
Finally, the brain of schizophrenic patients is also characterized by differential 
histone posttranslational modifications. Valproic acid (also known as valproate), a 
common mood stabilizer prescribed to treat schizophrenia, is a potent HDAC inhibitor 
[77]. Its administration not only decreases HDAC activity, but also increases reelin 
expression both in vitro and in vivo. Further, it decreases methylation of the reelin 
promoter [65, 66]. In vitro, other HDAC inhibitors such as trichostatin A or MS-275 
(for a review see [78, 79]) have also been demonstrated to activate the expression of 
reelin and GAD67 [80]. While the mechanism for the link between HDAC inhibition 
and altered DNA methylation is currently unknown, it is thought to operate via 
regulating the accessibility of DNMTs to promoter regions, or by direct induction of 
DNA demethylase activity [49, 80]. Valproate has further been demonstrated to 
reduce schizophrenia-like behaviours in a epigenetic mouse model of schizophrenia 
induced by methionine [81]. Additionally, two antipsychotic drugs acting as dopamine 
D2 receptor antagonists, haloperidol and raclopride, induce phospho-acetylation of 
H3 in mouse striatum [82]. Thus, it appears that decreased acetylation may be 
involved in the pathology of schizophrenia, which can be readily reversed by HDAC 
inhibitors. However, due to the non-specific effects of the antipsychotics described 
above, direct evidence for this hypothesis is still needed. 
 
5. Epigenetic dysregulation in stress - how early life events influence behavior in 
adulthood  
 
Increased stress vulnerability and other forms of pathological and inappropriate 
stress-coping behaviors are also common brain disorders. These disorders are 
complex and have intricate mechanisms, which are still poorly understood. It is 
recognized that they are strongly influenced by environmental factors, in particular by 
early life detrimental experiences (pre- and postnatal). These experiences are 
thought to induce lasting epigenetic modifications resulting in changes in gene 
expression in adult animals. In mammals, the quality of early life is primarily defined 
by maternal care and nutrition. In mice and rats, maternal care is provided by arched-
back nursing (AB) and licking/grooming (LG), two behavioral traits exhibited by most 
rodent species but which vary greatly between strains [83]. These traits critically 
influence the offspring’s behavior and determine their responsiveness to stress and 
their level of anxiety [84]. At the molecular level, such responsiveness is in part 
regulated by glucocorticoid and glucocorticoid receptors (GR). High levels of 
circulating glucocorticoids raise the body alertness and increase the stress response, 
while lower levels result in a more “relaxed” behavior and attenuate the stress 
response. Conversely, high levels of GR in forebrain areas such as the hippocampus 
provide a negative feedback that reduces the production of glucocorticoids and 
thereby dampens the stress response (reviewed in [85]). Offspring of high-LG-ABN 
mothers show increased GR expression and reduced reactivity to stress, whereas 
offspring of low-LG-ABN mothers have decreased GR expression and increased 
stress reactivity [86]. 
 
Stress reactivity and the GR system are subject to epigenetic modifications in early 
life. In the offspring of high LG-ABN females, DNA methylation is reduced and H3K9 
acetylation is increased in the promoter of the GR gene, a promoter that is in part, 
controlled by binding of the transcription factor NGFI-A (also known as Egr-1 or 
Zif268) [87]. In contrast, in the offspring of low LG-ABN females, promoter 
methylation was increased (but acetylation was not changed), suggesting that 
differential epigenetic marking underlies changes in GR expression. Recent evidence 
further indicates that NGFI-A itself conveys these epigenetic changes, because its 
binding to the GR promoter region is required for these changes to occur [88]. 
Importantly, although stable, these epigenetic changes can be reversed by 
environmental or pharmacological manipulations. Cross-fostering of pups, or 
treatment with the HDAC inhibitor trichostatin (TSA) lead to GR promoter DNA 
hypomethylation and histone hyperacetylation in low LG-ABN offspring [87]. 
Likewise, methyl supplementation via the administration of L-methionine, a SAM 
precursor, can reverse maternal programming of stress responses via glucocorticoid 
receptors [89]. Both treatments have further been shown to modulate the 
transcriptome in the hippocampus in both high and low LG-ABN offspring [90], which 
suggests that the type of maternal care not only influences DNA methylation and 
histone acetylation at the GR promoter, but also on other genes.  
 
Importantly, the implication of epigenetic regulation of GR was recently confirmed in 
a study involving post-mortem human brain samples [91]. In this study, the correlated 
decrease in hippocampal GR expression, and increase in DNA methylation in the GR 
promoter were found in suicide victims with a history of childhood abuse, but not in 
age-matched control subjects including suicide victims without such history and 
people having died from other causes. These findings strongly suggest that in 
rodents and humans alike, childhood neglect can cause lifelong epigenetic 
alterations of gene expression in the brain’s stress system. Remarkably, rat pups 
raised by mothers that display high nurturing levels become high nurturing mothers 
themselves, raising the intriguing possibility that this early-life induced behavioral trait 
can be transmitted to subsequent generations [92].  
 
 
 
Conclusions and outlook  
 
It is now clear that epigenetic mechanisms play a pivotal role in higher-order brain 
functions under both physiological and pathological conditions. A deeper 
understanding of these mechanisms is therefore of utmost importance for the 
development of potential treatments against brain disorders involving aberrant 
epigenetic modifications (for all brain disorders not described herein, the reader is 
referred to [4, 18, 35, 93]. Promising results have already been obtained, in particular 
with the use of HDAC inhibitors [94]. However, most of these inhibitors still act rather 
unspecifically, and further research is required before such treatments can be safely 
administered. It is therefore important to identify more specific HDAC inhibitors, but 
also to determine which HDACs are involved in different disease states. For 
instance, it was recently demonstrated that although HDAC1 and HDAC2, two 
structurally related members of the class I HDACs that often form functional 
heterodimers, it is only HDAC2 that is causally implicated in negatively regulating 
memory formation and synaptic plasticity [95].  
 
In addition to the best-understood instances of aberrant DNA methylation and 
posttranslational histone modifications in brain disorders, other forms of epigenetic 
regulation such as RNAi are likely to merit further attention in the future. Although so 
far, no example of naturally occurring RNAi-mediated epigenetic silencing of gene 
expression in the nervous system has been documented, this mechanism is quite 
common in yeast, where RNAi regulate the heterochromatin structure around 
centromeres [96], and in eukaryotic development, where RNAi is implicated in X-
chromosome inactivation [97]. Moreover, RNAi has proven an efficient means to 
artificially silence genes of interest, which has recently also been achieved in the 
mouse brain [98]. As a result, RNAi-mediated gene silencing has the potential to 
emerge as a powerful tool against various brain disorders [99], including the 
neurodevelopmental and neurodegenerative examples mentioned herein. 
 
In summary, although the importance of epigenetic programming in brain diseases is 
now fully appreciated, a more thorough understanding of epigenetic processes is still 
required until safe and efficient “epigenetic treatments” of these diseases can be 
envisaged.     
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Figure 1. The importance of posttranslational histone modifications in a rodent 
model of depression. (a) Under physiological conditions, i.e. in the absence of 
stress, the promoter region of the Bdnf gene is characterized by moderate levels 
of histone H3 acetylation and H3K27 dimethylation, and is bound by the histone 
deacetylase HDAC5. (b) Upon chronic social defeat stress, a rodent model of 
depression, H3K27 dimethylation is increased, leading to increased 
condensation of the Bdnf promoter, which shuts down Bdnf gene expression. (c) 
Upon chronic antidepressent (imipramine) treatment, HDAC5 levels are reduced, 
which leads to increased H3 acetylation, whereas H3K27 dimethylation remains 
unaffected. Nonetheless, the increase in H3 acetylation is sufficient to reinstate 
Bdnf gene expression. A, acetyl; Bdnf, brain-derived neurotrophic factor; HDAC, 
histone deacetylase; K, lysine; M, methyl. Figure reproduced, with permission, 
from [49].  
Table 1 
Epigenetic mechanisms in selected brain disorders 
       
 
Brain 
Disorder 
 
Pathological 
epigenetic 
modification 
 
Disrupted 
enzymatic 
machinery 
 
 
Gene(s) 
affected 
 
Organism studied 
 
Potential “epigenetic” 
intervention  
 
Reference(s)  
       
Rett 
Syndrome  DNA methylation   MeCP2  Bdnf  Young MeCP2 GOF transgenic mouse  Overexpression of MeCP2  [19, 21-23, 34]           Histone 
acetylation   MeCP2  Bdnf  MeCP2 LOF transgenic mice  none suggested  [25, 34] 
         Histone 
methylation: 
H3K9/H3K4  MeCP2  Bdnf  murine cell culture  none suggested  [25] 
       
Alzheimer’s 
Disease 
DNA 
methylation   not assessed  PS1  human cell culture  Methyl-donor SAM  [44] 
       
   not assessed  PS1  human post-mortem 
tissue  none suggested  [47] 
       
   DNMT1  APP  macaques  none suggested  [46] 
         Histone 
acetylation   not assessed  not assessed  p25/Cdk5 transgenic mouse  HDAC SIRT1  [40]              CBP  CREB-
target 
genes  human cell/ murine neuronal culture  Substitution of PS1-mediated enzymatic activity  [39]              Tip60  not 
assessed  human cell culture  none suggested  [38]           Histone 
acetylation   not assessed  not assessed  p25/Cdk5 transgenic mouse   HDACi sodium butyrate  [43]              CBP  not 
assessed  PS1 transgenic mouse   none suggested  [42]              CBP  c-fos, Bdnf  murine neuronal culture  none suggested  [41]             DNMT1  APP  macaques  none suggested  [46] 
       
Depression DNA 
methylation   DNMT3b  GABA-A α1  Depressed suicide victims  none suggested  [58] 
        
   MeCP2, MBD1  not 
assessed  rats  Chronic administration of antidepressant fluoxetine  [57]           Histone 
methylation:  
H3K9/K27   not assessed  various, e.g. Bdnf  Chronic social defeat stress mouse model  Chronic administration of antidepressant imipramine  [54, 55]           Histone 
acetylation   HDAC5  various, e.g. NK1R  Chronic social defeat stress mouse model  Chronic administration of antidepressant imipramine  [54, 56]         
Schizophrenia  DNA 
methylation   MeCP2  reelin  human post-mortem tissue  none suggested  [63, 64]         in vitro  5-aza  [65]                    mice and in vitro  HDACis valproic acid, TSA, 
MS-275  [65, 66, 80, 81]                 GAD67  human post-mortem 
tissue  none suggested  [68]                    in vitro  HDACis TSA,  
MS-275  [80]              not assessed  SOX10  human post-mortem 
tissue  none suggested  [69]           DNA 
methylation   not assessed  COMT  human post-mortem tissue  none suggested  [75] 
       
Predisposition 
to stress  DNA methylation / 
Histone 
acetylation  
not assessed  GR1  rats  TSA  [87] 
          DNA 
methylation   not assessed  GR1  human post-mortem tissue  none suggested  [91]                        
